var title_f3_11_3248="Esophageal squamous ca Lugols";
var content_f3_11_3248=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F71269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F71269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chromoendoscopy of esophageal squamous cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 307px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic view of the esophagus following staining with Lugol's iodine solution showing squamous cell carcinoma, which appears as an unstained plaque (arrow). The dark brown areas are normal squamous mucosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marcia I Canto, MD, MHS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3248=[""].join("\n");
var outline_f3_11_3248=null;
var title_f3_11_3249="Mefruside: International drug information";
var content_f3_11_3249=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Mefruside: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4304151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Baycaron (DE, GB, IE, NL, NO)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1979486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Diuretic, Miscellaneous",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1979489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of edema and hypertension",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1979485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: 25-50 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821121\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1979488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 25 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10413 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-71122602D8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3249=[""].join("\n");
var outline_f3_11_3249=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4304151\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979486\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979489\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979485\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821121\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1979488\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10413\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10413|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_11_3250="Patient information: Bullous pemphigoid (The Basics)";
var content_f3_11_3250=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/87300\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/7/5238\">",
"         Bullous pemphigoid",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/48/37637\">",
"          Bullous pemphigoid",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?4/60/5058\">",
"         Patient information: Blisters (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/30/483\">",
"         Patient information: Dealing with side effects from medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/43/37554\">",
"         Patient information: Medicine brand and generic names (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/57/37778\">",
"         Patient information: Steroid medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/34/32290\">",
"         Patient information: Taking medicines when you're older (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Bullous pemphigoid (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H587774541\">",
"      <span class=\"h1\">",
"       What is bullous pemphigoid?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Bullous pemphigoid is a skin condition that causes blisters. Blisters are fluid-filled bumps on the skin.",
"     </p>",
"     <p>",
"      Bullous pemphigoid is an autoimmune disease. An autoimmune disease is when the body&rsquo;s infection-fighting system attacks healthy tissue instead of infections. Sometimes, bullous pemphigoid happens after people take certain medicines.",
"     </p>",
"     <p>",
"      This condition happens most often in adults age 60 and older.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H587774556\">",
"      <span class=\"h1\">",
"       What are the symptoms of bullous pemphigoid?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most commonly, bullous pemphigoid causes large blisters to form on the skin (",
"      <a class=\"graphic graphic_picture graphicRef87308 \" href=\"UTD.htm?5/7/5238\">",
"       picture 1",
"      </a>",
"      ). Most blisters happen on the trunk, arms, legs, armpits, or groin, but blisters can happen all over the body. The blisters can come and go. After a blister pops, you might see an open sore. These sores usually heal without a scar.",
"     </p>",
"     <p>",
"      People with bullous pemphigoid also often have red, raised areas of skin. The red areas can be under the blisters or in other places (",
"      <a class=\"graphic graphic_picture graphicRef87309 \" href=\"UTD.htm?36/48/37637\">",
"       picture 2",
"      </a>",
"      ). Some people have only the red, raised areas of skin and no blisters. Itching is common.",
"     </p>",
"     <p>",
"      Some people with bullous pemphigoid also get sores in their mouth. These sores can hurt and can make it hard to eat.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H587774571\">",
"      <span class=\"h1\">",
"       Is there a test for bullous pemphigoid?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. To check whether your symptoms are caused by bullous pemphigoid, your doctor will do a test called a skin biopsy. He or she will remove small samples of tissue from a blister or from the red, raised areas of skin. Then another doctor will do tests on the samples and look at them under a microscope. Your doctor might also order special blood tests.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H587774586\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to manage my symptoms?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You should not",
"      <strong>",
"      </strong>",
"      pop your blisters unless your doctor tells you to. Also, you should follow your doctor&rsquo;s instructions about how to take care of your sores. That way, your skin is less likely to get infected.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H587774601\">",
"      <span class=\"h1\">",
"       How is bullous pemphigoid treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment usually includes 1 or more of the following:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Steroid creams or ointments &ndash; These steroids are not the same as the ones athletes take to build muscle. These medicines can reduce inflammation and itching and prevent new blisters from forming.",
"       </li>",
"       <li>",
"        Steroid pills &ndash; Steroid pills can also reduce blisters, inflammation, and itching. Since steroid pills can have side effects, it is important that you take them exactly as prescribed and see your doctor for regular follow-ups.",
"       </li>",
"       <li>",
"        Other medicines that &ldquo;calm down&rdquo; the immune system",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Treatment usually lasts 1 to 2 years or longer. Sometimes, symptoms return after treatment.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H587774616\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/60/5058?source=see_link\">",
"       Patient information: Blisters (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/57/37778?source=see_link\">",
"       Patient information: Steroid medicines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/483?source=see_link\">",
"       Patient information: Dealing with side effects from medicines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/43/37554?source=see_link\">",
"       Patient information: Medicine brand and generic names (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/34/32290?source=see_link\">",
"       Patient information: Taking medicines when you're older (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?3/11/3250?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 87300 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-4563C940AB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3250=[""].join("\n");
var outline_f3_11_3250=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H587774541\">",
"      What is bullous pemphigoid?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H587774556\">",
"      What are the symptoms of bullous pemphigoid?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H587774571\">",
"      Is there a test for bullous pemphigoid?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H587774586\">",
"      Is there anything I can do on my own to manage my symptoms?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H587774601\">",
"      How is bullous pemphigoid treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H587774616\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/87300\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/7/5238\">",
"      Bullous pemphigoid",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/48/37637\">",
"       Bullous pemphigoid",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/60/5058?source=related_link\">",
"      Patient information: Blisters (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/30/483?source=related_link\">",
"      Patient information: Dealing with side effects from medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/43/37554?source=related_link\">",
"      Patient information: Medicine brand and generic names (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/57/37778?source=related_link\">",
"      Patient information: Steroid medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/34/32290?source=related_link\">",
"      Patient information: Taking medicines when you're older (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_11_3251="Appendiceal orifice endoscopy";
var content_f3_11_3251=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F83339&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F83339&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Appendiceal orifice",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 374px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Appendiceal orifice seen during colonoscopy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3251=[""].join("\n");
var outline_f3_11_3251=null;
var title_f3_11_3252="Psoriasis";
var content_f3_11_3252=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Psoriasis (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?3/11/3252/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/11/3252/contributors\" id=\"au1600\">",
"       Steven R Feldman, MD, PhD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?3/11/3252/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/11/3252/contributors\" id=\"se7157\">",
"       Robert P Dellavalle, MD, PhD, MSPH",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?3/11/3252/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/11/3252/contributors\" id=\"de2840\">",
"       Abena O Ofori, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?3/11/3252?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      PSORIASIS OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Psoriasis is a chronic skin disorder that causes areas of thickened, inflamed, red skin, often covered with silvery scales. Children and adolescents can develop psoriasis, but it occurs primarily in adults. Women and men are equally affected.",
"    </p>",
"    <p>",
"     The severity of psoriasis is determined by how much of the body&rsquo;s surface is covered and how much it affects a person's quality of life. Psoriasis is not curable, although many treatments are available to reduce the bothersome symptoms and appearance of the disease.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      PSORIASIS CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     Researchers have not identified the exact cause of psoriasis. However, they believe that the disease develops due to a combination of immune, genetic, and environmental factors. There are some common triggers such as cold weather, medications, or stress, although many triggers of psoriasis are unique to an individual.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Immune system",
"     </span>",
"     &nbsp;&mdash;&nbsp;The skin is made up of three layers. The top layer is the epidermis, the middle layer is the dermis, and the inner layer is the subcutaneous layer (",
"     <a class=\"graphic graphic_figure graphicRef70895 \" href=\"UTD.htm?41/22/42339\">",
"      figure 1",
"     </a>",
"     ). In the epidermis, there are several layers of skin that are constantly being shed. To replace the lost cells, the body makes more epidermal cells.",
"    </p>",
"    <p>",
"     Psoriasis appears to be caused by the action of the immune system. Immune cells enter the skin through blood vessels and cause the top layer of skin, the epidermis, to grow too quickly and to stop shedding properly. This causes the scaly build-up seen on areas affected by psoriasis.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Genetics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Genetic factors play a role in determining whether someone develops psoriasis. About 40 percent of people with psoriasis or psoriatic arthritis (a type of arthritis closely related to psoriasis) have family members with the disorder (see",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/36/36419?source=see_link\">",
"      \"Patient information: Psoriatic arthritis (Beyond the Basics)\"",
"     </a>",
"     ). Several genes have been identified that make people more susceptible to psoriasis, but there is no genetic test that can definitely tell whether an individual will develop the disease.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Infections or medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Infections caused by bacteria and viruses can cause flares of psoriasis symptoms. Certain medications can worsen psoriasis symptoms, including beta blockers (eg, propranolol), lithium, and antimalarial drugs (eg, hydroxychloroquine, Plaquenil",
"     <sup>",
"      &reg;",
"     </sup>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Environment and behavior",
"     </span>",
"     &nbsp;&mdash;&nbsp;Environmental and behavioral factors also affect the risk of developing psoriasis. It is unclear if these factors actually cause psoriasis.",
"    </p>",
"    <p>",
"     Physical or psychological stress may trigger the development of psoriasis in people with a genetic risk of the disease. Psoriasis has been associated with obesity and an increased risk of heart disease. Smoking appears to increase the risk and severity of psoriasis, particularly for psoriasis of the palms and soles.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      PSORIASIS SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Symptoms of psoriasis include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Areas of skin that are dry or red, usually covered with silvery-white scales, and sometimes with raised edges",
"      </li>",
"      <li>",
"       Rashes on the scalp, genitals, or in the skin folds",
"      </li>",
"      <li>",
"       Itching and skin pain",
"      </li>",
"      <li>",
"       Joint pain or aching",
"      </li>",
"      <li>",
"       Nail abnormalities, such as pitted, discolored, or crumbly nails",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      TYPES OF PSORIASIS",
"     </span>",
"    </p>",
"    <p>",
"     There are several common types of psoriasis:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Plaque psoriasis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Plaque psoriasis tends to affect young and middle aged adults, but can occur at any age. The skin plaques (which can range from 0.4 to 4 inches (1 to 10 cm) or more) usually spread evenly across a person's scalp, elbows, knees, and back (",
"     <a class=\"graphic graphic_picture graphicRef74211 \" href=\"UTD.htm?38/13/39135\">",
"      picture 1",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Guttate psoriasis",
"     </span>",
"     &nbsp;&mdash;&nbsp;This type of psoriasis is sometimes linked to a recent streptococcal infection, usually pharyngitis (eg, strep throat). It often affects children or young adults with no past history of psoriasis, and causes a sudden eruption of small plaques on the trunk of the body.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Pustular psoriasis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pustular psoriasis can be a severe, and occasionally life-threatening, form of psoriasis. It develops quickly, with multiple small pustules that may join into larger areas (",
"     <a class=\"graphic graphic_picture graphicRef75984 \" href=\"UTD.htm?11/56/12174\">",
"      picture 2",
"     </a>",
"     ). Symptoms can include fever and abnormal blood levels of white blood cells and calcium. Pustular psoriasis can also cause pus-filled blisters on the palms of the hands and soles of the feet. These blisters can crack, causing painful breaks in the skin.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Inverse psoriasis",
"     </span>",
"     &nbsp;&mdash;&nbsp;This type of psoriasis affects less visible body areas, such as the groin, armpits, buttocks, genitals, and the area under the breasts (",
"     <a class=\"graphic graphic_picture graphicRef65454 \" href=\"UTD.htm?41/15/42237\">",
"      picture 3",
"     </a>",
"     ). Sometimes this is mistakenly diagnosed as a fungal or bacterial infection.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Nail psoriasis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some people with psoriasis develop nail problems, including tiny pits over the surface of the nails. The pits look as if someone has taken a pin and pricked the nail several times. Their nails may change to a tan-brown color and they may separate from the nail bed, a condition known as onycholysis (",
"     <a class=\"graphic graphic_picture graphicRef71998 \" href=\"UTD.htm?13/35/13886\">",
"      picture 4",
"     </a>",
"     ). In more severe cases, people have thick, crumbling nails.",
"    </p>",
"    <p>",
"     Treatment of nail psoriasis is difficult, and may include injections of steroids into the nail bed, or oral medications such as methotrexate, cyclosporine, or immunomodulatory drugs. (See",
"     <a class=\"local\" href=\"#H18\">",
"      'Psoriasis treatment'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Psoriatic arthritis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Up to one-third of people with psoriasis also have psoriatic arthritis, a condition that causes joint pain and swelling. Skin signs usually develop first, although about 15 percent of patients develop arthritis (joint swelling and stiffness) before symptoms of psoriasis. People with psoriatic arthritis often have severe nail problems. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/36/36419?source=see_link\">",
"      \"Patient information: Psoriatic arthritis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      HIV-associated psoriasis",
"     </span>",
"     &nbsp;&mdash;&nbsp;In addition to the specific types of psoriasis listed above, psoriasis may develop in people infected with the human immunodeficiency virus (HIV). Symptoms include sores on the palms of the hands and the soles of the feet, nail problems, joint pain, and swollen, red sores all over the body. However, most people with psoriasis do not have HIV infection.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      PSORIASIS DISEASE COURSE",
"     </span>",
"    </p>",
"    <p>",
"     Psoriasis is a lifelong condition that is not currently curable, although the severity of the disease can improve or worsen over time. About 25 percent of people have periods when their symptoms go away, called remission periods.",
"    </p>",
"    <p>",
"     However, in people with certain forms of the disease, itching or pain and stiffness is severe and disabling. Many people with visible psoriasis lesions are embarrassed by their appearance, and suffer with stress, anxiety, loneliness, and low self-esteem as a result.",
"    </p>",
"    <p>",
"     People with psoriasis have higher rates of depression compared to those without the condition. Patients often benefit from working with a psychologist, clinical social worker, or other therapist to discuss their illness and possible ways to cope. A number of organizations, such as the National Psoriasis Foundation, are available to provide support to patients with psoriasis and their families (see",
"     <a class=\"local\" href=\"#H33\">",
"      'Where to get more information'",
"     </a>",
"     below).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      PSORIASIS DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     Psoriasis can be diagnosed by examining the skin. Rarely, a skin biopsy or scraping may be taken to rule out other disorders. There is no blood test that can definitively diagnose psoriasis.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      PSORIASIS TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     Psoriasis is not curable but many treatments are available that can reduce the bothersome symptoms and appearance of the disease. Treatment depends upon the severity of the disease, the cost and convenience of the treatment, and a person's response to the treatment. A combination of therapies is often recommended.",
"    </p>",
"    <p>",
"     Referral to a dermatologist (a doctor who specializes in skin conditions) may be needed if the diagnosis of psoriasis is uncertain, if the initial treatment does not improve symptoms, or if the disease is widespread or severe. People with psoriatic arthritis may need to see a rheumatologist (a doctor who specializes in joint conditions).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Medicines applied to the skin",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h3\">",
"      Emollients",
"     </span>",
"     &nbsp;&mdash;&nbsp;Keeping skin soft and moist can minimizes itching and tenderness. Topical emollients (or creams) such as petroleum jelly or thick creams may be recommended; these should be applied immediately after bathing or showering.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h3\">",
"      Topical corticosteroids",
"     </span>",
"     &nbsp;&mdash;&nbsp;Corticosteroids (sometimes called &ldquo;steroids&rdquo; but distinct from body building steroids) that are applied to the skin help to reduce inflammation. These cortisone-type creams and ointments are available in a variety of strengths (potencies); the least potent are available without a prescription (eg, hydrocortisone 1% cream). More potent formulations require a prescription.",
"    </p>",
"    <p>",
"     Applying hydrocortisone cream or another corticosteroid directly to the skin (usually twice daily) can decrease the inflammation and development of new skin patches, although complete and long-lasting relief is hard to predict. Clear liquid, foam or spray forms may be easier to apply, particularly to the scalp.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H22\">",
"     <span class=\"h3\">",
"      Calcipotriene or calcitriol",
"     </span>",
"     &nbsp;&mdash;&nbsp;Calcipotriene (Dovonex",
"     <sup>",
"      &reg;",
"     </sup>",
"     ) and calcitriol (Vectical",
"     <sup>",
"      &reg;",
"     </sup>",
"     ) work by slowing the growth of skin cells in the epidermis. These medicines can be used instead of or in addition to topical corticosteroids. They are usually applied twice a day when used alone. The side effects are usually minimal, with skin irritation being the most common problem.",
"    </p>",
"    <p>",
"     Another preparation, Taclonex",
"     <sup>",
"      &reg;",
"     </sup>",
"     , combines calcipotriene with a corticosteroid (betamethasone) in a once daily treatment. &nbsp;Although Taclonex",
"     <sup>",
"      &reg;",
"     </sup>",
"     is effective, it is quite expensive.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h3\">",
"      Tar",
"     </span>",
"     &nbsp;&mdash;&nbsp;Tar is a substance distilled from coal that has been used to treat psoriasis for many years. It is not completely clear how tar works, although it appears to reduce the overproduction of skin cells that leads to psoriasis. Tar preparations are available in shampoos, creams, oils, and lotions without a prescription, and are usually applied to the skin or scalp once or twice a day. Tar products do not cause serious side effects, although they can stain skin, hair, and clothing. Tar products are often used along with corticosteroids.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h3\">",
"      Tazarotene",
"     </span>",
"     &nbsp;&mdash;&nbsp;Tazarotene (Tazorac",
"     <sup>",
"      &reg;",
"     </sup>",
"     ) is a skin treatment derived from vitamin A that is available in a cream or gel. It is usually applied once per day, in the evening. It may also be applied for 20 minutes and then washed off if skin irritation develops. Improvement should be seen within two months of treatment.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H25\">",
"     <span class=\"h3\">",
"      Calcineurin inhibitors",
"     </span>",
"     &nbsp;&mdash;&nbsp;Topical calcineurin inhibitors, including tacrolimus (Protopic",
"     <sup>",
"      &reg;",
"     </sup>",
"     ) and pimecrolimus (Elidel",
"     <sup>",
"      &reg;",
"     </sup>",
"     ) creams, can be used to treat psoriasis, especially on the face and is skin folds, such as in the armpits or under the breasts.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H26\">",
"     <span class=\"h2\">",
"      Ultraviolet light",
"     </span>",
"     &nbsp;&mdash;&nbsp;Exposure to ultraviolet light is another way to treat psoriasis. During the summer months, people with psoriasis often notice that their symptoms improve. Ultraviolet light treatment (from a dermatologist) may be recommended to treat psoriasis. However, it is important to discuss the potential risks and benefits of ultraviolet light therapy before beginning treatment.",
"    </p>",
"    <p>",
"     Before receiving ultraviolet light therapy, you may be asked to bathe and gently scrub areas affected by psoriasis, and then apply mineral oil to these areas; the oil allows the light to penetrate the skin more easily.",
"    </p>",
"    <p>",
"     Although ultraviolet light therapy is effective for treating psoriasis, office treatment can be inconvenient and expensive, despite insurance coverage. Some dermatologists may recommend brief sun exposure or home light treatment as alternatives to office treatment.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27\">",
"     <span class=\"h3\">",
"      Risks",
"     </span>",
"     &nbsp;&mdash;&nbsp;Long term ultraviolet light therapy may increase risk for skin cancer. UV light therapy is not recommended for people with a history of melanoma or other skin cancers. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/6/28772?source=see_link\">",
"      \"Patient information: Melanoma treatment; localized melanoma (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Some clinicians also use lasers to treat psoriasis. The laser allows higher doses of UVB radiation to be directed to skin areas affected by lesions; as a result, skin may heal more quickly than with traditional ultraviolet light therapy. Laser treatment is most suitable for people who have small areas of psoriasis.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H28\">",
"     <span class=\"h2\">",
"      Oral medications",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H29\">",
"     <span class=\"h3\">",
"      Methotrexate",
"     </span>",
"     &nbsp;&mdash;&nbsp;Methotrexate treats psoriasis by suppressing the immune response that triggers the disease. This drug is often used to treat moderate to severe psoriasis",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     psoriatic arthritis. It is usually taken once per week, and it may be taken in oral (pill) form or as an injection.",
"    </p>",
"    <p>",
"     Methotrexate can be used for long-term treatment of psoriasis, although it is important to have your liver monitored during treatment; methotrexate can affect liver function in some people. Improvement may not be seen until three months of methotrexate treatment are completed.",
"    </p>",
"    <p>",
"     While taking methotrexate, many providers recommend taking folic acid 1 mg daily or folinic acid 5 mg weekly to reduce the risk of certain methotrexate side effects, such as upset stomach and a sore mouth.",
"    </p>",
"    <p>",
"     Severe side effects can occur with methotrexate, including damage to the lungs, liver and bone marrow, so careful monitoring is essential. Serious interactions may occur with certain medications, particularly sulfa-type antibiotics.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H30\">",
"     <span class=\"h3\">",
"      Retinoids",
"     </span>",
"     &nbsp;&mdash;&nbsp;Retinoids are derived from vitamin A. An oral form (acitretin, Soriatane",
"     <sup>",
"      &reg;",
"     </sup>",
"     ) may be recommended to people with severe forms of psoriasis. Improvement may be noticeable within one month, although the full effect of retinoids may take up to 3 to 6 months.",
"    </p>",
"    <p>",
"     Side effects of retinoids include cracking and drying of the lips and hair loss. Acitretin may cause increased levels of triglycerides and liver enzymes in the blood; blood testing is usually recommended to monitor for these changes. Acitretin can cause severe birth defects and is only slowly removed from the body, so this medication usually is not used in women of child-bearing potential.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H31\">",
"     <span class=\"h3\">",
"      Other immunosuppressive drugs",
"     </span>",
"     &nbsp;&mdash;&nbsp;Several medications that suppress the immune system can be used to treat severe psoriasis for a short period of time. These include cyclosporine, hydroxyurea, and azathioprine.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H32\">",
"     <span class=\"h2\">",
"      Injectable medications",
"     </span>",
"     &nbsp;&mdash;&nbsp;Several injectable medications, known as \"biologics\", target the immune system and may be beneficial in the treatment of psoriasis. Medications include etanercept (Enbrel",
"     <sup>",
"      &reg;",
"     </sup>",
"     ), alefacept (Amevive",
"     <sup>",
"      &reg;",
"     </sup>",
"     ), infliximab (Remicade",
"     <sup>",
"      &reg;",
"     </sup>",
"     ), adalimumab (Humira",
"     <sup>",
"      &reg;",
"     </sup>",
"     ), and ustekinumab (Stelara",
"     <sup>",
"      &reg;",
"     </sup>",
"     ).",
"    </p>",
"    <p>",
"     These medications can cost several thousand dollars per week, may affect immune function, and are generally reserved for people with moderate to severe psoriasis that has not responded to other treatments. Improvement in skin symptoms usually begins within a few weeks of starting treatment.",
"    </p>",
"    <p>",
"     Etanercept, alefacept, and adalimumab are injected into the skin or muscle by the patient, a family member, or nurse. Ustekinumab injections should be given only by trained healthcare providers. Infliximab must be given into a vein over two to three hours, typically in a doctor's office or clinic.",
"    </p>",
"    <p>",
"     Biologics, like methotrexate and cyclosporine, affect the immune system and should not be used in people with serious infections. Screening for tuberculosis is necessary before starting therapy since the risk of developing active TB infection is increased. If there is evidence of prior infection with tuberculosis, treatment to prevent reactivation is recommended. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39475?source=see_link\">",
"      \"Patient information: Tuberculosis (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     There may be an increased risk of lymphoma in people who take biologics and other drugs that affect the immune system; more research is needed to define this risk. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/19/3384?source=see_link\">",
"      \"Overview of biologic agents in the rheumatic diseases\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H33\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804440434\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H292594335\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/9/3218?source=see_link\">",
"      Patient information: Psoriasis (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/52/835?source=see_link\">",
"      Patient information: Psoriatic arthritis in adults (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/6/7267?source=see_link\">",
"      Patient information: Psoriatic arthritis in children (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H292594352\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/36/36419?source=see_link\">",
"      Patient information: Psoriatic arthritis (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/6/28772?source=see_link\">",
"      Patient information: Melanoma treatment; localized melanoma (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39475?source=see_link\">",
"      Patient information: Tuberculosis (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H34\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/28/37318?source=see_link\">",
"      Approach to the patient with a scalp eruption",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/48/15110?source=see_link\">",
"      Approach to the patient with anal pruritus",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28423?source=see_link\">",
"      Approach to the patient with pustular skin lesions",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30488?source=see_link\">",
"      Clinical manifestations and diagnosis of psoriatic arthritis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=see_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/4/41030?source=see_link\">",
"      Management of psoriasis in pregnant women",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23608?source=see_link\">",
"      Pathogenesis of psoriatic arthritis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40042?source=see_link\">",
"      Treatment of psoriasis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/18/40234?source=see_link\">",
"      Treatment of psoriatic arthritis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/19/3384?source=see_link\">",
"      Overview of biologic agents in the rheumatic diseases",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute on Arthritis and Musculoskeletal and Skin Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nih.gov/niams/healthinfo/\">",
"      www.nih.gov/niams/healthinfo/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Dermatology",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.skincarephysicians.com/psoriasisnet/whatis.html\">",
"      www.skincarephysicians.com/psoriasisnet/whatis.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Academy of Allergy, Asthma and Immunology",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.aaaai.org/home.aspx\">",
"      www.aaaai.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Psoriasis Foundation",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;1-800-723-9166",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.psoriasis.org/home/\">",
"      www.psoriasis.org/home/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?3/11/3252/abstract/1-5\">",
"      1-5",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 16, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?3/11/3252?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3252/abstract/1\">",
"      Strober BE, Siu K, Menon K. Conventional systemic agents for psoriasis. A systematic review. J Rheumatol 2006; 33:1442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3252/abstract/2\">",
"      Lebwohl M. Psoriasis. Lancet 2003; 361:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3252/abstract/3\">",
"      Sch&ouml;n, M, Boehncke, W-H. Psoriasis. New England Journal of Medicine 2005; 352:1899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3252/abstract/4\">",
"      Heydendael VM, Spuls PI, Opmeer BC, et al. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 2003; 349:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3252/abstract/5\">",
"      Leonardi CL, Powers JL, Matheson RT, et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003; 349:2014.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f3_11_3252=[""].join("\n");
var outline_f3_11_3252=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           PSORIASIS OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           PSORIASIS CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           PSORIASIS SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           TYPES OF PSORIASIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           PSORIASIS DISEASE COURSE",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           PSORIASIS DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           PSORIASIS TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H33\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/22/42339\" title=\"figure 1\">",
"           Skin anatomy PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/13/39135\" title=\"picture 1\">",
"           Plaque type psoriasis PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/56/12174\" title=\"picture 2\">",
"           Pustular psoriasis PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/15/42237\" title=\"picture 3\">",
"           Inverse psoriasis PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/35/13886\" title=\"picture 4\">",
"           Nail psoriasis PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f3_11_3253="Dicloxacillin: Drug information";
var content_f3_11_3253=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Dicloxacillin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?2/14/2276?source=see_link\">",
"    see \"Dicloxacillin: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/61/17363?source=see_link\">",
"    see \"Dicloxacillin: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F159525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Penicillin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F159496\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Susceptible infections:",
"     </b>",
"     Oral: 125-500 mg every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Erysipelas, furunculosis, mastitis, otitis externa, septic bursitis, skin abscess:",
"     </b>",
"     Oral: 500 mg every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Impetigo:",
"     </b>",
"     Oral: 250 mg every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prosthetic joint infection: Chronic suppression therapy: Staphylococci (oxacillin-susceptible) (unlabeled regimen):",
"     </b>",
"     Oral: 500 mg every 6-8 hours (Osmon, 2013)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Staphylococcus aureus,",
"      </i>",
"     </b>",
"     <b>",
"      methicillin susceptible infection if no I.V. access:",
"     </b>",
"     Oral: 500-1000 mg every 6-8 hours",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F159512\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/61/17363?source=see_link\">",
"      see \"Dicloxacillin: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use in newborns is not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Susceptible infections:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Children &lt;40 kg:",
"     </i>",
"     12.5-25 mg/kg/day divided every 6 hours; doses of 50-100 mg/kg/day in divided doses every 6 hours have been used for therapy of osteomyelitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Children &gt;40 kg:",
"     </i>",
"     125-250 mg every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Furunculosis:",
"     </b>",
"     Oral: 25-50 mg/kg/day divided every 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Osteomyelitis:",
"     </b>",
"     Oral: 50-100 mg/kg/day in divided doses every 6 hours",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F159497\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F159498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     No specific adjustment provided in manufacturer&rsquo;s labeling; a reduction in total dosage should be considered in renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Not dialyzable (0% to 5%); supplemental dose is not necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Peritoneal dialysis effects: Supplemental dose is not necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Continuous arteriovenous or venovenous hemofiltration: Supplemental dose is not necessary.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15826359\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F159474\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 250 mg, 500 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F159459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F803125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer 1 hour before or 2 hours after meals. Administer around-the-clock to promote less variation in peak and trough serum levels.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F159475\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of systemic infections such as pneumonia, skin and soft tissue infections, and osteomyelitis caused by penicillinase-producing staphylococci",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F159523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%: Gastrointestinal: Nausea, diarrhea, abdominal pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Agranulocytosis, eosinophilia, hemolytic anemia, hepatotoxicity, hypersensitivity, interstitial nephritis, leukopenia, neutropenia, prolonged PT, pseudomembranous colitis, rash (maculopapular to exfoliative), seizure with extremely high doses and/or renal failure, serum sickness-like reactions, thrombocytopenia, vaginitis, vomiting",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F159478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to dicloxacillin, penicillin, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F159463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactoid/hypersensitivity reactions: Serious and occasionally severe or fatal hypersensitivity (anaphylactoid) reactions have been reported in patients on penicillin therapy, especially with a history of beta-lactam hypersensitivity, history of sensitivity to multiple allergens, or previous IgE-mediated reactions (eg, anaphylaxis, angioedema, urticaria). Use with caution in asthmatic patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea and pseudomembranous colitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Warfarin: Monitor PT if patient is concurrently on warfarin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neonates: Use with caution in neonates; elimination of drug is slow.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F159519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Induces",
"     </b>",
"     CYP3A4 (weak/moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F159468\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inducers may decrease the serum concentration of ARIPiprazole.  Management: Double the oral aripiprazole dose and closely monitor clinical response.  Reduce the oral aripiprazole dose to 10-15 mg/day if the inducer is discontinued. Avoid use of CYP3A4 inducers for more than 14 days with extended-release injectable aripiprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Axitinib: CYP3A4 Inducers (Weakly to Moderately Effective) may decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fusidic Acid: May diminish the therapeutic effect of Penicillins.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Penicillins may increase the serum concentration of Methotrexate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Penicillins may decrease serum concentrations of the active metabolite(s) of Mycophenolate. This effect appears to be the result of impaired enterohepatic recirculation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Penicillins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: May diminish the therapeutic effect of Penicillins.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Dicloxacillin may diminish the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Penicillins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F159488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: Food decreases drug absorption rate and serum concentration. Management: Administer around-the-clock on an empty stomach with a large glass of water 1 hour before or 2 hours after meals.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F159470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5720683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have not been observed in animal studies; therefore, dicloxacillin is classified as pregnancy category B.  Dicloxacillin crosses the placenta. Teratogenic effects have not been reported with dicloxacillin, but adequate and well-controlled studies of dicloxacillin have not been completed in pregnant women. Other penicillins are considered safe for use in pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F159502\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F159480\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if dicloxacillin crosses into human milk.  The manufacturer recommends that caution be exercised when administering dicloxacillin to nursing women. Other penicillins distribute into human milk and are considered safe for use during breast-feeding. Nondose-related effects could include modification of bowel flora.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F159481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer on an empty stomach 1 hour before or 2 hours after meals. Some products may contain sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F3422221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Dicloxacillin Sodium Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (100): $66.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (100): $120.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F159472\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor prothrombin time if patient concurrently on warfarin; monitor for signs of anaphylaxis during first dose",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F159482\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Brispen (MX);",
"     </li>",
"     <li>",
"      Dacocilin (TW);",
"     </li>",
"     <li>",
"      Damacir (CO);",
"     </li>",
"     <li>",
"      Diamsalina (MX);",
"     </li>",
"     <li>",
"      Diclex (TH);",
"     </li>",
"     <li>",
"      Diclo (IT);",
"     </li>",
"     <li>",
"      Diclocil (AU, DK, EC, FI, GR, NO, PT, SE, VE);",
"     </li>",
"     <li>",
"      Dicloxane (TH);",
"     </li>",
"     <li>",
"      Dicloxane-F (TH);",
"     </li>",
"     <li>",
"      Dicloxapen (PY);",
"     </li>",
"     <li>",
"      Dicloxno (TH);",
"     </li>",
"     <li>",
"      Dicloxsig (AU);",
"     </li>",
"     <li>",
"      Diloxin (TH);",
"     </li>",
"     <li>",
"      Distaph (AU);",
"     </li>",
"     <li>",
"      Ditterolina (MX);",
"     </li>",
"     <li>",
"      Dyclobiot (PE);",
"     </li>",
"     <li>",
"      Odicoza (HK);",
"     </li>",
"     <li>",
"      Posipen (MX, PE);",
"     </li>",
"     <li>",
"      Uniclox (CO);",
"     </li>",
"     <li>",
"      Ziefmycin (TW)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F159462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F159477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: 35% to 76%; rate and extent reduced by food",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Throughout body with highest concentrations in kidney and liver; CSF penetration is low",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 96%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 0.6-0.8 hour; slightly prolonged with renal impairment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 0.5-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Feces; urine (56% to 70% as unchanged drug); prolonged in neonates",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Donowitz GR and Mandell GL, &ldquo;Beta-Lactam Antibiotics,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1988, 318(7):419-26 and 318(8):490-500.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/11/3253/abstract-text/3277054/pubmed\" id=\"3277054\" target=\"_blank\">",
"        3277054",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lipsky BA, Berendt AR, Cornia PB, et al, \"2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012, 54(12):e132-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/11/3253/abstract-text/22619242/pubmed\" id=\"22619242\" target=\"_blank\">",
"        22619242",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Osmon DR, Berbari EF, Berendt AR, et al, &ldquo;Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guideline by the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2013, 56(1):e1-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/11/3253/abstract-text/23223583/pubmed\" id=\"23223583\" target=\"_blank\">",
"        23223583",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pacifici GM, Viani A, Taddeucci-Brunelli G, et al, &ldquo;Plasma Protein Binding of Dicloxacillin: Effects of Age and Diseases,&rdquo;",
"      <i>",
"       Int J Clin Pharmacol Ther Toxicol",
"      </i>",
"      , 1987, 25(11):622-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/11/3253/abstract-text/3429065/pubmed\" id=\"3429065\" target=\"_blank\">",
"        3429065",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wright AJ, &ldquo;The Penicillins,&rdquo;",
"      <i>",
"       Mayo Clin Proc",
"      </i>",
"      , 1999, 74(3):290-307.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/11/3253/abstract-text/10090000/pubmed\" id=\"10090000\" target=\"_blank\">",
"        10090000",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9349 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.77.166.39-9D3D6B0F7E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3253=[""].join("\n");
var outline_f3_11_3253=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159525\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159496\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159512\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159497\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159498\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15826359\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159474\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159459\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F803125\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159475\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159523\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159478\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159463\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159519\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159468\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159488\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159470\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5720683\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159502\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159480\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159481\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3422221\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159472\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159482\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159462\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159477\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9349\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9349|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?2/14/2276?source=related_link\">",
"      Dicloxacillin: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/61/17363?source=related_link\">",
"      Dicloxacillin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_11_3254="X-ray and MRI lunate fracture";
var content_f3_11_3254=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83517&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83517&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 603px\">",
"   <div class=\"ttl\">",
"    X-ray and MRI lunate fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 583px; height: 481px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHhAkcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6K8YeJ4vDFtYSS2F9qEt7c/ZYYLPy95bypJSSZHRQAsTd/SuGuPjdptvcy283hfxMk0Rw6lbTIP8A4EVufFOaO3u/Bck2PLGtMDk4xmxux/WvOfiT4cZm/tGyDGWPrg5DrQB1S/G7TG6eGfEn5Wn/AMkU7/hdenEZHhjxIR9LP/5Irxe2lDoCp4x+dXEcH5sjGTg9vpQB67/wunTyMjwx4k/8k/8A5IoHxq04njwv4kz9LP8A+SK8mUgHIBBAxwcfrSljvKsFHGSemc9OaAPV2+NmmgAnwx4kwe4Fmf8A24qez+MFpeMy2/hXxG5U4IzZDH53NePsRnA5OOcf/Wq34fufI1MD+GQBfr/nmgD2aD4jyTgGLwd4kYE4H7ywH/tzUv8Awn9zv2/8IX4kDehlsB/7dViaE+4FAQQe59f8/wBK1bwmKffHuUMeWz/nj3oAnm8fXUH+t8FeJV4zzJYdP/AqsF/jXpyStG3hfxKHVipG20yD6f8AHxWxJJHcWgYHDgYYDtz19wa8n8a2RtNV89R8k3ynjuPX/PagD0AfGvTiMjwv4l/K0/8Akimn43aYASfDPiTA9rP/AOSK8mV8qOcnBqK46kHnrgn9KAPYYfjVp8wzH4X8SkZx0sx/7cVrwfEaW4txPF4N8SNEejeZYD/25rxLR8mHBA+ZyORjuK9hslMOioeQwhyaAJbf4oi4uDBF4Q8SmUZ4LWQ6deTc03UviommwPNe+EfEsUaDLNusjj8rmuM0aQw6ssr4x5nOecc1r+OoDJpd0CPupuHfnPb8KAFX4/aEwUjw74lIPT5LX/4/Th8e9EK7h4d8SYxn7tp/8kV8/jMasN3Qntnmp4m3J8w6Z780AfQFn8cdKvJvKtvDPiWSTGcBbQfzuK0p/ipHAqtL4R8SKGGR81lz/wCTNeO/D+08u5lu5yU3qETPB9TXTa1MZfLDAqAgySOmTmgDuE+LUEkPmp4S8SmP1Bsv/kmmTfF+1h3eb4V8SLtGTk2XA/8AAmuX0iNZtPCKmQAQQOw9a5XxDcBHuFZ8nGBj0FAHfN8fdDXOfD3iTjg/Ja//AB+tG2+Mllcx+ZB4W8SsmM5/0MfzuK+f9Ms2vLhZJPubt3TrXah0ttPZV5HUH9D/AFoA9JPxmsA20+F/Em70/wBD/wDkinR/GOykk8tPCviUv0x/of8A8kV5MrEvyOp9OSfpWhpyhWyzYYHaOeDzn+lAHomofGzTdPjZ7zwz4kjRep/0M/yuKzP+GiPDhwBoHiXJ6fu7b/4/XlHxFuP3McQzhn7j864NsqDnpnBz60AfSR/aK8NjroPiX8Irb/4/Tf8Aho3wz/0AvEn/AH6tv/j9fNbn5toHb8/84qCUnbkj34PSgD7O+GnxL0n4hS6nHpNlqVo+niJpRepGu4Sb9u3Y7f8APNs5x2rua+b/ANkP/kJeMxxxFYd897mvpCgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPMvjq/l2XhN+eNa7f9eV1WVo+opd2ws7hlA4EZPY+h9K0/jyN2neFRjOdZP/pFdV5xaTtAQpP4/T0NAFTxpoL6Tey3dtn7MzkSIB/qz6j29awhICd2evYd/wDGvVba7i1W0NvdbGkwVVjyG46H/E1534n0GbRppZIFZrMnLAnJTP8ASgCsjnKjpj5QSc5p2dpxxwOMgH8KpRSgqGOGXGdw5yKl3YJG5WJ5wBQBZDApjceDkj/69R+YUk3qQGQhl7d6QkZ25zjsBUbsp6EFepxzmgD1bw3crKkThtyuAxb/APX1rqNUQ7UEYLZXZ15/D0NebeArovAYWPzI5Xp2r028GdPRyC/y4yO57Ef57UAZFncCO5II+RwepwCQOvt0rH8Y6ct9pztGPnxkMByD2ps1w8cwYsdzPjIGcelalpeRS2n7wnynJQhuqn0z29qAPIFIZBl2GMjjrxxRM2VbnHfk9q1vFunPpWtOOsE5LocYw3f6+tY0j7uSeTwf/rUAafhyHzZ0R/lXzCcEZ9yK9g1JvsmkYAIGwRkdhnpn2rzP4f25lu1YliobGBjnn9K9B8T3EMaxRfMXT5guflGO/wCdAHHD5JDhtzEnkDn8K63VF+26WHcbiYwrEdu3865RbpGlEs0a4yBge/Ga7K1VP7OBDAq4IA6AAds+vagD581iA2uoTKygHJ4x3FM0yESTH5SYgu566bx/Yn7e1zGoUhtxXGPY8VjaGi+UrHHzHkeoHtQB2Wgnyo4l2rvdccg49/wq5rQKq2/HJyGHOR7D0x/KqWmT7cEx/MBv3fd68A/ngCoNRvI5JI9pMSxL5a4XOGHfH50AdV4WmQ29xFuw5UAAnt2x61554yDrqrxAfPORGNoxkVrafqElkxmikVZF24GOOvGfrV6+s4dWKao67bnJIiJ5z647CgDnrO3ESOwBVj8oCk4/3RVm8m+XytucEEsOpJGMD2qxDb7EztPGSwz0JPA/rWdNKEkeNf3h3HcQCo49D3NACwsO5IJyc+/oP8a6GxKRwxOww+N3tkjsa5q1YAqwyB8wCnnt0/xrYExWPLZOzauTxux349jQBxfjyQNe28eePmOO31rlXOBlRjHTA5re8Zuza4ctyqZBx6mudbgkHrzgA9qAI2YHjp6jp+VQyseeAMdsdqkd8LuHPvVaRgAATn8aAPff2QP+P/xl/wBcrD+dzX0lXzV+x4c3/jQn/nnY/wA7mvpWgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPNPjipe08KALuxrJJHsLK7J/SvM71dpWRGXBG7f/AENelfHTUoNItPCF5dsEhTXArMeg3Wl0o/VhXDa/aJDieEiS1n5Uk4w3px3+vpQBlW968Ui5Yk9Dnn/9ZrpLbVLe7gMN6AwxjzeuO3I+lcNIwCsUK4B5yefxqS2uWifIUZHPHYf570AW9e8JNA73OksJEJ3GNc4/D0NcwXaOQxTK6OOqkYIFdtbahLAcKx4G5FznI7fX2qC9az1GILd2wk5OXQ7WHrigDlkmHY+445pzOeQNowex4/Sp7zQ5YgXsbgzx9w67Wx6ZrLeWRX8uZSrjqCMZ+ooA6jwTcbdXaIcLIAcH64H6V7N4hmNpokCfNuk5AAHykDnjsK8U+G0H2zxhaqzEwwqZJDjJwOQPzr0jxHqgu9Qntzt+5mNM8IQD39c8UAc9NcqZWkBGCe5x+Ga0NH1UQxyCPGTw6PypAHIx689a5MHzGyd7lfmHcf8A6896u207wnfGy+ZICoYjBBIIoA6jxBaWmq6Y8JK/ugGjkVhuGehB7DtXl19by2MpSU7to25Axn3/AD4ru9FvWKQs3yqo2fMPzB/p9KyvFNojO+zBSUZU9C3cH6g8UAaPw/2wxFn43fJkH5gxBwff0rV1Ro2jD/MZcAF3z94A5B98Vy+iTPAsMaopBwwJ4JYDjB/z1rb1yc3Cx/LuSaFs5bGG6E0AY0MxBj6Ft44J6Z6DB9q6/QLprxkhkcGBj8oxwM9SPrgGuBnnMMittba2AwHZh6VvaNffYrKeKRVlG/5MHYUz3H55oApeObNkvpoJkcSFyQG54PQ/lXM+HIDbxzxzuu8y7AmM/Xn/AArqfFoNyDOkjSuqB1dlwfdceuf5VgqvmzCQJjzBvb1BHBA980AWHk8uPamFZnB4OQMcf/WqC5Zt8bgoARxuPLHPOKrTyyeZ9056hR24x8361JAwbaCQVACj5cjb6D27UAS20U05WJgphYofc4zge3vW55yrGJJYwsg55PB7Cs2ygMcQ3p/tNu+QkE4q5NKjmZfMDKVyynpx1A/lQBk6vJulbYxDYG72J/z3rMmbPlpuByNqkZwcDk59T0rS1CM7WkOAhOcoeSdvH5ZxWMoZFiMY+ZQWAUep4z9etAE0ErK4dgS7YEajGPTp9K0PPYRYOdoGMng+/XtWVA4SdvnwEGMr69Ov+FXPMDQOOoA4bPTPc0Ach4kfzdZu23Z5AAJ6DFYkh6njnjJFXdRmE1zK+SwZzj1OKznIGPc/lQAwv3HPr9aq3Eg5z36+1SyvxwOvccVQupOGGfmPXH8qAPob9jY5vvGx/wBmx/ncV9M18xfsXHNz41/3bH+dxX07QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHh/7XBx4B0TIyP7ZQf8AktcV598J/FC6lZt4f1aXdIFHlOxyWAGAfqP5V3v7X7bfh5op/wCo1H/6T3FfMGnXk1tcRXNrJsuIWDo/uOx9qAPZdXtms72WGVSSHwCqnOR1Oe4rPDsAvlkY52qTWvFqMPijw/BqkXyzRgRXKZOUb19sevoawZS8TlCV5OQCO/Y0AXYJ9oAQjepLBwcLz1B/wqdbrc0agokg4GehzWSH/eMVUNk5ZSevf8qngbfkM2BjBkbrQBrB3c5G8dhz9wdMZ71XvisyPFMiyj0P3o/XnvU1q0ybYYG3PjDbhxIO/wDTP51bt4lMkMYjYrjBLg5T29+lAGj4T006Rbtc26yyGXqB95EAz+OPSmLqAMmQwdgF2sRyPqPet20FxCF2/JDG2C2MAEjnmsbUreIR+ZOyo2073RQMjOQvHBPagDOuVSV8kZRQcgdc59ug7VJHdMsvyP8ANtOC3UY5x+Hb1rJW7AZ4JH2KDlAjbeT3/EVeVCGDrs8sY2454x39T7UAWba6aYpJKC7qWJYrn3HsOO9Xysl5ZFCEPlncH6lT2/TPtzWRGsNvMqRJujXnoSTnjBH059q0bfzfNiypCKvBXuOx/wD10ARLEfKnZNw8rE0ZbqO+D+tarIL2NBAjs2DtRcfMCDnH19Kitowy4Usqtn5VPb+f+FZmkTtbXctpI2FGRk8DOenrQBE9oxjU8AY+Y5569c/0qYRjaytFIpCkI/X6ZHvmrUsG6aXaNwwAFDYwB79qc8KRoese777Fjzx1B9aAEtMy2aGQkyquSD35xuHtWCcWOovBIA8MhEiZ6EHg1uiSKKNyqhEccmRwA31z0rl/Ed5C4CpIrNGSVVTwuew9RQBeulTkNgAZbaOg7Yp1o8KFwCC+1cErnHuKwk1GOVUSRv34AAbbgn8a1NNjYSFd6kkgZ3ZGe/8AnvQB0SGTBnlj3mThQxG7AHP61mahLD8rFRE5BO1hgEn0rptX0mb+zrKWLBHk7XGOrA9R6kjtWXBpqzowmuAY+/GGPfnNAHMjV7d2Mcs0RLHJ/eAbfXvRdSQ7SzqvOSJY2Bz6dOK19U8HaRJECYLkyEZ3B1wv046+5rnrjw3BYvJ9hkkdv7shAbHrgcGgBkfkru2MMdAB3HpVfV5/I08sjYMikIAQcmq13FLEGXZtA7Y7etYk7SyuTO7Mw4BPYD09KAM+ccKOMDsO9VHzgc4HIq3NyM8HHoOvvVKckAnH4E0AVJnyM7gBjoazLuXAIB79u1XLojacrg4rFvplzID0HFAH0r+xK26bxt7CxH/pRX1FXyt+w0dzeNyep+xf+3FfVNABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeA/tqEr8LdJKnBGtRY/wC/E9fJ+k3oljGcB1xnFfV/7av/ACSzSv8AsMxf+iJ6+MbScwShh909RQB6z4I186NqhMzH7Fcjy51B4APRq7nVYVt5vLDExNhopByGB9/pXi9lcoyAnBDDn6V6F4U1lbyxXSrxsOi5tXc9cdFoA09pDHYBuRvlGeo9vwrQtEYSMxUeYAFOT19M+nHfoaoxR7WBfBCn5ueOOv41aEpbaGZcjccPncF79Ov0oA17QrkRxE7Rghh1U/4e1bdpaF3MxJQg9M9+xwen9ao6LFBGDJyDxgk9OOMH1pviDWRbWZG1sYAVOhZj0APpQB1y6tbS2O2TDXULldqjPnjH3gO1c8uiX+tyHAwiEbcH5Ix7np+PWmeA9JfzxqmstIyXDbViU4yfb+6BXosrqiyh9kcSMI8K2BnHAAHpxk0AcdB4QtLXL3TSXl4VK/u1G0fQ9/rirIhkibybaKKMgBtka9F+p61YvtRBgdYpAsKjy/MI6f3ueoP51T06eR235/cbgEnJ+c/4CgCpPp+1nlCMCCA+FPzEeuKb5bJKsO0hlPl4yfn+vpya6u5Cyxrcn5JVb5wgyHYcZ9s5+lczf3TiZmk8xkJ3AhBx7YHXP6UASwQFWYMIwQck9SSRzx17Vj6rGo1dWjYs2zOccnGDV/7a9vNhLSLy5BuLkcYPPJ9azzI95qrFgoGAB/EOfX16cUAb+xfJ80IflGTjgdPzPNV7g7kUjaeByRgJx0x61o2qBoQZA5+XGzI4H+fSs3VJEnkWRNu49Qq7ckZ4z68UAZlzpMd4DM1wrox2kKuWXPHQ/lWNe6RaWSRsILp5W+TzJhxj0AFbRuggVY9yTZUkg7vLPv65qnq1zdeTtZmEiOQXC8Ofb0oAyILCGS/TMG3JxkZwuatXWbSZPKLeaj8gc7ccZFJaufMmcjDhFJ7HOfWnEObhWDbGYjGe3f8AU0Ad1p2tR6lp8cEsoD7NyDkfUZ+vauV1HVphK8Vxaq0iEA7V255zjNQWsih5VjIU+Z+7JJy396qms3BkXLmRywwzK3VffPagBbbxBetOFiGzzGZQFI59VqO/1B7hS04y7cqGIDAY6Y/nVCDKukgD+WuU5H3fUg9e9RyPHN5SD52Ri27k4BP3uaAK16d0hQAhgT8uDnn0/wAaxNRQR3RV8MAoJrau3275DgncSx7Z/vE9x0xWFfybpicn7u3J65oAzro/Lz94diKz7j7meCe/ua0Lk4Tkdfyz61m3LEn6/gKAMq7fqeeexrn7+T5cDOTwa2L5ufm/L1rnbpy8p7Y4xQB9SfsMf8zt/wBuP/txX1VXyr+wx/zO3/bj/wC3FfVVABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeAftrf8AJLNK/wCw1F/6Inr4qr7V/bW/5JZpX/Yai/8ARE9fFVAGjpl2Y2EbE7eox/KulsJ+hDsGU5BB6EdK4oVs6bebgFb7w/WgD1/RNYXUoDFL8t3jBHZ+OoraisbxyClu2Mnlu2O/0ryizu2R1kjcpIp3ArXVQeLNXaMIt7sUADKLg0Aeg2lw8aojEAL03/lkisy7nS+1bAffFbtjGerH/AcVyC6ncSOTLKDJ/exyPetbwpNs1LyGxtmU8k8hhyD+PNAHsssiW9uPID5SJYwFAPboM+/P0rAu9anmCW8SlokXaMt8x59u59KvWu270seTIfMICsrH7voB6Z61ysy/YZyWLRDd8oxy/qCMUAasRN5cq8hCwQc4RuMt29+PWt2DePKVC8JfKlimcHsAO3brXN6NNvhaVEX/AFjLgdFI4yB0Oa2tME01xDEFlBCszOOmAehPr2x6UAdlEputNKHafJUEAjaWOMYBHXntXP3kI88KsSyEqQAowBjnr2/+tW/azrBaSZCY2r8w+VFXtz2A/rWVfalaRyrFbMGwP9cQ2Mnv79qAC73AxkqquYxhUOO3cdzjFcvFeQ/bSZo/KlDHBxtLjH/166gxfbftF0qS7Y8g5HXC9if6V53qjSWt8hEg3dTgZG3PSgDsbm9QWqiEfOo2HLYwB7/41iyCaWaGJ9y7dygLy2DyDj0qqLh5iJEhIZAMqf4h/U1ohbi2toJVRijPhHTnaAcDPpQBAlpLF5MpOyLyyGRzwx6DH096L1i1qJ0ced0cjkNgEYA/KrV5CGeKNTIAhctycBs9foeM1RlBmsXj2sWY5Hl+g65FAGbYvGbyOKJNodSDnpkDP4iopY9zb8B0HVf7o6ZFRz/upopWKEJ8zhQfmYcDjtV2DD/KrAHrgdeDnHpigCnKTHebN8mANqMuDyfvc+vaoJZfMVCuAyKFAYcqQe3rmreoKbtlKouS27egwTz19OPfrVZIkmmJId5GOVDDGRn09QaAKaAzSSYlOWwWVs/L/wDW9KimZVRVUZO4KS4xtHWtaS3+zJ87qAvQkc98isiVGmUbf9XnGTgZ+n+NAGZezgKeoXgY9fasp33nJxknnjNbN7ZMUyymKMYUbuv1NYk8bRTMjqdytnFAFa6A2HaDkmsq6fcM5Ofp3rSu2yM8kHn8fX8axLxjg+ucfh6UAZN9JhHbArAJySa2tWOIPesSgD6q/YY/5nb/ALcf/bivqqvlX9hj/mdv+3H/ANuK+qqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA8A/bW/wCSWaV/2Gov/RE9fFVfav7a3/JLNK/7DUX/AKInr4qoAKfG5jYMp5FMooA6SxuRJGGUgc5OP61s275wwOeODXG6fcGGcc/KetdJayZ77s0AdBDMynkkkckitfSbsWd9DPjKpkY9K5y3kGMMQOeT7VfjcFUDA4PBB60Aei6Xr09tO8sE2FfP8XVuxA/xrbl1W11RFDpm7A+8V6H6dwRXlEMskTllZgT3XpWnFqF4iqY7h+COMDH0oA9G0WaKOM7I4MnJ3cgoP939PrXTWtzbQ2BMrrDGuHdIl5zjg5Pf27V5jZ6hJKyzIoaRT8xXqPTI7irWrao91cR21pjuQueVPdifT3oA6671GfUriOG2JSCMkxQBuZAepb0/GtfR9Ghtv3t+/wBplVcgljgHOOQOtchpFl9iRXuJNzsQSVPOeuP/AK1b8V8IbYxxBdpJCH7xTPpQBreKdaCWLhTtOSAN/LewA+veuNvYJWijlfBLDALHHT/DJqW/kL7CrIBlXwBknrnH86ikmFzpUi/edHB2t1/H3oAitHaEhZCPLyCd7bfx9avxTRskvks5JbeF5AA67SB1+tZIA+Y58xehUnAPcgelSzQyQiBkYPFG25hz8vAOFPcZoAutcM6SESfe+Vow+ERc/dP86bvkCYjKRqoyir8vIPSq96IVnmiRlEC/OJSvJl9/b0HemqdzyyN5Rx1G3JzgZ256Zz3oAsXUaSxyIr8t8pHbd6/SsvRrnEkaMcFG27l7/hVxNsG2Kd1doTsI9cnofSsq/wA2WqxTMy+W8ghds5xnp/SgDU1C1EWFLDaeoV/uHOfz/oam0m2SCJ7m6bbsBEZYZP4mrbZkRxsDsowCeowcZGOtY3ijVk0y28oBHnTgIWyqvj7x9QOeKAKerzveXqwqqq7HhCe/fmtf7F9liEzOryJtzGF6DPX3rP8AA+lTXEkup3jl5H/dwsw3YJGWb2OK6W+hxnCJvK4aRlH3R/Q9/wA6AOK1ZjFM7xnzF34ZW7r3B+mawb5Y5RwxOP4vp0zXV6lbmRYwoJY8gE9iPTt6ZNc1fR+Q6IkY9C7dPYfjQBzV6CpYEZHT8KxLkncO+O/pXR6h8sJOAHUZO3oPWuZnxuboAPTjAoAxtYOIwOeT/KsitLViCwHfPNZtAH1V+wx/zO3/AG4/+3FfVVfKv7DH/M7f9uP/ALcV9VUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB4B+2t/wAks0r/ALDUX/oieviqvtX9tb/klmlf9hqL/wBET18VUAFFFFABW5pk+6FecFfl/wD1Vh1c06UJNtPRuKAOtgfnJGAeCfWtOAnHUA9MkdRWHbP8oBOT2rUhf5SBnJGefagDTiI+8cgY5GMD61fj+YDOevrWVC2TjAPOPcZq/G5Ycn3xjr+HegCypYHcMhvVT+H4V0nhW1JkmnnQ4GG3dnPYCuct8STorEqC2D2yfr9a7fTtiRxwxHLOShfOFQYzxQBZe+mMxTsH2YC4x+P4nGaLeV/NdD90EDbtwFPXP4d6nnRCSwyqlmQFjkgZH+RSQLHJ/q/MJYgAbclfx7f4GgC1cWgkPyKBtGVY9MnrgVi3h+wCRGDQo3BGOR7k+orrNOlSKPbenDdCFIOSRwPoMVX1eyTUYBhvm28Dv9Pb2FAGBbt5hZXU/KNpPYe5FTSRyDynTIZX2KAQFGRwce3SqNojRS+U68qSpHQEdvxFb1pCtx5YxuwMkt29Bn1FAGJKUkdG3eaJOWUKQQeg4+oz+NOt/wBzmfMUjKAXjd+WH97PqORituOwbarExuzD7p649fc1AbfYQ+xXXGcAA4IOen0oAyxGXhnaViQpB+Zvmdj/AD4xUeu2putMnhZU81UDoV74AIz9DWvNCkgRUKklchR2PX8PXFYviAi0sXEeXmlBVRnqD1Y+w9+tAEWmeLEhskkmQvcqvfnnGMj/AOvWXpelXXiHVPtV9mOxQ5dmb5mwegHqaxrFC1ykRwpBAy3TFeh2s1va6WTAjM0XD46k9OaANy1ZEtHW2VoVjwmwddufT881m3cvmBd5zhtpDMCMepGOTwKw57t5bxLmUuqEKgw23Z65/r3rQUkTmN2SISEMzjkMQTjke2KAKd6YQm75gy5ZAemR15Hb/CsTVxmN5FJD9+ABt+prSuJnVRuysrks2w5ZPTrxg8/Wue1s7bIqP9YBt+93OPyoA5jUpla3fA+VjgK3XHeufm6HrjHHtWjduWJ7BcgH6f1rLuehPJz+VAGFqbZkXr06VSq3qH+ux6VUoA+qv2GP+Z2/7cf/AG4r6qr5V/YY/wCZ2/7cf/bivqqgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPAP21v+SWaV/2Gov/AERPXxVX2r+2t/ySzSv+w1F/6Inr4qoAKKKKACnxNscMO1MooA6ezkyByDwOO1a8BGeAa5zSZP3ajPQEfWt23JOAD29eKANKF1K5HzDr6d6uwZ4JbIB+Xnn/AD7VRiI5LDnuB6VYtQXcbByex4xjuaANAEYJyM46k9a29C1i5tJTGJfMiKkBJBu5FRafarEpAXe5BO88EN2/rTr6xIMc0eQeoYHPPcZ9aAO1sNQgmil8mCMzBMgZwGwOn581Xl1KXagjkRBzlY+mT0rlLG9aJ9k26MlgzL0DY9P6+tdJCiypuQAyZOTs5zxjj+RoAkjuWRUwFBAwBjIB+nc9BW/pt67RmPDFyf4e7dDz9a5opJ5YyXVg5JB7nnBP69Ks2avFKoBYhBhMHaWbsM9hQBs6rYLew5t0dZy2QMck9yv0rBa/awl23sboQQrlc8+jEev0+tdJZ3W+LfI6B4yoIU4ySeM+nFQa+LS/hDSHbdDgShdpH9GH60AUtU10RaesttJbyuWRcMepI4yKy11u/lUSlbctwoAxksOuefTjPvXNeJoIxpqFdrBpkTbjkNnGPxHNa+mabGtoVUebKi7Tt4C4P96gCjqnjK5tpW2JBLKRkqFICH0Jz+gp+mpqmpQG6na33TYLNICvy+g57UklpDvdYcTMrY8xgCA3XOOlPt7sxwv5r/IyhWJ+YoT1GfegDm9fhvrckWtxZyyA/IhRl+nJ6VT0LxrqCuUdYEmi+UqVKl8fwtz19K2dTUXCuYV2lG2iNjlmXHBz3Pv34rjtXsBcZdWCXoHG4Y3j0P8AjQB2M2uSTxSSCCCKRU3spQ4Y9CMZwD0rqLTUIlt4I5QjEosgdgTgdxn1PrXkVjq6hZLe5/dTLwN+MHAwAfavRPOAjjXd87xqrKe/AOT+lAFy8dZS8yBD2BU84B43e4HeuZ8T3KoPIAw7sXPGCq44J9zV29uls18wnL4zFGuAZD/RR+tcvOzSSSSu5eVjuZ/7xoAzbk8kbeQuMelZ9y3JCjbnHQVoXGd3JycgEdPyrOuBkN0/Dv7UAYN6f35+lV6nvMee2DmoKAPqr9hj/mdv+3H/ANuK+qq+Vf2GP+Z2/wC3H/24rmvG/wAZviBp3jnxHYWXiNoLK01S6toYxZ2xEcaTMqjLRknAA5JzQB9n0V8MzfG34lLFuTxS5P8A14Wpz/5Cqn/wvj4mHp4nbOcYNha//GqAPvKivg3/AIXz8S9xH/CTsAP+nG1/+NUH48fEzP8AyNDY/wCvC1/+NUAfeVFfBZ+PXxM5/wCKnfA/6cLX/wCNUR/Hr4mO2P8AhKCB/wBeFr/8aoA+9KK+FIvjn8SXH/I0tn/rxtf/AI1Uq/G/4kcbvFMgJ6f6Ba8/+QqAPuaivhz/AIXZ8SCM/wDCUSj62Np/8apP+F2/EgkKniiXOMk/YbTH/oqgD7kor4Zf43/EhVJ/4SiU46f6Daf/ABqo4vjj8S2+ZvFDhf8Arxtf/jVAH3VRXws/x2+IcYLSeKJ9g4yLG0/+NUTfHL4j7A0Hip2B6E2Nr/8AGqAPumivgZ/j78T1z/xU549bC1/+NUg+P3xOOP8AipmOfSwtf/jVAH31RXwP/wAL8+JxDH/hJjx2+wWv/wAapR8fPiaf+Zmb3/0C1/8AjVAH3vRXwqvxx+JTJn/hKHyBk/6Ba/8AxqgfHL4k5G7xPKARnH2C1/8AjVAH3VRXwhJ8dfiWrKB4nc7un+g2v/xqon+PfxKDFV8UMSP+nC1/+NUAfelFfBA+PvxMx83ids+1ha//ABqpE+PXxLYkf8JO2QM4+wWv/wAaoA+86K+DI/j18Sn4/wCEnfd3/wBAtf8A41T0+PHxJbn/AISlgvqbC1/+NUAfeFFfCE/x5+IsSknxTJnsPsNpz/5CqCL49/E5iN/iZgDyD9gtf/jVAH3tRXwk/wAcficAGXxQSnf/AEC1/wDjVOPxy+JQYg+KWHH/AD4Wv/xqgD7ror4UPxx+JYwP+EpYn1Fha/8AxqmJ8c/ia4OPE75BwAbC1BP/AJCoA+7qK+D2+O3xNHXxOw9QbC1z/wCiqryfH34nJIFPic7T0P2C1/8AjVAH3xRXwM3x9+Jy4/4qjnv/AKBa/wDxqkT4/fE5lLDxP3A/5B9r/wDGqAPvqiviPUPjP8RraNHj8UzkMoOTY2nX/v1Tbf40fEaSIO/iqYf9uFoP/aVAH29RXB/AvXtT8TfC3RtX126+16jO1wJZvLRN+y4kReFAUfKoHA7UUAeeftrf8ks0r/sNRf8AoieviqvtX9tb/klmlf8AYai/9ET18VUAFFFFABRRRQBe0x8S7T17ZrobZ+mSB0wD/KuWtmCzKSK6KzfOASMHj6/SgDaiZiFOTwRznr9a2NIAXe+fvHavTp3NYcLE4z2HWujs4ysUQ+XlCwyB/n8aAN/T1UhGcn5vlBI689Mf1rcsoYp42WR1SLaxbjhD/jntXNWMpRvLQsu9Mbh1JOMnNbSTKJcRCQKJApHTnsWH9aAItQ8PzR5C7ZAfmYYPHGdwqTSJJoZFjuImCHG2UEnjoARXVaLP9o3eYQUAHyHspPT3FaMulpMPMijyJCwAXAJHoPT0oAp29ik8am6CkEnEsbcCtA6TaOSkSBsHG0HuOg/+tWQ9tc6dLIsckkDEfdH3CM+/WrUOtmEyx3MTPsRSPKGMntwe9ADjYMj7o1ZPmzkjI79R+dULu3JiZVUEjIDBgce3+fSr03iS2kyEjmAIyG25wf646YrKudXtXjmEfmJu5cbTz6D+tAHBa9cNFeS28xeNZpI2UkfckGcVat9Qfz1dpCp2h146N3BHfnNReInEssMh3KHuUGCOvrn0pHj3HbtHDMBnooJz+ZzQBBeXG2ZCwYAK24ICo3Hg/L6dCPrUNtO0QSMDbtfG3b8voVJz36/Wp7uwV0dpSxdnKEq3I7sP0FUDA5nbcjBSxYhlypJxjjtQBZYREtJHgApjO70z8prLvFLMhby+uGwDxnkH681pXEW1WRVVSoyowPkINU7nAiJyWUsGYE9ff+lAHKa7ZK1u0oH71FOB1LD0P4V1FvNIttEquSBGmAfmxwOntWLrU6Q2zjCksG2qO+R+lbMWVt4QoziJOM9PlFAFed2d2d3JduNzH/P5VBcK6EZjKkj5crgZrqPDWmJPMby9j3QxnbGvTex/iq1rkSy29xA6II9p24HcDIxQB57MccAfQZ6f/WrMu2xu65z0rVuR+7Y8nI4IPWsq7GFOMgdPWgDAu/8Aj4eoakuP9c/pnio6APqr9hj/AJnb/tx/9uK8P+JM3l/FDxmj4KNrV7wf+u717h+wx/zO3/bj/wC3FeC/Ffn4m+MgFBP9tXvP/bd6AI9JmMoNu+PNHKHtj0qtfwGKXzFG1W4II6GqenTHg/L5i8YJxXQLGs8RcsGWT5WX0PrQBggfNuI5HXFNOdxPUntVmWBrado2BIHU+tV0B80gZwfWgCFkOc5yeuTRGxJO0gjpjFaH2YfZGk6kHFZcWBITgcHGKAL8IHG7b9D3rTigLwvnqR8o64rGMpiII4PYH/GtrTbv7QvyLgx9R60ANiUsVVuoHOTTyuQHj4xwcDg1KxG8s2Exz0pyWrzguhZIhyW6A0AUFhMkm0cr3I6CmSMC5RADtOKfcziSQ29n/qx99+1TWtsqAcHJ70ARLFgMMDkZK1lSKbWX5D8rHO010AiHmbcAjqrA/wA6ytRxLcbl+Z1GMDkUAUWTco75PbtTGgKuo4zU9lkyAAHr3q9JBu4zgLyTQBlYAPRi2fWpo1yTuX8M08DDZUYHrTyBs3ZIU/maALkDAxjJxx0FR3UqhVH3m6nnpUUrfu0Odr44Ze9UrqZjtBP5UAK8oUk8/gaqMx256irbx5hXHTOSCKcYAI8Z4PIPagCCFh5Y4G4c09mURtIMZ6fSoW3IWVQCTViEb4GGBwM8UAR2o3SAEj61aZURiXG6MntVeyXdOeQDjOKulYXfzT9zGOB3oApJCXw2fmZuB7VKuRIcjAHc96uRRYG4cjsRUEoIOMgD86ALsC7wCFGPSnGA+Ycrk98c0ungADcQT2AFXJUITIO1j0x/EKAKjxqYyCcAe1EUO4OXwGHQGrOzciRjaM9j2PvVjyi8ihFVgv3jj5QaAM2W2PljZje/UYySKzr62P2bMa/cPryK6cRiUgRkh8/M3T8qqXMQ3ycgbVI5/joA5rUFx5TAcMoIPrV6ysy8AYjK7xk4psVs1zLbgL90HjPSujhgWGxReskkgGR2oAi8W3C4ijU8gqp7VSW7WO2IxuznANUNflZ7+SI7srJz6UyxR57aeXBZYo9ufc0Afcv7MBz8DfDZ9Tdf+lU1FH7L42/Azw2PQ3Q/8mpqKAOT/bW/5JZpX/Yai/8ARE9fFVfav7a3/JLNK/7DUX/oieviqgAooooAKKKKAHKdrA8/hW/YHIGFO3rnPSufHBrZsHBRSeff1PrQBvRNtTnbk8ceprp42UKgbIAiUfMMjPWuUgzjjnj1yPbiultp8QwuxODGNwA6r0oA14pEZk3MHymSW9PYetXba66SNxj51C5Abn5unpWLbuURQcBMseOcCrdo/ILKrMh2EFuucgnH4igDbsLxli3uj9AcKduCD6/lXWaXr09uyCdhcRqm8sRghSOgY1xFuxWEbuQqFSSOQM8n862rWMXI8syRxoCNocAemB+eaAPQbPVrC/PlMw82TlYp1yAcdT6VYuNAsLqMOsEcchX5fJkI6DoB3PNcdaiZ5jJG1urjhiz7fl/u/wBa2LSJ4AJDdyP8pb9zIANuc4ye/AoAhn8MbbMtCySbwchSd3B/lWVe6PNy8hdWZSFyMkfL3H4H9a6ZdfkikCyIPlyI2BBIBAPXHr3pTrdnczRCVJV2HaTjPWgDynxVbvBp6kDaFkRc/wAJ/Pv3xWENVdSTdRFmPGUwMj+9XuUmi6Tq8EimYTxhwcL8uVHA/wCBVmXnwx0WTZIUaF88skpPHYAe30oA8qt9QsnZVaUxuScCRTjH17Hikn1Oy8lwl1FkZGC3QDpz3Ga6vW/ANtpcEsixfaIAQWeKRs5x/Evb+Vcff6JYLAxeKQIFJx5p69+aAMptetIUUm4ErDnZGpJz6VjXuuSudtsoUHncfmb8PSul0rwamprixs5njPG95Cqe/Nbi/CtmQ72iUnk/vG+mDQB5NdM0qFndnY53Enk/j2rtsnyI/eNRx67RiuoHwiheHJu0B2nI3NgDoe/PatC28H/2bcRtPJ5rRqCGA+XbjgjPXigCe3h8rS7dXKh2QfeHA47j/PNZFyAQzZ3gD5QCOR6/zrbvZpJIWYQOuRgEn+EdPxzWVN88IKbchc4HGMnmgDz+/hMMssSrwrEAE8daxL1G59CM9K6nxBDs1FzgDeoYgHqfauav0wpyCSOaAOXmOZWz1qOnyf6xvrTKAPqr9hj/AJnb/tx/9uK8D+Kx/wCLpeMgOv8AbN7/AOj3r3z9hj/mdv8Atx/9uK8D+K2P+Fp+MeOf7avf/R70Ac7YPsmw3Cngkda6DTpGgEisAUP8q5hh0OMVu6cwljj243Hg80AapVLmMjPI6Gsia3McnGSD3BxWrBGyyqD91jg1qyacLm0YOMMnCkdDQBjJCDp0hIK4GQcZzXPwKd78YLH0rr4tyWVzbkDzET5gewrkoSAwVScE8e9AG1aaNNdEbEyMfnWlZ6PPbsF8l2JOMKK6fwfFthLsoICgKWHArtLW3tbdBNvi8wjIx1oA4QaBBYWbXesShYxyIz1auX1PUJtZcxacnkWK8M4HUegrf8bR3F9fAXDFbYt93P3qgkthCiRRIEULkBBmgDDhtljULDGRgcKO59TWhbWmI0MuQR82R1+lTWqKioTubJ4XoSferNyEKhZRuAPr3oAosqTW0vkOTHnJ4wB7VD5S+SRDtVT90LySa1GRHhKHGBwsa8DNVXQpvMQHnRKdqrwBQByALQu0xIJ37QMVdR/MDIG8vPUmmPbNmOe5+VCxLAc4NI0e0O2Mxk8EigBcRkqNowvAz3qvcSZC8BV9KWRyH2lR8w49qinGTktkYwOKAImY8cH/AAqvIS8w4yTwOassuEBPzDGCaXTrcyznI6dB60AWo48KEbGT39Ks+R50IXBVG4AK9aveXCsMbKh6/Njqv1oni8szkszKMMGzgfSgDCubUpuyCpHQ0logPnLjnbnkVem/eA7gc9QAO1R2CAXSSr1ztYEdRQBUihZDkA7sdj2rQgSM2o3r8vbacVdntT5ZaBVOOuRVMWVxkYUYA6GgBpSNVxvOevXiq78v84PI/SrX2aSNSDF8p6kVCYn3DOcrx+FAFqx4kUKuD6juK2GXoCDt7Y61m2KAOpBIXOK6OK3Z487c+mKAMl7fDjzVVVPOTV2KJXQu7gLnG3HJqy1m6MxCL65PUVZt7JXctd3D7ANwCrjP40AZOoXawROI0AfGAvc1l+VKY0LDdcycCPsi+tbRtbSS+JMi7Qcs/TA9BXQ2Wk2sji4jstse3CSMfnegDlNL0022GYcDlmPYVUiuFlu0CBtjTjbz0HrW54s8q3tmSJybhx88Sj5UHua5jQk8+/t0XJyCQBQA/VrESajeuG3K0gAZelLe6edM0FHVsGebbgdcV0dpZL9hQsBzKS+R0FVPGyLFaaQISvluxOT3oA+u/wBmTj4I+Huc/Pd/+lU1FJ+zHz8EPDv+9d/+lU1FAHI/trf8ks0r/sNRf+iJ6+Kq+1f21v8Aklmlf9hqL/0RPXxVQAUUUUAFFFFABWppjZUADBB6isurmnuBJtY8HAoA6W3YdsAE54rfsmL6bCQclWKrj+L2rnYH2sfmAxyeK6HQf30pgAy24MB/9egDVbMfmODtUrjK4zk9quWsO2ZE6hhna/GcYyfXFRRqGyf+WhIZmYZ4z/MVbsEeS4Qykea+5gP7gB5OaALtmsIZCMlhu5I7Z5+uatWgZ8g4VmOd3XGDx+naqdiWEfmOh3LGBhsk9SeO3PHFasSII7dZFd2bDOynH3geg9v5igCZ1KtHGWI3je7Mv+yMZ9v1ppRjErAPtyQ7YyDyDjH5VNcNvumWZ3YqFjDMMngY4xx+NOgQ+Wpl8wl8sMdCSMZPpQA1t/7sRHBHy/e4zinM7KFG4sCwyehPY0KSjkqEHAzgZ+Xjv3P+FDspZmLDYcAEDoTnvQBZidI3BQ/6txMygYBO7IH6Zrf0jVissi3u9kkd2JLfdU+/qe1czGoyqEuA6HaFOQAevPr7VfgVyxZR91cHcRjJ6cfT8KANzxBKzaRJOXZRwoJHXqRz3GMfjXnVpbQTaiZLiIywRKGMTH7757+1dxrbGPQCW2qGbbyegX0/T9a88imB1B4kPRVDEc89aAO+sdQVolSFIxGUGFA+UDHr+dWEkXY/nMeRk4POf7v6dawNOkwu5iFA44PT1/DFXbi4LrLJn95wcLkdv16ZoAsz6lFHHzklPmRcAZGOaItftFBhmJUbQVEg3AHOeo5x2rCvBMqmMrg7sA5/HOfxIrGlfyZGMjnIOAffGeaAN/WLxXQ29vtMeS4JHHqcevpisa5ja6tLiSIhpIcApjHy9D9etVZLgbEjbkAHaQ33SO/tjNW7Od5bvahIJUrvJ74xz68YoA4bXebqLH9whRjtmuZ1AZXBzkdfauk8TZXUsM2AFByPeua1AklgO3pQBys2fNfPXJplPm/1jY6ZplAH1V+wx/zO3/bj/wC3FeCfFjn4oeMRn/mNXvb/AKbvXvf7DH/M7f8Abj/7cV4F8Vsn4peMv+w1e/8Ao96AOXzxjrgVd0uTa7IAS33lwKpAkDHTH61LaSGK6Ug7ecGgDurS0eezS4BBRu4PINbNkUMU0TsSy4asPQnlZBDGd21s7P71brw7Z4dibZJmCMfSgBk1hI9pqREaE+XvWRjgkeledWCZvEBPy5zxXtPiCOFYZCiMipb+V/vHHWvE4W8qVsH7jbQfxoA948O6XJe+H4UgPlZ5fI7VLqenroliztmRuzN2re8KYGg6ao4gMQZmx941N4ptf7R0yTaDvxgZHagDxm7vJ9Uv0lxtiX5QCOPrU0zlflAOFGM+prs7Xw/FaQp5/DEZwacdOscth0I6YJoA86MzxysGHGMAdzUynzDGdwDoPur0Qf4112o+H4yA0WM44welcVdq1rdtGxx2PqaALoRZCpJ8xS2EJ4x9TTZbcyQthljLPsIB/rVRt0N4m2VjG68I3SrcUyB1Mn3FHDZ/i+lAFU24Ae1bJUcZA71Xe0SD5ZGyVGArVqpGJY2Pz+a4O4Hjd7isq+ZfsIWHEko4J6kfU0AZGpon2uBYuT1OO1ONk0uW6c8etU9wF8jSsAOn0r0TTNIhv7bek4hjRdxfGc0AcBeWbRxDKttz1FT6XGQY9ipk9cmtfxMba3tWjtPMkDHlj1zWZpoKiMntzjFAGk0TKBLkCOU7dvoaW7G+B1Y8gbQAOv1NT7w8kW9RuP3UxwPeluQTZt8w3M23PagDnpUIZgxKuuMnNTWjBZ8tgbumeKvfYlRXxkvxkkU97Hem5FJBHGeufUUAdDpFoLqNZI+vR1rXTTrdCSyrkjuK53wndtDfG2kLZP8AFmuk1xmQBkIGOvNADfsFm7YONv0ptx4TtpyZIeG7CsJrqQNuDnIPQVfsNdmt5NsjEr60AQt4buoJciInmtSKAW8CCXIkJ4PQV0ugazbXWPMOQe1dPNotjqVqjSR7lHTFAHC26W6Ss8gSVoxk46H2NY2uWTXqjPyoTuYBsAD0Fei/8IwsT+XbR4B5zitC28JWhYPdb5JByV/hoA4nwj4Pj1GJJJbfyolPLt6e3rXoOo6Ha/2TKgQKsaYjPQ1twwRxRIqhY416LjgVzvjW8mjs5RErDCkLt5H1NAHgvjC9S3tZYvvHJX3rF8EOg1iNnGSsZwPem+LEZWw7bmJLMzHPNM8IF4b5JFAORjB70Ael2liDHaxyH5Tl2rjvHDMdbKDHlQw8KOQPpXocEbLAGYAHyuRnpXlvinUDeareyMm3yovL9KAPsr9l7/khfhr63X/pVLRR+y7/AMkK8M/9vX/pVLRQByn7a3/JLNK/7DUX/oieviqvtX9tb/klmlf9hqL/ANET18VUAFFFFABRRRQAVNaMUnUg45qGnKSGBHFAHTWzHaABwe1b/h2YJqttu+5K2wg+p6E1zFk/yqQcHgitSIthSmd64Kn8aAPRVjHlSBvlKFvujIHI4J7UungoQTgEblCEdcgnr+GcUQXBu1truADZcxZJHZvcd+Qam05h5mSFc4K8j7vXnH49fagCxF+6Rf3oGyJXw4wcY7ns1aNhGYrqFFi3ysgABPBJUnPsBnOar2zOdPktHCs0LLEGPX1zk1ct5A90HkbYFQsxB4Y56D86AIpZJGgd8jcq/MWPAbcPmAHsP1qQCRlBjXahONrEA9B+fWo5MRwOZA5Ah8sYOGIDEYP6U+PyvtCHYxjyuY2bcUAwSfegCRIxwICGDEr5kjfLjODgVYCR+cI4sqAoGfx7e/FQERySEbVRmDImDuCgtnn1PTJqSFFkcNuL72Ixx97B5/8Ar0APtyXMgVyBnJ29cnACg+uOfbNaACqBucYODgc5yf8A61ZytmPvtReFzgK3GcnvXX+GNOjvNXWScqtnakTXDAYOxRkD6UAYXxHuhpqWdnKwa4W3U7M8LuyeR+OfwFeZaRKftxLNlnO/jgZ//V3rU8c6vLqniK8u5SfMuJC2M5AXPygfUYrFjJXa8YGeDjHp296AO2sy6IFBBcnBOOSOc1PJIFWMSNkk7idxwBkjNP0Yx6jpkd4jMUP+sTH3HA5X29qdPBi2COjsdqjoMnGcfligDMndfKhLko4y21T14wT+eKyZ5P3kzHaCJBuB45I7/QVqXS+WGBPmHapbjBAOf0BrKnjw5G1WCAZGME89T7E8UAU2ZiNvykfebnt05/StLTM/bbchQZT8oU89eM/yrPERNwoRQSvG9hwTnjPt2zWr4ci83V7JVOC1yoAJzt5zge/fFAHC+LJAuv3yoNgQqv1wBmuYvHzuOe3StzxZN5nibW2z/wAvki+wAbH9K5y8cEZzyRQBhSffNMp8v+sb60ygD6q/YY/5nb/tx/8AbivA/iuP+Lo+Mef+Y1e/+j3r3z9hj/mdv+3H/wBuK8D+Kg3fFPxl7azen/yO9AHLE4OOMGhs7skik4wCeTQRkDGd3TFAHaeErxItSt3dQ0bjBB7H1rstWgaGa2lQ4WOQSE15nocu0AliQjD5R6V63cILrw7a3irhOFbuaAL/AIjlX9yy4dJo9wyMEHFeEXZ8rUZ884kPJ+te5zulxZ2xkYhoF+Ujv7EV4r4lQx69d42jJ3EdqAPov4Vbr7R7SDfuUrwS3T2Feix6WrBFCg/NjmvIPgJeKjwxSZ2Fcj1zXuMUwEMr/L+7DEEdKAPAvFlxcXviHVdsjRwW58tY0PU1ystvdKBKkpUg45Oc13k9rvv7liCwmkZ3K8frWFeKWSM43K7lewxQBjJq1/aSATL5i9jR4igF/YpfwBSU+/61NLCWkdWXLpwctyB7UujSrFdzWdwQUlHHcUAcqkksyCIEhh8ytV21YSIoDgFuHZhnaabr2nPpuosoLeW3zRHFWdPVSP3i5k6udvGKAJfmm2ROzJF90t3P4+lZ99G6yMkZUBeBtPX3rdmiGBMpCE8BCPvD6VDIkGWXY6I3B/vr9KAOTu9OVFkc4Ztuciu7u2bRfA9iqELNOu45HOK5/UEB8qAKcSSBBnqRXT/EWNI7bTbckjy4gpQjoPWgDzLUZZLuYbSSyjOB3qfT47hFVVGBgk5602IBLx4YsyFhnIHOK2IlQtZvbJ8h+ViTQA21W4laMnIPIHv7VqCFgY96BHfgqTwDVGZWt9Onudv+qlzGRUEqmF5YS8rOkaB8yEgyY3MeenUdKlzSko9zeGHlOjOt0i0vm72t9zNxYVeRgMNtXDKvc0iwTLbpK0IZt2FIbB21naTfxtcQRx7tzdedtdAHZGeFAHDc8HhfxqjAwNQxaalBdRZRGYA45rtNaCnT4pcZDqDiuV19EfSHlxho3A65ya6PVHCeFdNcnO9RnFAHLagXiVirFAeSKqpL+5+dZMseF6ZHrmtZ1VoDIQHyDw3AxTNMskFt5jBSz52q3zACgCO3uZbGWNogQp5xnNem+DvFEU2xJGbDDawzjFef/YNqqWj2HOAB3oWynLeZbERSo3Lkd/TFAH0ZZok0StEQUI4PXNT28Z3OrZO3jA715p8MvF7TWs0N8dzwyeXIFHK++K9JguVmuPMhZZFI6qf1NAEMweNyZIyUJ4Yt1ri/GWsy20f2W1ZFluG2szc4Fb2tasbdGYlMoTweleTahdXepa2s0u0hCThjhQPagDgPFsG/UbkBlYKQuQOtS+ErJjcZXAVXA3VLqgjbUZgflXfkDNbfhK3aW+toZY3hG/eBt4ceuaAOxvAIoOpVRjJPWvFfETI9zfzxBQssmNvevatfk22pXgMxbIPYfWvB9QOIJOfmM5P1oA+6f2Xh/wAWL8NfW6/9KpaKP2Xv+SF+Gvrdf+lUtFAHKftrf8ks0r/sNRf+iJ68T+DPwPT4keEb3XZfEi6THa3b2rRtZ+aMLGjly3mLj7/THbrXtn7a3/JLNK/7DUX/AKInri/gZa6/qH7NHivTvCVp9p1W/wBWltVHmpEI43hgEjksR0Xd05yRQBj+Cv2evD/jfT577wv8R1vraCUwyMNFeMq+AcbXlB6Ec4wfwNfO1fdfwo+H2v8Aw7+IF1DElpd+GdR02FZri1jFusNzCNi5iaV2JZQSzDgs2cDFfClABRRRQAUtJRQBr2D/ACKT2GBz92teE/KGJbGefasHTXxx098962IHyoG45zx3x9BQB2/g26aS0msyzfu282MKedp4P+NdDaKwuAzD5W+Riw568ce9cH4dvBY6tbSOcRufLfnGAe9eixW7JfyY4VgGHOB6CgC1FGyxZAUguMliRtHY1NEq4ceV8gXYAFx/Fkn8c5qMKDbuFGN6gqScZIPPNWoG2k5BDtIHHbOMDB9utAEEj7NPn4BJyFPTk55J+n8qc4BuCD5qx52fKvIyqkc/UZp/34ggf5lIBJUHgg5Huf6VG3HkKWbbuJyD8pI6n249aALCSFHdVjXcW3NnknscntT4m+4rKHKjcccDPOB+P+NRsFBOGTbu6H7xTB5/OlDcoQ+Qwz6E8Y/KgCWCQZBVQ2Ni45wB3/Gu8v3GgfDyaV3VZrwgISOcen1xmuK0aIT6lbxzc72UEKP4R0Nbvxvv/s+l6ZZRsAVVjtz0JAA5oA8TklM1xNIW4dieew7UtvJ8u3gADjnpkVIsKlRyRyB7DHGBTHRuCoy3TDAdM0AdT8N9VGneJ3t5hus70YdX+6zAccfjivRNX0YRTyxZMkW35eMHrn8sV4ikjW8sN3E2DA4kGPbrxX0LuGpaPb30TZHlAZ6nleDQB53exiOZiVOziUHceMtwPw/rWHcDClfvT+WEJb5eMng11OtDLMZGMhPATpxnpXIXylZgzAkOCuVPAXOen6UAUlO4EvgKyqhGcFfX+ldB4NjabxLp5TaAs6sQDgjaCD9awSWfYyRjKEqFIwSDjiuq8Cqra3aSliRsYrjgB8fNx/npQB4tr0mfEOsMdxIvJeB2+c1i3bYz229+ma0NXffreqsDx9ql/H5jWVdH5Dz07Hp07UAZj43HHSm0rdTSUAfVX7DH/M7f9uP/ALcV4H8ViR8UvGRH/QZvf/R7175+wx/zO3/bj/7cV4J8V/8AkqPjEk8f21e/h+/egDliT/D/ACpo5o6ZwaT68+1AF7S22yMpOMjIzxXrngK9a40K4tW2sgXPXODXjVqxS4Rl9ec16N4DvPsl9c/N+6KYZAM59xQB0Gm3q7bt5AZDEpCDGOa808ThTqAncYaTlsetde1yE1R4YtwQ5yccmuW8ToGMbkEbWxmgDtvhleJbIpM7wyKcpIvb2Neo2vitY7iW2uZS5mXlg3T3xXgXhSSRWbYT16GurSxutRvUkikMSLw57mgDvftMc0DkMDJuI3dQRWZexMk9oAnmHktjgY+lWbaJLayaCQgSDG0ZwWpskdzIgdvLilTgL940Ac8wWKWeSRBIshxgDBSsjVI3kgWa2eP7RbHcAO61vy29xHdTJ5kcjt8xwuMVmXljc28hvmaCVzwVhHOPTFAFtPJ8S6LHyA6jueUaudCXFpN5JUpcLld2eCPWlM02hX/9oWiObKY/v4SPu++K6yWO01rT0ubZ1cMOGXqPY0AYunys6BXJeWPO+RlyT9KZdSwiN1HmtO4y2eSo9faop0ntLpUf5Uxh8cFh7VYMcUKyNBCioU5BJLk+5oAq6dC9xrukQcSKG3Y9frTviHM+oeLfsYkbES8kdvatLwLF9o8Tb5j8sERbpgCufmZrzX9SuE+eRpNq5HagDLmsbi1ZbuFgvlgg5GdwqxpF2ALeLyizvliFGAtas0JSV4JD+6VcsCOp9KhtdOjh1BGCgxupaQBvuigC3qB22djYsgXzZRI5POVX5j/LH41nGGV7OO5WBma4LNnHTccjP0GB+FSXTC6mkSEttCLbRk9jI3P5KAa6V7SAyRi0Bht0XLIThfrk1jD3qkpdtP1f6Hp4j9zgqVLrNub9Phj+UvvMG20iGC2WZkbzoTzz976VpzESyw7Ar7cYjH3j9aku0WVilvJ5kR+ZGkHytjsDUcU4mjdnlOOy4A2n8O1bHmFLXUVdIuBHu+aVVAHrW/4xxaaJpVqAMpCGKnjnFZkFqLi+srcovl7vOlKnI4qv401B7vWre1jYuxOTjsooAfCAYIx8iRvGc57Gk0tmFkkMvzyKx+bPBFSSRyy2rbUBwPucZNXrYeTbKHVF3DjnODQBFqLt9mhiZdrtIBjOcfjV8S4tEV2ESo+DL1JPoKrSsiFfJcvOfmYf0qvsuJbeb7O4BmO5N4/1Te1ABpkEtpdS3NrI0c/mZa3/AI5B6mur0zXb/wAtxbE27ngkjJ/KpfhrpNlF4htHuYJbu6kGJZG4BP1r1u+8GWDu8sKKHJyT/EKAPGL6V5wrulxLLnDkkgVzWp287znIYqxyAByfpXsWoWTadfx210FktpgfIfGcN6GuN8VW0loTJaCMP0yedhoA8whtDcajFasjmSWQAqB83WvU2SFNXS2jVUisLbGV/vGsLwg8s2oz31xGrC34jdR941sacrmC7uZGA8+fJ9aAMHx7MYdBY4HmRjLMp5Oa8c1VlIiAztIzXpPxHvUkgZP4nkHyZ6gV5pqzZlX+7t4HpQB92/su/wDJC/DX/b1/6VS0Ufsuf8kK8M/9vX/pVLRQBiftd6JquvfDbTbXQ9MvtSuU1aKRorO3eZ1QQzAsVUE4yQM+4r5g0TRPi1oNo9roemeO9NtncyNFZ293CjOQAWIUAZwAM+wr7P8AjX8Rf+FZeFbXWf7L/tPz71LPyftHk7dySPu3bWz9zGMd+teKf8Nc/wDUk/8AlW/+00AeVf8AF7/+qk/+T1cr/wAK48cf9Cb4k/8ABXP/APE17/8A8Nc/9ST/AOVb/wC01cT9qqR1yPBkf/g2P/xigD50/wCFceOP+hN8Sf8Agrn/APiaP+FceOP+hN8Sf+Cuf/4mvqbSf2hdQ1SxN1b+ELQIrbSr6w27P4W5p8n7QGpISD4Qsz9NYb/5HoA+Vv8AhXHjj/oTfEn/AIK5/wD4mj/hXHjj/oTfEn/grn/+Jr6nT9oTUWcKPCFmCe51hsf+k9Lq37QWpaZGXn8H2jKGCnZrDd/rbigD5dtfh742ilDN4O8Sge2lz/8AxNatv4H8YJ18I+JQM5/5BNx/8RXvo/aXuyR/xRsA/wC4wf8A4xTh+0peH/mTbf8A8HB/+R6APCB4L8XCMgeE/Em5eRnSbjk/98V6Fpun60bO0N34c8SxzoFDg6NdsfcZEddv/wANJXn/AEJ1v/4N2/8Akel/4aRveP8Aijbfn/qLt/8AI9AHLLZ6kAc+H/EuNm3H9iXZJ5/65/jUpt9TwB/YHiYhAQB/Yl2Mnrn/AFVdJ/w0je/9Cdb/APg3b/5HpR+0hen/AJk62/8ABwf/AJHoA5Z7TUyqqPD3iXYd5YDRLsHPbH7ukkttWIQ/8I/4lZt7FsaJdj5SOn+rrqD+0leD/mTrf3/4m7cf+S9Wrb9oXUbhA6eD7QAnHOsN/wDI9AHHpa6qIgDoHiQkNuBOh3e7pjr5VOFvqeJt3h/xJycgf2Hd46dv3dd1H8dNWk+74SsP/By//wAjVND8bNZlOF8J6d65OtPj/wBJqAOV8MrdWmtW811oviWO3TBLNoV63I9hEao/FZtV8QalZtpvh7xLNBGpLn+xLteSf9qMZrtbr446vbKTJ4S0/AGSRrL/APyNWKP2lLwjI8HW+M/9Bg//ACPQB5imheIEwf8AhGfExx0/4k9zn/0X1p50LXyMjwz4kBJ/6At1xx/1z9a9N/4aRvcZ/wCEOtv/AAcH/wCR6a37Sd4v/Mm2/wD4Nz/8j0AeWnw3r5VlPhnxIQTjP9j3XTH/AFz9a9Z+HWoXFj4VSw1nQ/ElvcKCADoV64H4rEeoqu37St2oJPg634/6i7f/ACPS2v7Sd7c3SW8fg2DzH6Z1g4H/AJL0AZfiFLy5Mgt9B8STIxwP+JJeKQB05MXWuXk0rWgNsfhvxKVUfL/xJbrpjp/q+vXmvV4/jfrDrkeEtPH11p//AJGqo/x+1JJjH/wiNkSO41l//kegDylNF14bWHhrxKHU550a6+Y9j/q66TwlZahpl0ZLjQvESBI2VQuh3hBJ6H/Vdea72P43ay6Bv+EQsFBGfm1l+n/gNVG9/aD1GzdVk8I2ZZv7usN/W3oA+cLzwP4xkv7yRfCHiVkknkdW/sq4GQWOONlU5/h/40dCo8H+JP8AwVT8/wDjlfSR/aNvuM+Drbn/AKjDf/I9DftHXygE+DrbH/YYb/5HoA+YD8OPG/8A0JviX/wVz/8AxNH/AArjxx/0JviT/wAFc/8A8TX1Tp37QOp38jJD4OtAR1Law2P0t6nvPjxqlpIySeErElTgldZc/wDttQBh/sa+HNc8P/8ACX/29o2paZ5/2Pyvttq8PmbfP3bdwGcZGcdMivm74rkj4peMv+w1eY/7/vX3B8JPiTP4+utZgudGj0x9OSBwUvDcCQSmUd40xjyvfOa+H/ivz8UvGQHX+2b3/wBHvQByv6Ggc9OtIWyMGn9SOo96AAHBBNdZoE3lXAKsFZ1xnP8AOuSOQcY46VtWUjLGhVQHHf2oA3jexwXbqQPPXoRyDmqWsqZLBy3OG3HvWU0pn1dSMLn7wrSvZm+1eUhAiZc4NAF7wOiNqKBxlccg16bY2yrchQ2QPmU7cbvYV5d4Ok2a3BhWxvAOTjPtX1do/h3TtZ8MCCVCsqkPDIn3o2+vpQB5kYkkQuVCF2+TPLZ/pUccLSxyMRJCyNy4/irtb/whfWMzeU+RjLAjO4+xrnPsckTSCSQxSE5MbHrQBhfZysVyJWLKxDZIw350XNlHCoMbukQXJDNuZz7DtWjraXDTwQ+b+8mXgKM4FVY1bfOYFKPAuA7tlnNAHKXdvcWMFwb5UKMcruOeD2+tYsMtzoVw15peZLKQfvbU8Ee4ru9Qja5sUtbpFjeQ7nMnJrF1bR/s6QxQSksecMOcUAT2N5p2v2beS2WHVD95Kz77SL6zBFmTLCxz6ZqtZ6NJb69ZT6ex+0SHEsSj71en6lc6fomjwWWpwxT3Qbezb9rIPSgDjPDthPY297dTbknkhPy9SBiuO0p3+zz/ADE5ZiB05r0hfEOkzI8dpbx2+eGLPuLVzGr+HpI1afTyskMnzeWDyD7UAZOFvbWNzKEnhGZHk4B9h60lpeJJLiOFw7KvoFwSR3+n602aNkhyyHcgw6t1qeNHTVIxKdyS2xxkY4BHH/jxrGvUdKm5pbHo5Tg4Y7Fww03ZSur+dnb8Stp6NNdQPCHILvdHb1wfkj/Nc/lWy6SLO0tw8jTHgREZVBVG7jjWQQ26hZ5ECnDEKsa55IzggZOB6n61dtoPIgAtywGNoDc/L6k9zWWDqe0hzW6nocSYNYPFKjzqVopWXRJJK/m97eYkt15qxwyAxyLkiLGAfwqCIFZFnXyYV6OoU8n0qSRYkl88nDHgOTkn2FammWDn97OvlDG4ox4QeprrPnhbZY9OsJ76YrGxQlh6CuN0PffXdxqs4JadtkOf4R61Y8Sag3iS/XTtN3f2bAf3sgP+sb0rYtbWFLVduY1UbMDoDQBPCoeRvs8R3qAA/QsfatW0t1nyAu+brhulOs4WVbdD+8Yqdh24FLvhL7YxhR99S2DuoAZc20EcqTRRh1bg8YKmmw2/khSWTcD0HU1pqNkMso2FSOnYUmn4muQYkLKBwoA60Adh8O9AWfUInZ5lKnzACfumvYo1LFjnDA9h1rmfAmkvZ6Z9olGJX9fSupUFVKk57Dtk0AeefFd0sdMtbj7rm4GBXk/iq7a8ldBIse3tjrmu9+MGt276oNMeRfJt1DMD/frxvV7v7Rq0ZRwDgDP/ANagDrPDlqsOkyqrmOGFS8sgGMk9AKvJGU0dLcsEdommc9wO1MjAGi2trb5IncBy38VSeKpVj03U2Q/NsS3QjqKAPJfF0sEjWka7mnILE55Ari9Qk3XLegwPWuy8bxmDXECbSVtlUrXD3HMzgjkHmgD74/Zc/wCSFeGf+3r/ANKpaKP2XP8AkhXhn/t6/wDSqWigDlP21v8Aklmlf9hqL/0RPXxVX2r+2t/ySzSv+w1F/wCiJ6+KqACtqwbMS59Kxa09Of8AdgE9KAPRfh7cAw31qc9pBj8q3boh2bsDwfauL8E3P2fXYxnAlUpj9a7e/ARzt5yCefrQBmAlJj0rV1qH7doxJ5YoQfYjvWPPgEHnHrW1pj+ZbmE85GQKAOEgPyDtxgg9qspzTtTg+yahLGR8rHev41GpyKAJB2GP/r08njB6Him5605eeCPoaAFzzk9uwpwHAGPwpBgjjp60pJ5z+FAEch+vtXRaTDsgRefu9RXOqN8saerAfrXYWEfKqKANK3TC5xnj0rRs12xMxxyeM9KrFfLjUZwT04rQZSkOABwv/wCugDk/F10YrTaD88h2D+tcgi4wB0HStfxTcCfVjGp/dxDH4nrWaoxjk57e9ACEHBwOKjcDPHQVMOBn15IHSonI6dMelAFabrxxWz4OsjJPLcuM8hEz+prEkVmwo5ZiAAK9E8N2It7ONFwdo5Pqe5NAF65/0e1btgHtnNZunWu5/MkAyecHtWtqACxIhIznefSmQKI4t2AM8UAR3kmEJJwB3rirmU3Nw8mMKTtX0Ara8RXZWIxrgu5x9BXPj7vtgAUAKevHAIpm1pJAq9T6mlxnkmrllaNI2X2qW4AxzQB0vha3WKMyBcA/MD3IA4qpqjF5mYnnk/8A6q24VFvp5UcZGB61h3RDE8ZJ4HtigD1f9lzP9teMMjH+j2H/AKFdV8t/FfP/AAtLxlg/8xq9/wDR719TfsvDbrXi8f8ATtYf+hXVfLPxWP8AxdPxlz/zGb3/ANHvQBynI60Anb14pewP8qO/XigA3HjuBWxpzLJDz9ME8Vijp0rU00/ucZAyeuKANDTbaP7Yk0ikrn5vpVrWniOr27RRMIXGEU1o6DaiW2kd+Y0OMH1qPUEWTWlyVC26ZMeKAKuhMBqwcDhX+mK+pvhprIFnCCBnGDhuv4V8v6SQt4ZHXGWyB1Fes+Fri7t3WaykEigZKFcD6UAfRV35NxANrDOM+4ryvxtEksiup256sRjgenrU1j4nuJfkCtBIg+bcOG9hVLxcJp7WC7jyQo+cZzt9wKAOOuroyX0EhmlecjbG7jaAPpUqiGPduQGX7zAck+9ViJJpBKCXQDG4DacfjVhXMSQvCSXPGzILNQBHeXEMRO7bJO4yCRnH19KwbmX7Jbz3V0xedjtiUjvV29TZdE+Y0XmfNMmMgD61T0iD+29bWaXmyteRk8HFAHQ6CsXhvQ5db1PD38y/uVx9yvMfEEt/rgkvJrnZ5hJHPJrqPFWotrGpLbq5FnD2Wud1MKI+gwDhQDkigDkDa3kY3LO4BPODzXSeH/GV1pINtfxG/tB0ZTh0+lZl1EqKzAlnbjyyO31rNQFZf3XzL6Z5oA9etLjS/E9sHth+9HI38Sfj61iaxpl3pt3ayiGWcvKY1VQdxJQkD6ZA57VneFgXu4mDtCCeWU17JbXAg01BLks3ILfzqZwU4uL2ZvhcRPC1o16fxRd18jyKLS9YimdpLZfPlIJdugPp9B2rXt9F1CZ8zXsMPdkUHAqxq2tSTzqtnNMFMhVhEOfrmtLwJf3estPa3rndayEiTAyw96cUoqyM6tSdWbqVHdvVsqCCw0i0kvLmTYo+9c3A5J9EWuK1zxHd+IQbHSo5LfTif3krD55PetDxZHceIfFMqXJb7FatgAHqfpUNnpNzuD/IpViFVOMimQLZ2kdjZQrBGcIRhAcNKfpXWaVaPDj7SoEsnzFP+edULK1SGWK4bAlmyhdhkx4/lWs0itGriQFj8kijr9c0ASzh1RYXJZQ3PHIqFMK5kA2sPlO1envmj7SYCsjKFcDHzH7wrPu743G+K2lRkY5YDqtAEtzNJcTIluuIjwyk5Mh9hXo/w+8OG6uYmkAKhdxG37vsa5Twno8kl7G6r5s7DC+34V61qN3Y+DvD3+mzCJiuXw2DQBb1jxdo3h2bF5eJvI2iNPm/Suc1P4txLG/9lWGXPypPcN9w+oFeGeIdXPjTWHg0WI2tmhzLcseSPY1WNlqOhzApM99Zjkq6/MPegC94ynna8331x5txcsZXcViJOiAPcyeXIB8ihMu4+lM1rUVvbmN84UkBiw5WtEWrvcH7OVlukjysrf3fagDr4tYtE03TblSFEa7fLc4YH6Vhf2vJfWssDjy2ebHJzketcp5dxeAvcy+a2/GduNlb8EMVlqGlQhwUMnmSH1oA5LWJN+pziR9zI2zDdSK5GdsyMc85Nddr8kc+v6lcJglpSFC9hXIScyPnHU0Afff7Lv8AyQrwz/29f+lUtFH7Lv8AyQrwz/29f+lUtFAHKftrf8ks0r/sNRf+iJ6+Kq+1f21v+SWaV/2Gov8A0RPXxXQAlXtNb5mX8ao1ZsWxNj1FAHRaXN5N7by/3HB/DpXp2oOJIYJDjDLtyO5ryiBsnjqRXpVpP9o0G2kBIIFAFaY+hGPpU9lOyFSp6dcmqcuCwyOTwaSNzzjjAoAveJLRbu1W5gHK8jjp6iuZiIOMk/hXU21xhNrDKk4OKxdXs/s0pmiA8hjg47GgCshxgk/WpF4AweRye9QqeO1TLzjrz1IoAdgYye9D9e3A6+lLyF4H/wBemOc/05oAn02My38fHA56V2+lQkksR14Ax6Vyfh6MPcO3p8td9YRrFbGRhyFyBj8qABU33SrwAOoHOMVNfuI7Z2Ycck/1qraMDcqATzxz6VB4km8vTLjnGEIBI65oA89dzNPJKTy7kn86eRtGR9aZEDhc88Yx61NjjP4Z7UARtxn09KgmOAcfWrLDGctjHrxmqrqXcIudx4oAt+HrM3V+shyVU4H19a9OsoVigAbAAXP/AOque8KWIVCxHCe3OfWugvZNkG3HLccGgCkzfariRzwP6Ci5cBCTgADgVKAIYRuPzEZPvXPeJb0x2/kqwDyHGB6d6AMK/nN1fPKx+XO1cDsKhPGAfXqKVAVwKDkfNtwaAHQRtI2QOM4AHc10WlWv75QRyvJxyTVPS7c5jC9hz71vaYoQyHjbnqenpQBNqLBYVQdxyQawjzIR1wfWtLVZA00hzwoxWfbr8zMfu9Sf8KAPX/2Zl2694uGeTa6eT7HddV8qfFb/AJKl4y6HOs3v/o96+qP2Yn3694wOc/6PYf8AoV1Xyt8V/wDkqfjH21m9/wDR70Act6+lBzgentSH8aOo9qADvzWnpTExuq8nt7VmEY6frWjpbYDYI45PFAHY6QDJYQKsmyIyZcgfeIoAS4vdQuzhOdmCO1TWFnJ9isxMV2HMiBOPzptwwgsWkwN0rH3oAj0y33TLIeAWwuOtegXmoR6FowlkchiM8Hk1wGly+bdRA4yD24xXQ31i3iDVDEdzWVogygON5oA0fBviyzv7lTfXu2ctlFLdvTmvSYtfjkuJIJowwZflRsBiPUV5DrPhK0itVKbY8jIVOqH3NVNC1e4uAmnagxN9Zv8AupTnJSgD0290mxnmMthNy/3klz8v0rD1G2ayQMJ42VD36n8a6K8tYWtIHj3LK6A8Hqa5+8gDyCObAXvnpQBzE97cavcGz05H8onE0pPA9q1NUuU0jT1sLHaJCADxzVmJVguPLDLG+flVVyGFZuo2mb+R5AenXvQBlwklcByFXq3dz6Vl6sY1tGKs5ffwvQ/QVqSqEMI27NpJHbNUL2E+eWd1yDncegoA5m4M0krZVlRuNh7VNZ2LyDdFH8g4LU7UBD9okkDSSN/BhTya29HictC0i5VsfxcflQBseGtKMQWWYAnouK7eRne2SOZi8Q9eMVDo9mGmjXazE9MdBWrrdm8VtII2MbAfM4XJxQB59fzoJ5QqCJIwSAhwD711/wAJrMNZXc5YAyKTurz/AFKV57hrWJpHuHO0EgZx7+leiaSf7I0S2WEkFcBj60AcNN5kfinUUIJXrkdq1EEbAKhb5MFeeaj8SWgPiIX1vuaK6Xa4Q85qW1t5V3LJHIMDC7kwKAGy/uxJHtzuYMATmq93Kk9uYoVKsrYKqOD+NLL5STjewz3Bzx+AqbTbC+ncrawOqM335F2j8upoAovHPJsaaUMUO1SHxge9bug6NPe3aCCMtITzJjtW5D4Zs9Ltxe+IbmKCPr85wT/urXM+KPilDZW76f4Yh8kN8vnEfO/+FAHo194m0X4eaY7yTRXGrMvHOdhrw/V9d1n4jayz3csiWCHLHPGKyrLS7vV7p73XZW8v72wnl66uzy8Edppdtm2XmRooj8nsT3NAG1oNla2NmsNsj+WvzMWAw1avkvdsdsamSVf3hU8Io9ao2Md1Naxvcwvbwg7VDAZYepxWpYqHZYmcJFyVRePN+poA4bxLo0bRyXMEY3fdIjOVBFZEE8qxRq7bbmZhG21sECvQNahLWc4WEojdI0IwDXm9u6w3vzqrMHy6nqPxoA6a/snsPDwh/wCWjSAM2OcGtTVba1tNS0BVZBCkWWZu5x3qnrV/9r0iBgEKs4XHTn60yLzr+K4Mqoz2ybR5n3Rx2oA891UsdR1B3HzGRsMo4xXNcg5710Es7SGXLJtBIIrAPTJBNAH33+y7z8CvDP8A29f+lUtFH7Ln/JCvDP8A29f+lUtFAHKftrf8ks0r/sNRf+iJ6+Kq+1f21v8Aklmlf9hqL/0RPXxVQAVJAcSqTwM1HSjrQBvQt8wPUV3fhuYvoCoCcq5FefWz5VfpXYeGZj9kkTJwCcj3oA0ZmGTg9O5psbAtzz2zTZcDle56dRnuTRGePlAHYf40AWoRwV3bfQkcCpo3XY0U6FomGGB9P/11V+YqHLH5cEY6VKylgATxjselAGZeWrWcqhWLQNwkh9fQ+9CH88ZrQ+8rK67onA3Kf51nTRtA+1vukfKSO1ADzjHHP+etNY4HrnApNwwQD2601VeaRIolJdzgAdaAOp8H2hliQjJ3ktwOcV2l+BFbpGB156YwMVHoVjDpOnK1wRvxz7YHQVnanffaJc4wMbtuensaAJLNv9IXAGOv+fSs3xbIV0+Rc8tjIq1p8mJV6k9Mj0zWf4y/1CKAAGYdPSgDlY16AHA7VL0wQO+aRc9B9fqKe/C/hznpQBEwwoH55qxpkBklEhHzE7VFQFfMkCjufyFdd4X04GX7QcBY/ugjqaAN2xt/s1rHF7ZP1PWoWPn3Y7ovbtgd6nvpjDFtG0SP8qjGDnuc1HaxhIs4PXrQBFfSFQzHsM89hXA31x9svXlzleiD0HrXR+KL3yYPKQ4eU4+g71y8SDbjB69M0AOjHy46juafbozzKMcD5jj1prYVflP9K0NJty4UEYLnPHXAoA2tMgKoZDgknAOO1XnkWCNsYOfXvSrtgtSw25JAHsapXk2+dVye2SBQBDIPN5bJOc5x+tMvH8qAgcFuoFTAADcAMVja9c7V8sH5iCMUAew/spS+drXjRu3lWAH53NfMHxY/5Kl4y/7DV5/6Pevpn9kY51Lxl/1ysP53NfM3xXI/4Wl4x/7DN7/6PegDlie3bvQO3JAozx04oOOM0AIRz61f0sgNJnkY6VQ96uaaMyPyCduaAPSoJgmnwB8HyoPlI6ZrCvrsizRlxgLzj1q5YI9xZ2qqThkJYA5rF1I4tGDMAMkECgCXS5wJQSwGF3HNdz4FsZHZr+SWUCd8Iqnt6mvOLEx+WyqWLEbRjqa9j8LqtrpNnHCFDtw5POKANbVQfLcTpuhI2gbflPvn1ryfxLusdYtbq3ciRWwMfxL717HcJdPYztGqP5fyxIvP44rxv4lWstq9pcAFUkOTu67qAPRo9YW5jgR5Fjdk+Rwfumq93rJgiZLqOMP93rncPX2rzN797jT4NrbSOpXrV7zncgGTGRjJPJoA7e31NFlDRCN48YGWzj6GrkTQXYRW2hwc7n7+1cVp1vDJAzW5kSRDyM8VtaZZ3csmWkbd2waANS+0ASOhWUoevI3VkXPhu/BJytwjdgcY/Ct6Q6jbMvlRscDqec1PbeIFVTHeQ8/31GCDQB57d6TfBQrWzKmeMVqeG4gkhhuo5IsHKttzz6V16a1aN975lzgn0rZ019OmxIeMHIYgUAS6FHiJXgUCRDkggndWJ4sTXbq+kQSi1s2HOEyT7Cuxh8QaTpzkyzxAHqKyNc+I3h0KEm2OBzjIoA5HQtDtrOQyTCSSVj35J+tdY+jahrEKw2cJ2qM7sYUCuTu/inpMLP8A2dppY/3yM1i6j8W72eLy4Y5IUPAVDtFAHV3eiXkKrCkbrdwnKg4wwqzp+nT3cbfbbfY6/wB+Xj8q8quPHGv3Uzi2jcMR3yTUf2vxTqLKklzJAG9TigD168l8P6MqyahfQK3XZbJub/vo1yOtfFaC0Yx+H7Tyj0E8nzyH+grzq50uUsWv712BbbgNmtOLSYooLiazgR2gXJ3tux78UAV7q91rxPcM93PIVPLSSt0qxZaXb2ZQwH7TeOcfOc4+g71sabpEstnDcy4lt5Fyu19qufStrRfD9+l1a3UtjBFKhIRrWYMwU98HvQBl6Tp1xeSk6q09nb7tqEqFMh9PUCuztLSG0jSGzhCxbseWrEqW/vMe9SafpUFtcD7QryXSsW3ud7nPf0rTEazsiXI8xBnaVUgfU4oApG1jtn+RPLMbbpGjHyufTmpra2eG6E7lH3cgOdwUH09KHiU2biKYxMThWUZ3D8asIqLv2lGGwDk8Z+lAFHWIRbgtEUclT+77E15HrDvHdsSiRuDyo/rXs1zbh02ux3kfcYYI9wa8g8WwmLVZ4y2SPU0AQLehoQhlYIjK+zORXUb5Hi1dbAqGa2ExJ6YxzXnwaNGXnAIwfeuy064ZbO7CEh1tTkj+JfSgDhZrlZNOOyPax+YkDrWPj3GfbvWpc3AOnDCgb88elZgXHXvQB99/suf8kK8M/wDb1/6VS0Ufsuf8kK8M/wDb1/6VS0UAcp+2t/ySzSv+w1F/6Inr4qr7V/bW/wCSWaV/2Gov/RE9fFVABRRRQBpWL5jx6V0vh+fZOVJwGHI9a5OxfDEfjWzZzeTLHJ/dNAHYu2JGQAjIz17/AFpq5ViQBtxnHvUEsgf94D6GrMLfLyOOOn+elAFiPIIHIXu2eOaemSR22jb6E4/+tUAfj5yMDjpxx3qzC277y8OMkZ/zzQBL5WAGZlypzwOxqrdRCa1JBxKjZHv6g1oLG3ljeAFUcbqgeSHd5ZlUEdsc0AYkMbSnbjGzhuOh9BXW+GrSK0YXMgGV5Xjp/tH/AArJQReaNqkZPcdB3Jq/9pZ8AKduQgB5zjuaANq9vnmgQt8uT29PesprhleR2OSf1/z6U26mJVUVzgHJAOc//WqrhtqllIXnn1oA6PSUMryNHyVjBAHXNZvjQ4NoB3JOM+1S6ZMYSBG2CWznGe3JqHxV++srOQj5hyM9xjpQBz6HI4wR/Ohzg47d6YDzwSB+VWLCye/nVBjazcnPb1oAtaFZSXUoIU4J2j0r0GOKOxsuTsRBliec5/rUWkaULS2Ej4zjAA4FUdcufMkWEH5Iidxz1NAEMb/btRVz90Zx7D0rRu3WKAnHGO1U9Ih2LJISQ2No56fSqXim9aGBlVsN0/GgDldTuGu792ySi/KO/wBaYoIUA4z7VFCoAABzj3zzUjnAwD2A+lADoYzNMoPTOSOua6rS4Nq7mXk4GOmKydDtGkBfB+c+nUdq6O4IghADAEDJ9qAItTkCBIc/LuGT3PrVCJvtEkjKowDgfTuaiubksPXPTP8ASrtlAI7dcqfU47k0AFyVhjHBBA3EiuL1K4M10x/unaoA61v69ebIWIYlj3xxk1m6NYF5PPlH3egPYmgD2r9k63e31PxeJfvNBYNj0+a64/SvmP4rAf8AC0vGORx/bN7z/wBt3r6t/ZrQx6/4tB/59NP/APQ7uvlD4r5/4Wl4xxn/AJDV7/6PegDlthPIx+dB+Unj2pCfpSqx6Z60AHboan09sXS5HUEcVB154H1qS1YLcRnHGcUAeheD7q3SaFLkkbgVwOcVzmsKVa7RWG1JTg4xkVpeFhENQJfcEzyVPIFZHiDat1dbGdlL8N3oATQ4x9sgBOSen1r2vwy0a2UCKG87uyjIFeO+EIBPrC7j8sYzg8817jolmLexgcwsrE7gF5H1oA07eLzYwkbSPKp+Zj8ox6E1znj3wq2o6LNbQIq3CfvIip3Z9s11tu8ayybmZ0lXcQoJ5qF7yJYo2lR1XBBLrsJoA+bLVPssjRSo6TqcOvYGr63E8e4JaySHrmvRda0e01G9E8tq6MM8fd3e+ap2Vvb2xVJ0OBkKzDP4GgDkIdZv7cKDp8xUc8CtrTvHMVsVFxbvETxyvFdVBFC0OVEaD+Jl5/Cq95o8M1ujuinJ6bR0oA0tI8ZaddgCOcB/QHp+BrSnNjfJ823zCc704/MV5rq/hKBlEtmHhkY8bOOayF1bVNBuVivyZoA33gc4oA9oOh2UekeYHDzM3U9K8+8Uarc2kq2tr/rXOEUCur8L6tHfqvlyNLDKmVHoax9WsY4/HFrJNGzoYyQpPGaAONbRL+8V5NQunTuQWxUlh4e0+Nd13ch/cc/rXWXUULSR210kTy+buDQMWbH91hVx9IimuFaDSVjWVgoE0mAffAoAzdO07SYLhoooQ7ogYrMwAA/rU2pW2nRJJL9ngCMu5WdMKD6CtuLw8I7qTcUEx+XIXOB6A1c/sC3zulh3MOA0jZ/SgDjrV0e1t2hu7aEyn5thBZB75qS203ydZWVLiGVfvJtO7ca6j/hH7OZGZ0t0YnGBGPmqpe+GbOG3ykeMNhQhK80AZaaPpsxlfUI3OW3FwvOfStTStL0FTaNblYrlpNhwx2uvuOhrKu/CMMMqvbNdbv4iJSQSe2DW14bP2GBbLUUOxXyJWUED2J7UAatjbWvlXKvhhDPiMKoUAe1XpLeBrs2pdVaT5kjC7Tt+tQQJBPHNGJFdfNBQL8oA9zVkxObu4ngUoQAmRg5HsaAJmjSO4KRMRiPlWHQfWqQaSO2by2USXXyQqo6DuTV67kCRsnzKDiMFvmY5qRof+Jk6Rsyi1jAVkUck0AZupQLbyRxALO0CAA9RnvT7QSbJ0VYUmkxtiK84p0sab7gSrvn6En+L8qmtYI2u0wQFjTK7Gwc0AVb1XCorQsrnhkVuTXjvxDi8rxDtVwFdcnj7te0OVZGnwWkclUwcsfrXhPjK4ebxHeGUsVjO0E+tAHPkDzAuTgV18Nw1rod3cFNzFBGAT2rkrRHeUf7+M10+pBLbRpVfmGQgEk8k0AcfegCGMcKOpx2qhjgHPPpVzUflkUKAAF4AqsXwegP1FAH3z+y7/wAkK8M/9vX/AKVS0Ufsu/8AJC/DX/b1/wClUtFAHKftrf8AJLNK/wCw1F/6Inr4qr7V/bW/5JZpX/Yai/8ARE9fFVAC0lLRQA+F9kgNa9u42gZwOmKxK0LWTKj8jQB1WmzGS328l1Gz8P8A9VX4SU27gPlPPfiud06cQzqx+4eD/jXSKpMYKYPce9AFuPBJGBknjPQnPar9ooPLHJznn1+tZ0T7BuLH5u578VYjlItGZfvM2DjnAoAfeTyTfu4Scf3h0+g/xrQ0Hw8TdgztsLIcbup70aRCEhWVcF2+6Txgf/XresJoLeYyGRg2AMkZz2oAoXGgFDmGVWZhgKe1VWsJ7UAzKflU8jnmuge7jLny2KqCQXPJIPeqly7TI6o5U5PQ9u4oAxrmF4Iww6MdzADBAI61DbuCxzglcKBg9hmtO4Hyr5o2Kwx7MKxlCkR4dtpYk5PNAGnbFlmIJDBhn5TnrUniFybeIYwdmDjtxVa1U4UEEgnd16gCpNYbdHHg5G0LnvnNAHPwKZJkiYYyQCK73RrOK3RA4CJjpjkAVy2g26tqEk7LwkuxN3QY7/pXTNdALvYEA/Nt7lR0H86ALl/qbhE8l+M/Lk9/X+lUP9bHwoBzjp0+tZrXDSTyFiu4nj0HrWjpp81mDHKtzgcY9/8APrQBp27CG0U5yp6Z71xHiG4Mk5GSQTux7dq7G+kWGxJT7uOD2FcDOhnucZICjrQBHCflUKMnsB3rRsdOaeVRLkIT0z1p9rZNgFcMAM4A5rcs4AiGSRQABnJbjA7f/WoAtwhIEXy+HxhQOMVFcOHXacgsME+1RGQsxLHPQ5P8qjuZCY5Hycn5QvSgCmUD3MS4AVeSP5VoTTLHCCDjHJ/z3rPicl2bHI/Kp5Y28pWYfMcBAO3vQBjSRPeXZeT/AFUZ4BGc1txItvECevb3NQRxrEFU8kc+nNR3UzPgYwcY+lAHsX7Mshl8QeMWPe3sP/QrqvlX4sH/AIuh4xH/AFGr3/0e9fUf7LJJ1rxiTnmCw6/711Xy38Vv+Sp+Mv8AsM3p/wDI70AcrgYob9PegHNKOp9e1ACcY60+JsSKenzD8KYxJPNKv3gODyMUAdfobv8Ab3VFZwVydvHFU/EWN7FAFV24xWh4ddotXUhT5kkezgZGKzvEoaK4RGXHzHgUAXvBLtHrnyBTkYJYcmvaLVpvJiMsaqqjCouTmvD/AAuGXV7cmRlXPJ9favddIeSWGB2UlQ2BzzmgDStroGFRG4V067f4famztG43uA8x5BY7jirqQBZZFyQrDJUDnNP+zhZEAVN235iQBgUAY62CSFm3ZBG7dnkH0rLv7ANHtmRFL8nviumeMxzkBuGGU29CKz51gkBUKQZG5f8ApQBy8ulrEsojXESrkIv8R+tZ5FzFvaEqyAAtkncD6V23lhphuhCrH0B7e5rFvLUyXCuuQCTkr0P4UAZNjdR3gMiowydquTxnvVS70u2vLCaK8jJDMdpHrWlJCtr+6ZAUU7lIXjPrVK7lMRJjkby5e56CgCl8IrSSHxXp9nKrGJpig9MV1fj20ax8cNbpnZET8y9cVf8Ag5okX/CTafLuLqJt+89CKqfGC8js/i1qlvcsqCRA0II60ANtrSMxLhAsbgs2Rlifc1pWNuF+fkEDP4VX0qUyadFtI5X7rcH8q0rctIkpWNXZV4O7FAE0gTAySncEdc01ywQvjjOMg80M0xgB24QgbTw2DSSBS+15GRgN29Fzz70AI8beYilVk3HOR/DUEqxywrGwyXfBXOKlIdk80zcIM5HyhhUc5SQW00U6pbgEkEZJagCN1AtCrFh5D5wD0qeWzR2mR1QK8YlA9T71Fjfa3DyAEEYDEHrVm7kkAt4wWMjoEkMa8KKAKCQTQyyxxKhjkhzjBKrTdNNwHMUakkpyvb6itK5SBbpoJLhljSLKrG+Gb61U04mW/wDJYvGGTKsFySPrQAiXVwrKs8LSCM7iw4GPerlndRSTXD7tjXA+UBs5ouAiSOmJCVjzknj8ahktkS5sbl8MrR4aPGfxFAF0qqJ5alOmAxHzFqYESGGVjK2Ih1AHWmIslvmWNWmVTwhOSBUVzPE6MgHlRuc4cck0ANmIhsbi5uOJBGWU54RfX6187axcfar64lRiA7kgnuPWvc/GN2LfwnqDNkuy7FCDgD3r59YhmQDJY8daANHSkzPGWBOPmxWp4hnYQ2tuCNrfO2eeaqaemZFTGMsEqTXnB1B7ZQNsGOe1AHL3rFrlznkcVBngdqfOczOfUnNNU9dvAxQB99/su/8AJCvDP/b1/wClUtFH7Lv/ACQrwzn/AKev/SqWigDlP21v+SWaV/2Gov8A0RPXxVX2r+2t/wAks0r/ALDUX/oieviqgAooooAKmtnw+D0qGlU4INAGxC2cdef0NaVneTQgCNyB3BGfyrGgbIweKvRseDu/+tQBsC8lkJbjeeM+n4V0NuAkMcatnuR3Oep+nWuRtzyMckVu2dxvZCc5X9KAOpmP2ZCmSQSPmGBxUNhIPP8Anf5m5wOgNTXCGex8yHnPvz/nNY8BKyYztOPvHqD6UAdOjnlmwwA6jsPXFTQx4IdhtGOVXkj3+tZUFyjlgpZAvYDqf8K2dOdjMrAFQCNxxk7cc0AJfxq0UaBTmMFck8/55rGkQouGzhenHWt26YSyOwOFPJx1+tULhHU4zkkY4HUd8UAV4Ts+bnGB7d/0NMvHAWHfgZ+Yjt3NXEjbgN97HU8gH0+oFUNSUEBR1VWz7j+hoAXwxGJIjI56sWz+HJq1cTtI/XGRk89PTP4fzo8Po0drnbwvyjjtjmmOoKsTn5uuPT2oAqwAsrH7pB445ye9dNotsXddr5LqflHTA/l/9aufRcFWJAj5yfQVs2t0bezcxjDoOMnqPp/OgCHVJFYvGjA+X8rA1z8UKKXJOTuO056j3q+Jmmiffjkk8cHNVYx5gbJwBx6kD0+tAEsMjIy7CQOx9u7EfpVue7cxKu4kcde59TVYxqqMV5G45z3A6D86rtKRKXc5PA+p9KANGKdnkwv3c4qy0JKlACVTkk9zUWl2vluk0owwPAP8zWzqKx/ZgsAUB8Hd/n+dAGTEqAE5AXduIB9O1MuJi8u4EgfdX2x/KnyFVUR+YM4zhOTweRms6Zy5yAAD0XsPegCV5Mjb1Ht3HrVUhpJFCnJPFTquQzZwRyTUsMIUsW+4p+boMn0oA9d/ZhiEWt+LVH/Prp5/8fuq+ZvG+lz678cdf0i0aJLm/wDEdxaRNKSEV5LplBYgE4yRnANfTf7Msgk8Q+MiBwLewH/j11Xz9/zdJ/3Of/t9QBp63+z7rOgyJHrnjDwPpsjjcq3mpvCWBzyA0Qz0P5GuV+KXwt1n4brpD61eaXdJqYkaBrGV5AAmzJJZF4PmDGM96+tnhufDXxr8Ua5relanfaTq2nW8NncWVjLeCMIMSQskasw3EbskY968p/bPEQ0v4eiCzNhCIbvZasioYRi3whVSVGOmAccUAfMfU/1pYwTKgPrimj9PeprPm5jGM/MOKAOs0OP/AImykMQI0yeetUfFAP2uHqwY5yetaPh5fN1XmQJszjP8XtWb4nbN5G6hgVYg9qAF0InzbdwCSZgBivftNWOG1UAPIVIJHTH0NfPenS+XZNMCRslAB9Ca970Fpo9JsRHtlV8F3J5NAHSWibpGa8kVUY/IoPIHv709YYImlAty7A4QKTvf60xfKKSGOOTaGABI5Y05T5UkwWNvPZeo5IP1oArO4QlSiRvnj5ske2aUIGlfzZFZEG846fh71Fkh0ARPkX94p5wfWhojHHGgDO33ifX2oArsCtjKo3gXDbmaRuQB2FUpyhlQjGNnGDVyZtyDc7Fd3zbhkqfSqUsgjvT5kfzRDJ4zn0oAztQJ2hjIenKEdK5zUGa5uobeIjzAf4TnA96d4t1gWrvb7v3rneQfSovBkTtcy317G8sKsCFUdqAPZfgvp4ivRNKR5aOEBHXNcr+0daRyXt/qMKK99byKm70X61674N01bbSbe8itBbveSBkUnPyjua868UWjeI4vFkbDcszlIwBnLL3FAHJ6Ptnt4OfNPkDfngpx61s6eI1t3jtztIOMkbg1cX4L1ZrvS0Qgo9lJ9nnGANwHrXZ2nltM4SPOzkZb5R+VAF9VKRsjQneTklTtWoZpELEpIQOjLg4+masQJLjbMrBl+cKTkMPWoJQZOHlY87l2jCp9aAJbtN6woiqFbjJPb6UTIrXoCLG2FwIyB+dOvYpjHHHG6G5kI/eN0x9Kje3h3SSIESSMYZU6MfegCKZncwsfNOHwwjGBVi58zeWSJwTIPn3bdw9Kq6lKsMViLh3iWRvlSIZBPvWi8G+SCMxSySgFnXPAHvQBSu0hivGuT5CnGFY5+X2JoiZ7i4tZZsFGBwqcbhUck1ufIgtwwR5Dj5cqD/WpIT/ptmTKzqzMuWTB/wCA0ANZXM7sygQhCVwen1qYl5W0yPaDIY2k+U4wB3qqTlJxE+AHKBc7mYf0qzBuXUmWKIgw2pARmyefegCSwzJbB1ZmkkYsd47D0qhKyGWMzJuaQkhsfdFXY5/JsYxKFjlMRVNrZGT2rOuCsLqbiQRrHEeA4bmgDg/iZqSw6U1rGrC5mfBweAleV2qB7pFPRTxj0re8Xak2p6hPI77hESqvnOaxtLQ/vJWB5GBzQB0Xh2FJr238xlEbSbixPAArP1eRJtTv5FCiJXIRs/exWlp8GLKS4AAjjXDMeeawbxgtrMVBzjqR60AYjHknPXvQTnIzxQo+uf0oB67ev0oA++/2XP8AkhXhn/t6/wDSqWij9l3/AJIV4Z/7ev8A0qlooA5T9tb/AJJZpX/Yai/9ET18VV9q/trf8ks0r/sNRf8AoieviqgAooooAKKKKALtowwPX6VfhPT0rLtzgg54FaMXB57UAaVtzgZwevSrcLMjZX5SDkdxVS3PzZ6ntVtcdF9j1oA6fRdRAgkRhkBSdnYH1FWRCJ5hHnY+3oRwR9a5ywcpKWXO7aRj1rodNlATO3zATwDyVHr+NAGxa2WBHl0AAwFxzxWmiALiNTsxy4OPqKyXu50y4yD2GMD0qNNQkLsBvbaec8D/ADmgDbw0e3cmeeBj+VMCK74G4seM5yayTc3Ekuya4kwvXnAPv/8AWq1BIUTO9wSOSc4A9B+dAElwUiR2diFjXOB3H+OayrRTLukkPVjwOR0qLXbyYSRwIh3Mw38g/QflV23CkAIGAVdvTp70AWLcmODIwApA4qRosIAfmfPQDkVLFF+7CDAIwSPX6f40zoed3A/zmgCi4/e8Z2nqT+gAp+dlrsPLZwWzwMdhUkrrC5ywPQqBzj61G0m4FiNxB5wOOv8A9egChFJiJxkgHjafUVZiiCx4U85xgjp/nNZzOXk2rllJIHp1610OjQLcPzubglyB0A7f/XoAh8tvL+ZVAGaghhWOR1AzjGDjnFaE0gZnxtCdB7Cq8qlVztxsOODwPSgCaJgr47fdXPYenvmmXtyZLRVV8EcFgOT7f/XqFiGjBbjgcY6mqk7ZU8jZ2x2NAEbygoxHLHnA4xjiiNtwUg/J698VBnOSuMYOcDIB9fenxF1bg/JtyGB60AW4WKxncqhm5Cj26GmXlytrZOXOCMk96RnJ6DPQYI7+/wBK53X7zzpvJRyUT7xHc0Ae6fshSvNqfjSSQ5Zo7E/rc185/EHULnSfjP4l1LT5fJvbPxBc3EEm0NskS5ZlbBBBwQOCCK+h/wBjlg194zx/zzsf53NfS1AHwF/w0F8Tf+hn5/68LX/41XK+OfiD4n8d/Yf+Er1MX/2Lf5GYIotm/bu+4q5zsXrnpX6T0UAflfkfj9eKmsSouULsoAPU9BX6lUUAfm9ok1mZZXmuYIwPu73AJP51l+IJ45blGjmicd9rhhX6a0UAfmHDPENMlXegkLg7SRzXvHhnxBosGgaak+raXFOibpFN4gwfpnrX2JRQB8pR+LNDkImbxBp7PnhHu41A/Wlk8UaJKUC65pCsD1N7GB+JzX1ZRQB8oDxN4eRlzremsc/Mv2uPB985qO78T6EsCMut6XJKr5AF3HwPzr6zooA+QZvEehglf7Y0vYzh3K3UZJ+nNU73xHorR3EsesaeNzgKouEyR7819lUUAfnH4g1C1n1mYx3Uc3nOBv8AMBVR9fSvZ/h/N4YtvsNrdeItFikbEk00t9EqKP7vLda+taKAPK/+E88GpJIyeKtB8u1jIjH9ow/OcdhurznQPGnhm3F5HNrulJLLM0qN9oTaM/jX01RQB+eUOsWmk/ES9VLyCXSrqcu8iMGjyTnORxivRbHxHoaNcsdVsIlPygJcp8w+ma+yKKAPkgeJNGEsU7a7pJxEVZTdx7vYdetR2nivRHmhabV9PAkQgg3UeE9M819d0UAfJD+JtBWGIJrOmZzywu49w/Xiq9/rmhyw+VY69ptuSwaQm7jJf8c19f0UAfItz4i0UxLFDr2mpyDvN3GxUe3NWj4n0J71Gh1/TkUxFHd7yP5vwzX1hRQB8fXHifQWWELqtgBaq2wJdINxPrzzVv8A4SvRt+n7NW0pFWJm5vUJRj6nPFfW1FAHxxe+INJY2UEWvaakbOXmMdzH+pzWjD4q0GO/uDHrGnksmxS13GFx9c19bUUAfI7eJNAWxmiTVtKLFcEfa48fhzXJeOvE2m2dnHa6ReWEyvDhzbyq/J9SDX3LRQB+X88iCONfMQnG5trCrVjLCkRHnIpbsWFfptRQB+dAvLSLwpcAXdt5zuAIhIpb67c5rlr2dGjyJFdmI6H0r9QKKAPyvyOvH+FBx61+qFFAHlf7Lv8AyQrwz/29f+lUtFeqUUAeAftrf8ks0r/sNRf+iJ6+Kq+1f21v+SWaV/2Gov8A0RPXxVQAUUUUAFFFFAE1ufm4rTiOB9DWXAcNz0rTj+6OelAGhb/wkfyq2h45wapwcH2q1G3OD16DigC9ZZaZMdQeMd66bT544QwijwTg1gWSbG44OOue9aELFXyMgheM+h7UAdJbeXdFjjHJJHXjpnmpmtSMgAjJPLcdPSsG2uWQttA3ZOCOMYrXttSD539cgYPpigCeRTKMYPcNng1SmlMHyqG4HA9c9c1owN8yhXPT1HPrUK28VxM5kY+yk4BoAzrRfMk86c7t3yqcdR3NbtlahRgDcuMD2HrWVesIpY4xgY/T/PSrltf5icY2tjBB4z/9agC3JIgxwCVyAT6VXkkxGxbJXksc8/hVeS9iCliAzDG5QOGJ71XmuHllwqgA4Gfp14oAncq8ZUjBxyw7d6zjCzTjypVG7kgnBH+FXJ3ML7tzKxQqcdvSorYK4klAGSfL9+nNAECxhEZ2+UnjnpkdhXVeH/8Aj2neLGXXKsPpWDIiyTKGxlRkZ9KuWE7W0TKCV3HIAPHPYelAD7gMXZ1VGU/MAD+YpjSB4lYrmPHfr7Go5H3b1yN2dxwePfHt70WiiXK45bpzg9OM/WgCKFt25crgnJIOOf6VHNEXxgDcOCPT3qtqdrOu6S1DGROoX+L149qhtdXWUk3C7JQeSv3W9yOxoAcUb5ccH6HgZ9KA3yZblc9R1qdp4Xj3K5J7571Ulk2ZJJAGSfTFAEd9cmG3fHDnheefrXKTyknAJ56nNXNRuvOkY/w9AM1lStjOcdc0AfR37Gf/AB9+M/8AcsePTm5r6ar5h/Ytk8y58akdlsR+txX09QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHgH7a3/ACSzSv8AsNRf+iJ6+Kq+1f21v+SWaV/2Gov/AERPXxVQAUUUUAFFFFAEsP3q04cdqyovvitSDkDHagC/B34HrmrUHMwXPHUe9U4OeoOKnRsPnvkHFAG7aHjHqRn2q8hIAIYkt147/wD6qpWLrIqtjO08+9XGdY9pVvmwWOOozQBIgVQSSRkDIz+HNWUG87lJ4PbgfT+lVAwCrtXdu9emKvWpQq7n7uM4x/nmgB5vHiy5PIz82cHn/PWktLsmIlFBPQ55JqtenIx1UjGM/rSWS/6MASFwM5IoAszM0k3zOHI6bu5759Knh+UxbRmMA5A6n1zRbwLJMFDnY2CwHUcVrWkca2xM65kbhe3Hf+QoAqQWaD7x+SJjx3JNDWu3Kod7KoaTI6E9s+tXjBFvjVnZiGBbPGD2qtLAFDzKxKSSBTjjaPpQBm3MpD5Kgg/eJ9PT/wCvV20i22qKeSckHrgH+tUZ9skwBHysc49OcdfpWokm6EsoXd1BGQB2FAFVjtG5QBuyAD/CBTGZgjA4wORjr6U+7kChnAOQMDI4yeCT71Wtl8y5EWPmU5zkDPrigCcoyfvXALrj+XT8qlhdgFIHBO457VYNuWAkCZOOT71JHbBN4UkncDnHAA5oArXEvm7CdqS7uM55HasbUESbc8iKJCfvKMHitO4VCu5ivzMcf59KyLoNhs4PGTzz9aAKAnaEsAckHB96rX15LKjAt8vcDgZ9Ka7ncx/UCqspA7e9AEU7DAA4I6E1lXsoSNsdquXEgC5x39Kw9QkzhefWgD6d/YbYs3jdj3+xf+3FfVFfKv7DH/M7f9uP/txX1VQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHgH7a3/JLNK/7DUX/oieviqvtX9tb/AJJZpX/Yai/9ET18VUAFFFFABRRRQA+L74rUt8YFZSffFaluOBQBdhIzx37VOp5O3rjOOtV4yATyRVgDLYPPbigDU0pwEZc4y2RzxWk5IwRyAcfQVj6eQHK5AbqP8PyrbALwq2Dweg+lADFYqwU9+B71rWgJgDjjJ+o6VllSXKsxUHlj6CtG2cqPnyPQdfxoAhusAbeMYyBUlkP3cYDHJUDgVJqEe6IEDBOMk9hTdNJdEXjGdpJ7UAaFqfLndg2WHCnHX3rRE4j3DLbQoKl+c45JHtVa2wjuqkqGiK9sj3+tNmckBnLDC4UL3+v0oAsRvLK2YlyMZ3Ec5Of0xTo9zyOwZjHGA/P6GokYiRerDAwemSD1/KlfeSAhG3kKTxnnv60AUtQiUSoygiJz37E1IZGMOclVAIziprpkYp8rAN8pHuKhUeYggON+7Oen5CgCvKrTqwVef73bkdqv6daCEpK2N4O0HPOPU1JawKLdDIpBPbHFWflAAZcHOVHcDuKAJ2P7zKjDE/dz/KorgL5bjIG7kYPU1MjfuNyhd2Thc9QelVJZQq4xjaRu+v8An+VAGdcsg+VcYK/5zWFq0pQSKCQOcA/z/KtO7mMjLjgHgnHVawL0h5nbGN2cj04oAzmbOPrxUMxzwDUjHjtmq8nHQdePSgCpdHjg4Haueum3TMRW3fNti3enf1rnz1NAH1T+wx/zO3/bj/7cV9VV8q/sMf8AM7f9uP8A7cV9VUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB4B+2t/ySzSv+w1F/6Inr4qr7V/bW/5JZpX/Yai/wDRE9fFVABRRRQAUUUUAOT7wrTtumTWWvWtS1BwOmaALsf3gB0xirKnOOB6YAqtGASMjgc1ZX35PH86AJ4vl+6MY6e1dBp7rJGMg47jvWCvXoDV3TrjyJ8Nna3H4+tAG+kKk8HJJwMjHHSrKGRX3E/7oxjHNJD845z8oxipyVPK4Y7sEHpjsB/WgCQwLJCy7cq+cn+6fWsq3Jt7h4XyoJwV9CP/AK1bNiUaQxnDbvuknALdh/Oo9Y0/eWcLhsYPuB3oAs6e6NIrOp3AHHcHPQVI6BGYMuWAyoU884/z9KxtFvC8rQzE+ahwMfxe4963lH3jgYIwQen0/wDr0AQrEwULEfmI4ZemfT6ZzTtgJJBZskn5eo9vzp0cWwjCgFsdePp+NSKhTIjBAK9xjn60AV7oH7XGrDvz2zUZTaVkJGActzReMzKB907Qx+bPHt+NVZrmT7MyMivJ0GR+p9aANU3C+SIweBkg44Pv9KqzysQxJDA/jjFULCeWdMzEs+CCT6f5/Sn3MrbkjX5T95Tnpn+E+2aALUNzs4ySn97Pb61XvbhvI8ssCWHPtz69z3qg7l3O8tls5x6gHtVWSd2b5zuT7uCeePf1zQBYmLuW5YkcDnjNYl63zbc5JOT7Cr9zLtU5znq5NZEzEszMeSe9AEDkngfWoJTzxz3BqZjnHYfTmqcpJyedxoApamf3LDtjoKwq19Qx5bE9xWRQB9VfsMf8zt/24/8AtxX1VXyr+wx/zO3/AG4/+3FfVVABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeAftrf8ks0r/sNRf8AoieviqvtX9tb/klmlf8AYai/9ET18VUAFFFFABRRRQAq/eFaVsRgetZo61pW2QByPpQBoJzjsPerAGWB7+gqtF645x2rRsFGDJjdk4WgC1bWhKncSSRnANLc25gdWzuifo3ofStC2RflHXcvrWhDbpcRGIqCu3PoD+NAFTSLwMqxu2GUdT/EPp61uxFJUAwozzz/AF9q5m406e2Ikh3Mi8gj7y4q7p+oh2CShllHYjhqANtCrOw4xu+6eD+da9rMkibJP9YOjgdfasaJmdlydpPr0q7Aj7zgMSVA+TsP60AZGqWgt7wTJ8qtgMAeh7Ee1UYr6TmLMjEMSCGwy/41papuEgBYAj5Qq84781n6ekczrhfmbIJJ7g9RQAj6x5DHzPNfaSfQn05q5a6m8wEcR8ttuAckkdDx78U/U9OhYAKpDAgk4zyeawbcTW86IAGkD9Sf0+tAG/LAUiDCRpA65zkjdnrism7DZADsWY4yGNbgb/Q4Xc7QOQxH54/LH41i3ZDM5RSFyQeec+lAFa1lZNTgbcdrsMjOecYroJUJVSrcg5OO4Nc3AR59uv8AEJQT29+K6u32Som7BAHIPYetAFHy9wHLbeoAONvtUMsawxb5EAOT17mteYw28akqozyM8kfWuc1W5aZzz0zj2H4UAVJXad+M+uPX61VuI5EHzjAPfsa0reLjdjPYfWo7lA1tIDzgbvpQBiyN8vHUjtVSY9uoNWJGyD61VlPUg5zmgChen9ywz2rJrTvfuPxWZQB9VfsMf8zt/wBuP/txX1VXyr+wx/zO3/bj/wC3FfVVABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeAftrf8AJLNK/wCw1F/6Inr4qr7V/bW/5JZpX/Yai/8ARE9fFVABRRRQAUUUUALWjbdAR0FZtaNqeBx0FAGjGSPete2UxxLngKuelY6fcIJ7d63c8bsDhQaALVp8x68kjB/u+9a0E/luGB2qMnafQ/SseLKM2SByDx3qeGQbwpUbFOfXj0oA6eBormIsMoMgYHY+gqtcWavk43KB6Yqla3DJIzow3knBPOB3rdtsyxghAp6bCc8e2KAMq1le3VcZZePkbr0zWpHqKGEgbs9ApXI/Opo7COcsRkHPIIwPTr+dJNpEvl4EZYAYzGeKAMCdmnmEjYUZwFI6DP8AOqGmXUcN15dyihRIxWT+HJ7fQ8fStx7KXZkKVUAEce//ANauekhkFy+Q4jR2JwpIJzzx6UAdTdZUs7A/vOGAPKnHGPas26iiD/MCFzwWHIGO1Vobu6ENsssUjxK2F4IIHoD3/Gknml+UtDvDBtrkfe5PH6UASmdfKSGYfMp4OcA8f4GqMky7i2M4P4g4qlc3M7qrrEd4GMbT0HfBrPEkswUt5hVh2B5oAt+aJNQt9v3Q+QR3NbouZUG1WAOeuOa52zBFxbllK4f72Olbyxu/yqmOM+gFAEM00rAbpHIznk/nVOQAghBlz0Hqa0zaEfNKQSOdoP8AM1PDEkS7ggAxuyO/pQBKYUigXc3zBQTj1PU/XtVKQqrksRtPBAPGDTpZz5oBLEdAOgNVpXLBeQS/B9j6n2oA5udfLleM9VYjOKqyHuOCKt6kSbuTnqQT7nFUZDgHAJxQBn3R/dnk1Qq7fHgDj61SoA+qv2GP+Z2/7cf/AG4r6qr5V/YY/wCZ2/7cf/bivqqgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPAP21v+SWaV/2Gov/AERPXxVX2r+2t/ySzSv+w1F/6InrzX4Qw6Tpf7OPivxRc+G9A1fVbDUysLapYpcDaVthtJOGx87HAI5NAHzpRX2z8L7bw94i8W6rouseC/B5W3soLyCVPDv2CWQP979xNucqCcbxgH8a+JqACiiigAq/ZEbR1x1PvVCrlkQVINAGtGBt/DvWwhJC5ycqMflWRFyBkHnvWrD/AMequCu7aB+NAE8TfICCMsCfqRVq3/eGMNnB3KO3NVEJVgBjA5AA9fSrMI28sc85+b8xyKAL0YH3xuCgZwRzjFXrNyREqnJB2jI6mqX3YZwuc/IAfUHqKsQHbMfMGdpBJJx2oA6Ow1FGhBkQs7Z3Ac5GcDFbcN0oTCEKTj7oPHr9a5KzQmXbgKFByfTPStSKeSNQ+4qCeCB93HHP1oA2t0bx4LqUyAF65FV5IInAKmInB7dcVlxSElNrNuDbSoH3fao0yWf7xYnoBj5aANIQkFsmIBQduDnj6dqk+zIwyAqBQW2h+mOwrIHnIgJdozjc2DinJLztJGVJ5APt+dABqdmgG4bj6hj096xJYkAO0Ek9DW5qsqmw5+Z3O3jjAx0zWPBhrmPJ4BGcnGDQBPaWaxKDLl2xgA9+KcVZvQegAx+FTIN8qhh2PB9Aam2bVyTyTk+/+FAGfMuQNg3H0I61UnAUdQTjPJ4//VWq6sMD5Q2cEDt3/wDrVl3QIYjhSoyQw69z+FAGdJ90AqDgk/U56VE6kqAOdoC/QVNOy5JA+bAyT396hTlW6b6AOevhi6Ix1UcGqUuCSCeRg/WrmoEG6l29Bgcd6qMMoMd6AMm8Pz9R9KrVavv9ZVWgD6q/YY/5nb/tx/8AbivqqvlX9hj/AJnb/tx/9uK+qqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA8A/bW/5JZpX/Yai/8ARE9eW/BfxX4Ci+C+v+DvHeuXGmHUtRaYi3t5Xk8vZBhgyxuo+aMjB9PpX0l8a/h1/wALN8K2ujf2p/ZnkXqXnnfZ/O3bUkTbt3Lj7+c57dK8U/4ZG/6nb/yk/wD26gDpfDPxF+EeieIpNem8b6lqurtZrp6XF9Yy5it1O4RqsVuigZ5yQT79a+MK+qv+GRv+p2/8pP8A9uo/4ZG/6nb/AMpP/wBuoA+VaK+qv+GRv+p2/wDKT/8AbqP+GRv+p2/8pP8A9uoA+Vas2Rw5HY19Q/8ADI3/AFO3/lJ/+3U+L9koxtlfGwz/ANgn/wC3UAfOcJOME1r6eQ9mVGdwk6ete/L+ytKvTxon/gpP/wAfqxb/ALMN1ArBfGkRBIPOkHt/23oA+f8AYdoJx3OR/Kr1tg8KMjB4HGMHoa94H7NF0FAHjC3GDnP9jn/5IqSL9m69jII8Y2x4xzo7f/JFAHiCqfLP3jyDk+2au2Sr80kj5RUzyPQV7MP2dL8f8zlbHgjnSG/+SKkH7POoBNg8X2mNu3/kDN/8kUAeP27tnLrgDBbtnjtUyyNGArLkxjJ9CD/WvXU/Z91JXLf8JhaHnodHbHTGP+PjpTj+z/qZLE+MLPJ/6g7f/JFAHkkbAhvl6Nzx0Hemo7sMnhgxJGc4GOK9e/4UDqnP/FYWfPX/AIk7f/JFOX4B6ooIHi+y55/5Azf/ACRQB4+GwTgAHcMjucA/40KSSvPQcL1JPevXv+FA6lz/AMVbY4P/AFBm/wDkil/4UFqec/8ACX2R/wC4M3/yRQB45qZLJEGbO3nP8/wrPt2/0oBduMEDPPWvcZvgBqcrAv4vs+Bt40Zun/gRUK/s8agrA/8ACYWnH/UHb/5IoA8oj4EcYHIJBH/1/pVwAGJVAGOuQevpXqafALU1wR4vssjp/wASZv8A5IqcfAvVhHs/4S2wK++jP65/5+aAPHbtQBtILkZU45AArPusyI+8bgG25J5AI7V7dL8BtWkLE+MLIFuTjR3/APkmoD+z5qO7d/wl1n3P/IHf/wCSKAPAJYAF5BIYgBv04ot4gJPK8wMHB6Hk173J+zvfuMHxfaDncMaO3B/8CKij/Zxvo5klHjG2Lo2RnR2/+SKAPmG/BN7cbs5DEc9qrOuRjv8ASvpmf9l64mnklbxnEGdtxA0g4z/3/qI/ssTEEf8ACaR4/wCwSf8A4/QB8o3wxLiq1fV037JZlfc3jUA+2k//AG+o/wDhkb/qdv8Ayk//AG6gA/YY/wCZ2/7cf/bivqqvKvgX8I/+FV/23/xO/wC1f7S8j/l08jy/L8z/AG2znzPbGPevVaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The images of the right wrist are from a 25-year-old male who presented with wrist pain following trauma. The initial plain films were negative. Follow up x-rays in the AP (A) and oblique (B) projections of the right wrist reveal a subacute nondisplaced fracture through the mid-portion of the lunate (highlighted in A and B). Subtle heterogeneity of the trabecular pattern is noted in A, while the fracture is obvious in image B. The T1 weighted MRI arthrogram in coronal projection (C) confirms the diagnosis of a subacute fracture (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Waite, MD and Anthony Romano, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3254=[""].join("\n");
var outline_f3_11_3254=null;
var title_f3_11_3255="Postprandial (reactive) hypoglycemia";
var content_f3_11_3255=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Postprandial (reactive) hypoglycemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/11/3255/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/11/3255/contributors\">",
"     F John Service, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/11/3255/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/11/3255/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/11/3255/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/11/3255/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/11/3255/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoglycemic disorders cause symptoms primarily in the postprandial or fasting states, and rarely in a chaotic fashion unrelated to food ingestion or deprivation. Some disorders that cause hypoglycemia predominantly in the postprandial state are the noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS), postgastric bypass hypoglycemia, and insulin autoimmune hypoglycemia (",
"    <a class=\"graphic graphic_table graphicRef70726 \" href=\"UTD.htm?4/19/4411\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The diagnosis, evaluation, and management of patients with hypoglycemic symptoms that predominantly occur in the postprandial state will be reviewed here. Other causes of hypoglycemia and the diagnostic approach to hypoglycemia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44664?source=see_link\">",
"     \"Hypoglycemia in adults: Clinical manifestations, definition, and causes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24184?source=see_link\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Postprandial (reactive) hypoglycemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postprandial or reactive hypoglycemia is a descriptor of the timing of hypoglycemia (within four hours after meals) and is not a diagnosis per se. Its presence requires an evaluation to determine the cause of hypoglycemia.",
"   </p>",
"   <p>",
"    The term reactive hypoglycemia is often erroneously used to describe a functional or idiopathic disorder observed in patients with nondescript postprandial symptoms and no biochemical evidence of hypoglycemia after ingestion of a high carbohydrate meal and with resolution of symptoms after dietary modification [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Postprandial syndrome'",
"    </a>",
"    below.) The danger in considering postprandial (reactive) hypoglycemia as a disease itself, rather than a descriptor of the timing of hypoglycemia, is the failure to search for the underlying cause of the hypoglycemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Postprandial syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the remote past, patients with symptoms suggestive of increased sympathetic activity (anxiety, weakness, tremor, perspiration, or palpitations) occurring after meals were considered to have functional hyperinsulinism or functional hypoglycemia, as a reaction to the ingestion of food. The diagnosis was based upon reproduction of the patient's hypoglycemia symptoms in association with a blood glucose value of &lt;50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    after an oral glucose tolerance test (OGTT) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/4\">",
"     4",
"    </a>",
"    ]. However, the value of an OGTT in diagnosing reactive hypoglycemia has been discredited based upon the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At least 10 percent of normal subjects have nadir blood glucose concentrations less than 50",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (2.8",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      during a four-to-six-hour OGTT [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There is no correlation between blood glucose concentrations and the occurrence of symptoms during the test [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/6\">",
"       6",
"      </a>",
"      ], and any abnormalities are poorly reproducible [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Many patients with postprandial adrenergic symptoms have similar symptoms after administration of a placebo instead of glucose [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Serum cortisol or epinephrine concentrations often do not increase when blood glucose concentrations are low or symptoms are present, suggesting that the fall in blood glucose was not sufficient to activate counterregulation and making it difficult to relate the symptoms to autonomic activation [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/8,9\">",
"       8,9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=see_link\">",
"       \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In a study in which plasma glucose responses to a mixed meal were compared with those after oral glucose administration, none of the patients who had plasma glucose values less than 50",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (2.8",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      after oral glucose had hypoglycemia after a mixed meal or any EEG evidence of hypoglycemia [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/10\">",
"       10",
"      </a>",
"      ]. In this and other reports, the patient's typical symptoms occurred during both tests even though there was no hypoglycemia after the mixed meal (",
"      <a class=\"graphic graphic_figure graphicRef72850 \" href=\"UTD.htm?26/7/26750\">",
"       figure 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/10-12\">",
"       10-12",
"      </a>",
"      ]. These findings provide especially strong evidence that oral glucose tolerance tests should not be performed as part of the evaluation of patients with symptoms of hypoglycemia in the postprandial period [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Few patients who have symptoms suggestive of postprandial hypoglycemia have low blood glucose concentrations at those times, as measured in central laboratories on self-collected capillary specimens [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/14-16\">",
"       14-16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of the above findings, many experts do not believe that functional hypoglycemia is a true hypoglycemic disorder. This disorder is sometimes referred to as postprandial syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of a postprandial hypoglycemic disorder cannot be diagnosed solely on the basis of postprandial sympathoadrenal symptoms. Postprandial sympathoadrenal symptoms may be highly suggestive of hypoglycemia, but they cannot be ascribed to hypoglycemia unless the glucose concentration is low (&lt;50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [2.8",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    at the same time, and the symptoms are relieved when it is raised. This triad of symptoms is called Whipple's triad:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Symptoms consistent with hypoglycemia",
"     </li>",
"     <li>",
"      A low plasma glucose concentration measured with a precise method (not a glucose monitor)",
"     </li>",
"     <li>",
"      Relief of those symptoms after the plasma glucose level is raised",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Only those patients in whom Whipple's triad is documented require evaluation and management of hypoglycemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44664?source=see_link&amp;anchor=H2#H2\">",
"     \"Hypoglycemia in adults: Clinical manifestations, definition, and causes\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The purpose of the laboratory evaluation is to document Whipple's triad. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24184?source=see_link&amp;anchor=H6#H6\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\", section on 'Laboratory testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation of patients who have postprandial symptoms of hypoglycemia should begin with measurement of plasma glucose obtained by venipuncture during the spontaneous occurrence of symptoms. When this has been performed in patients with postprandial sympathoadrenal symptoms, the glucose concentrations have almost invariably been normal [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. On careful evaluation, most patients with these symptoms after meals have some type of psychoneurosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/6,17,18\">",
"     6,17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, patients who have documented biochemical hypoglycemia (plasma glucose &lt;50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [2.8",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    at the time of the postprandial symptoms or have neuroglycopenic symptoms after meals require a comprehensive evaluation for a hypoglycemic disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24184?source=see_link&amp;anchor=H3#H3\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\", section on 'Approach to testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should be evaluated in the postprandial state either during the occurrence of spontaneous symptoms or during a mixed meal test. For a mixed meal diagnostic test, the patient consumes a meal of solid and liquid composition that usually leads to symptoms and is then observed for up to five hours. Samples are collected for plasma glucose, insulin, C-peptide, and proinsulin prior to ingestion of the meal and every 30 minutes thereafter for five hours. If severe symptoms occur prior to five hours, samples for the above lab tests should be collected before the administration of carbohydrates (to assess for correction of symptoms). All glucose samples are sent for analysis. Analysis of the samples for insulin, C-peptide, and proinsulin may be limited to those in which plasma glucose is &lt;60",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [3.3",
"    <span class=\"nowrap\">",
"     mmol/L].",
"    </span>",
"   </p>",
"   <p>",
"    If Whipple's triad is demonstrated, sulfonylureas, meglitinides, and antibodies to insulin should also be measured. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24184?source=see_link&amp;anchor=H8#H8\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\", section on 'Postprandial evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Standards for the interpretation of the mixed meal test are not established. Thus, the interpretation of the test results is the same as when the tests are done during a spontaneous episode of hypoglycemia or during a 72-hour fast (",
"    <a class=\"graphic graphic_table graphicRef56314 \" href=\"UTD.htm?12/24/12685\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24184?source=see_link&amp;anchor=H13#H13\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\", section on 'Interpretation of data'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An oral glucose tolerance test done in an effort to replicate postprandial symptoms should not be performed because misleading results may be obtained. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Postprandial syndrome'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postprandial (reactive) hypoglycemia is a descriptor of the timing of hypoglycemia (within four hours after meals) and is not a diagnosis per se. When biochemical evidence of postprandial hypoglycemia is confirmed, the cause must be determined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Alimentary hypoglycemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The concept of postprandial hypoglycemia as a consequence of upper gastrointestinal surgery (gastrectomy, gastroenterostomy, or vagotomy and pyloroplasty) had its genesis in the discredited oral glucose tolerance test. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Postprandial syndrome'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Symptoms ascribed to but never confirmed as hypoglycemia have been reported in 5 to 37 percent of patients who have undergone upper gastrointestinal surgery (gastrectomy, gastroenterostomy, or vagotomy and pyloroplasty) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. These symptoms were of the autonomic type and occurred about one to two hours after eating. Among patients who had one of these operations, blood glucose values less than 50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    after oral glucose administration were more common than symptoms considered to be due to hypoglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. These observations should not be construed as a denial of the existence of postprandial hypoglycemia when properly diagnosed.",
"   </p>",
"   <p>",
"    The dumping syndrome should be distinguished from hypoglycemia although it causes similar symptoms. The dumping syndrome occurs early (within one hour after eating), is not associated with hypoglycemia, and is presumed to be caused by contraction of the plasma volume due to fluid shifts into the gastrointestinal tract. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33688?source=see_link&amp;anchor=H12#H12\">",
"     \"Role of surgery in the management of peptic ulcer disease\", section on 'Dumping syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Post-bariatric surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients who have undergone Roux-en-Y gastric bypass as treatment for morbid obesity have experienced postprandial hypoglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/22\">",
"     22",
"    </a>",
"    ]. Patients in the original series were noted to have endogenous hyperinsulinemic hypoglycemia and underwent pancreatic exploration. One patient had multiple insulinomas and the others had islet",
"    <span class=\"nowrap\">",
"     hypertrophy/nesidioblastosis.",
"    </span>",
"    This phenomenon is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44614?source=see_link&amp;anchor=H8#H8\">",
"     \"Noninsulinoma pancreatogenous hypoglycemia syndrome\", section on 'Nesidioblastosis after Roux-en-Y gastric bypass surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Factitious hypoglycemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persons with factitious hypoglycemia from use of insulin or sulfonylurea have symptoms at any time and therefore from time to time may experience postprandial hypoglycemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/32/18951?source=see_link\">",
"     \"Factitious hypoglycemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Insulin autoimmune",
"    </span>",
"    &nbsp;&mdash;&nbsp;Insulin autoimmune hypoglycemia due to spontaneous generation of insulin antibodies is a rare cause of postprandial and sometimes fasting hypoglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/23\">",
"     23",
"    </a>",
"    ]. Insulin secreted in response to a meal binds to the antibody and then (it is proposed) disassociates in an unregulated fashion causing late postprandial hyperinsulinemia and hypoglycemia. In addition to a history of postprandial symptoms, diagnostic clues include evidence of other autoimmune phenomena and very high plasma total insulin concentrations. The finding of circulating antibodies to insulin confirms the diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Noninsulinoma pancreatogenous hypoglycemia syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noninsulinoma pancreatogenous hypoglycemia syndrome is characterized by endogenous hyperinsulinemic hypoglycemia that is not caused by an insulinoma. Pancreatic specimens from such patients show beta cell hypertrophy, islets with enlarged and hyperchromatic nuclei, and increased periductular islets [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/24\">",
"     24",
"    </a>",
"    ]. These histologic findings are characteristic of nesidioblastosis, a term that refers to neoformation of islets of Langerhans from pancreatic duct epithelium.",
"   </p>",
"   <p>",
"    The predominant clinical feature of noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS) is postprandial hypoglycemia, occurring two to four hours after meals. Neuroglycopenic symptoms, including loss of consciousness and generalized seizures, are common. This syndrome is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44614?source=see_link\">",
"     \"Noninsulinoma pancreatogenous hypoglycemia syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several other causes of true postprandial hypoglycemia (",
"    <a class=\"graphic graphic_table graphicRef70726 \" href=\"UTD.htm?4/19/4411\">",
"     table 1",
"    </a>",
"    ). (In each of these, symptoms are neuroglycopenic rather than sympathoadrenal in type.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with insulinoma typically have fasting hypoglycemia but may have postprandial symptoms, sometimes exclusively at this time. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12777?source=see_link\">",
"       \"Insulinoma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Postprandial sympathoadrenal symptoms have been reported in patients with insulin resistance or very mild type 2 diabetes mellitus [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/25\">",
"       25",
"      </a>",
"      ]. However, blood glucose concentrations have rarely been measured during spontaneously occurring symptoms in these patients. The presumed mechanism of early-diabetes hypoglycemia, whose existence is highly doubtful, is a supranormal insulin response to a supranormal rise in plasma glucose after glucose ingestion, followed by an excessively rapid response to the insulin.",
"     </li>",
"     <li>",
"      Ingestion of unripened ackee fruit can cause hypoglycemia in children and adults with chronic malnutrition by inhibiting the transport of long-chain fatty acids into mitochondria, leading to decreased fatty-acid oxidation and gluconeogenesis [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Postprandial hypoglycemia also occurs in children with hereditary fructose intolerance [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In rare patients, hypoglycemia can occur after the ingestion of toxic substances. The intake of large amounts (three drinks or more) of ethanol and simple carbohydrate (gin and tonic) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/28\">",
"       28",
"      </a>",
"      ], but not complex carbohydrates [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/29\">",
"       29",
"      </a>",
"      ], can cause hypoglycemia within three to four hours. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=see_link\">",
"       \"Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Type 1 diabetic patients who have undergone whole organ pancreatic transplantation occasionally report typical but mild insulin reactions postprandially. Biochemical evidence of hypoglycemia is scant [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The acute management of postprandial hypoglycemia is similar to the management of hypoglycemia during the treatment of diabetes. Patients with symptomatic hypoglycemia should ingest carbohydrates. Fifteen to 20 grams of oral glucose is typically sufficient. Glucose may be ingested in the form of tablets, juice, milk, other snacks, or a meal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27641?source=see_link&amp;anchor=H34#H34\">",
"     \"Management of hypoglycemia during treatment of diabetes mellitus\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with a bona fide hypoglycemic disorder leading to postprandial hypoglycemia, long-term treatment is directed to the specific cause. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12777?source=see_link\">",
"     \"Insulinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/12/11461?source=see_link\">",
"     \"Nonislet cell tumor hypoglycemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44614?source=see_link\">",
"     \"Noninsulinoma pancreatogenous hypoglycemia syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/32/18951?source=see_link\">",
"     \"Factitious hypoglycemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with postprandial autonomic symptoms (eg, postprandial syndrome), frequent (every three hours) small meals or snacks, consuming foods high in fiber, avoiding foods high in sugar, and a regular exercise regimen have been recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. There is little or no evidence that any of these dietary changes are beneficial. If dietary modification is not successful in reducing symptoms, some advocate a trial of alpha-glucosidase inhibitors to delay carbohydrate absorption and thereby reduce the insulin response to a meal [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/31\">",
"     31",
"    </a>",
"    ]. However, there are few data to support the efficacy of alpha-glucosidase inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3255/abstract/32-34\">",
"     32-34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basic topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/51/18226?source=see_link\">",
"       \"Patient information: Low blood sugar in people without diabetes (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Postprandial (reactive) hypoglycemia is a descriptor of the timing of hypoglycemia (within four hours after meals) and is not a diagnosis per se. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who have documented hypoglycemia (plasma glucose &lt;50",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [2.8",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      at the time of the postprandial symptoms or have neuroglycopenic symptoms after meals require a comprehensive evaluation for a hypoglycemic disorder. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial evaluation should begin with measurement of plasma glucose obtained by venipuncture during the spontaneous occurrence of symptoms. Patients who have documented biochemical hypoglycemia (plasma glucose &lt;50",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [2.8",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      at the time of the postprandial symptoms or have neuroglycopenic symptoms after meals require a mixed meal test. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are several hypoglycemic disorders that cause predominantly postprandial symptoms (",
"      <a class=\"graphic graphic_table graphicRef70726 \" href=\"UTD.htm?4/19/4411\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Treatment is directed to the specific cause. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12777?source=see_link\">",
"       \"Insulinoma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/12/11461?source=see_link\">",
"       \"Nonislet cell tumor hypoglycemia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44614?source=see_link\">",
"       \"Noninsulinoma pancreatogenous hypoglycemia syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/32/18951?source=see_link\">",
"       \"Factitious hypoglycemia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/1\">",
"      Scheen AJ, Lef&egrave;bvre PJ. [Reactive hypoglycaemia, a mysterious, insidious but non dangerous critical phenomenon]. Rev Med Liege 2004; 59:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/2\">",
"      Brun JF, Fedou C, Mercier J. Postprandial reactive hypoglycemia. Diabetes Metab 2000; 26:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/3\">",
"      Virally ML, Guillausseau PJ. Hypoglycemia in adults. Diabetes Metab 1999; 25:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/4\">",
"      Permutt MA. Postprandiol hypoglycemia. Diabetes 1976; 25:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/5\">",
"      Lev-Ran A, Anderson RW. The diagnosis of postprandial hypoglycemia. Diabetes 1981; 30:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/6\">",
"      Johnson DD, Dorr KE, Swenson WM, Service FJ. Reactive hypoglycemia. JAMA 1980; 243:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/7\">",
"      MCDONALD GW, FISHER GF, BURNHAM C. REPRODUCIBILITY OF THE ORAL GLUCOSE TOLERANCE TEST. Diabetes 1965; 14:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/8\">",
"      Hofeldt FD, Dippe S, Forsham PH. Diagnosis and classification of reactive hypoglycemia based on hormonal changes in response to oral and intravenous glucose administration. Am J Clin Nutr 1972; 25:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/9\">",
"      Chalew SA, McLaughlin JV, Mersey JH, et al. The use of the plasma epinephrine response in the diagnosis of idiopathic postprandial syndrome. JAMA 1984; 251:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/10\">",
"      Hogan, MJ, Service, FJ, Sharbrough, FW, et al. Oral glucose tolerance test compared with a mixed meal in the diagnosis of reactive hypoglycemia: A caveat on stimulation. Mayo Clin Proc 1981; 30:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/11\">",
"      Charles MA, Hofeldt F, Shackelford A, et al. Comparison of oral glucose tolerance tests and mixed meals in patients with apparent idiopathic postabsorptive hypoglycemia: absence of hypoglycemia after meals. Diabetes 1981; 30:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/12\">",
"      Buss RW, Kansal PC, Roddam RF, et al. Mixed meal tolerance test and reactive hypoglycemia. Horm Metab Res 1982; 14:281.",
"     </a>",
"    </li>",
"    <li>",
"     Lefebvre PJ, Andreani D, Marks V. Statement on 'post-prandial' or 'reactive' hypoglycemia. In: Hypoglycemia, Andreani D, Marks V, Lefebvre PJ (Eds), Raven Press, New York 1987. p.79.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/14\">",
"      Snorgaard O, Binder C. Monitoring of blood glucose concentration in subjects with hypoglycaemic symptoms during everyday life. BMJ 1990; 300:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/15\">",
"      Palardy J, Havrankova J, Lepage R, et al. Blood glucose measurements during symptomatic episodes in patients with suspected postprandial hypoglycemia. N Engl J Med 1989; 321:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/16\">",
"      Simpson EJ, Holdsworth M, Macdonald IA. Ambulatory blood glucose measurement, dietary composition and physical activity levels in otherwise healthy women reporting symptoms that they attribute to hypoglycaemia. Br J Nutr 2006; 95:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/17\">",
"      Ford CV, Bray GA, Swerdloff RS. A psychiatric study of patients referred with a diagnosis of hypoglycemia. Am J Psychiatry 1976; 133:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/18\">",
"      Anthony D, Dippe S, Hofeldt FD, et al. Personality disorder and reactive hypoglycemia. A quantitative study. Diabetes 1973; 22:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/19\">",
"      Gilbert, JAL, Dunlap, DM. Hypoglycaemia following partial gastrectomy. BMJ 1947; 2:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/20\">",
"      Leichter SB, Permutt MA. Effect of adrenergic agents on postgastrectomy hypoglycemia. Diabetes 1975; 24:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/21\">",
"      Wiznitzer T, Shapira N, Stadler J, et al. Late hypoglycemia in patients following vagotomy and pyloroplasty. Int Surg 1974; 59:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/22\">",
"      Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005; 353:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/23\">",
"      Basu A, Service FJ, Yu L, et al. Insulin autoimmunity and hypoglycemia in seven white patients. Endocr Pract 2005; 11:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/24\">",
"      Service FJ, Natt N, Thompson GB, et al. Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab 1999; 84:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/25\">",
"      Faludi G, Bendersky G, Gerber P. Functional hypoglycemia in early latent diabetes. Ann N Y Acad Sci 1968; 148:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/26\">",
"      Centers for Disease Control (CDC). Toxic hypoglycemic syndrome--Jamaica, 1989-1991. MMWR Morb Mortal Wkly Rep 1992; 41:53.",
"     </a>",
"    </li>",
"    <li>",
"     Froesch ER. Essential fructosuria and hereditary fructose intolerance. In: The Metabolic Basis of Inherited Disease, Stanbury JB, Wyngaarden JB, Fredrickson DS (Eds), McGraw-Hill, New York 1978. p.121.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/28\">",
"      O'Keefe SJ, Marks V. Lunchtime gin and tonic a cause of reactive hypoglycaemia. Lancet 1977; 1:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/29\">",
"      Joffe BI, Roach L, Baker S, et al. Failure to induce reactive hypoglycaemia by drinking a starch-based alcohol beverage (sorghum beer). Ann Clin Biochem 1981; 18:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/30\">",
"      Shen J, Gaglia J. Hypoglycemia following pancreas transplantation. Curr Diab Rep 2008; 8:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/31\">",
"      Ozgen AG, Hamulu F, Bayraktar F, et al. Long-term treatment with acarbose for the treatment of reactive hypoglycemia. Eat Weight Disord 1998; 3:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/32\">",
"      Lefebvre PJ, Scheen AJ. The use of acarbose in the prevention and treatment of hypoglycaemia. Eur J Clin Invest 1994; 24 Suppl 3:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/33\">",
"      G&eacute;rard J, Luyckx AS, Lef&egrave;bvre PJ. Acarbose in reactive hypoglycemia: a double-blind study. Int J Clin Pharmacol Ther Toxicol 1984; 22:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3255/abstract/34\">",
"      Renard E, Parer-Richard C, Richard JL, et al. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms. Diabete Metab 1991; 17:355.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1769 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-122.72.80.101-1C61674EA5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3255=[""].join("\n");
var outline_f3_11_3255=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Postprandial (reactive) hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Postprandial syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Alimentary hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Post-bariatric surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Factitious hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Insulin autoimmune",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Noninsulinoma pancreatogenous hypoglycemia syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/1769\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/1769|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/7/26750\" title=\"figure 1\">",
"      BG in postprandial hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/1769|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/19/4411\" title=\"table 1\">",
"      Causes postprandial hypogly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/24/12685\" title=\"table 2\">",
"      Interpretation 72 hour fast",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/32/18951?source=related_link\">",
"      Factitious hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24184?source=related_link\">",
"      Hypoglycemia in adults without diabetes mellitus: Diagnostic approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/39/44664?source=related_link\">",
"      Hypoglycemia in adults: Clinical manifestations, definition, and causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/30/12777?source=related_link\">",
"      Insulinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27641?source=related_link\">",
"      Management of hypoglycemia during treatment of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44614?source=related_link\">",
"      Noninsulinoma pancreatogenous hypoglycemia syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/12/11461?source=related_link\">",
"      Nonislet cell tumor hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/51/18226?source=related_link\">",
"      Patient information: Low blood sugar in people without diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29638?source=related_link\">",
"      Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33688?source=related_link\">",
"      Role of surgery in the management of peptic ulcer disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_11_3256="Gastrointestinal stromal tumor CPC Light";
var content_f3_11_3256=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F61000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F61000&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gastrointestinal stromal tumor (GIST)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 375px; height: 507px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Biopsy specimen from a GIST showing two histologic patterns. Part of the tumor (upper panel) is composed of spindle cells with elongated nuclei and eosinophilic cytoplasm. Other portions of the tumor (lower panel) consist of epithelioid cells having round central nuclei within eosinophilic or clear cytoplasm. On immunostaining, the tumor is positive for CD117 (C-kit) and CD34, and negative for the smooth muscle markers actin and desmin and the neuronal marker, S100 protein. This profile is diagnostic of a GIST. CD117 is the marker for the interstitial cells of Cajal, which may be the cell of origin of gut stromal tumors. CD34 is a less specific marker and is not positive in all GISTs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Heather Crowley, MD and Donald Antonioli, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3256=[""].join("\n");
var outline_f3_11_3256=null;
var title_f3_11_3257="Medial collateral ligament injury of the knee";
var content_f3_11_3257=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Medial collateral ligament injury of the knee",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/11/3257/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/11/3257/contributors\">",
"     William W Dexter, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/11/3257/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/11/3257/contributors\">",
"     Karl B Fields, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/11/3257/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/11/3257/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/11/3257/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries of the medial collateral ligament (MCL) occur frequently in athletes, particularly those involved in sports that require sudden changes in direction and speed, and in patients struck on the outside of the knee. Most heal well with conservative treatment, but some are associated with other significant injuries and careful evaluation is needed.",
"   </p>",
"   <p>",
"    The evaluation and management of MCL injuries is reviewed here. A general approach to the patient with knee pain and the management of other types of knee injuries are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=see_link\">",
"     \"Evaluation of the active adult patient with knee pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/24/32138?source=see_link\">",
"     \"Anterior cruciate ligament injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/15/16632?source=see_link\">",
"     \"Meniscal injury of the knee\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to one systematic review, studies of the epidemiology of knee injuries are fraught with problems [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/1\">",
"     1",
"    </a>",
"    ]. Nevertheless, ligament injuries account for up to 40 percent of all knee injuries, and of these, medial collateral ligament (MCL) injuries appear to be the most common [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. MCL tears accounted for 7.9 percent of all injuries in an observational study of 19,530 knee injuries in 17,397 athletes over a ten year period [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/4\">",
"     4",
"    </a>",
"    ]. The precise incidence of MCL injuries is unlikely to ever be known because many low grade injuries go unreported.",
"   </p>",
"   <p>",
"    Given the limitations of the medical literature, it is not possible to determine the exact risk of MCL injury by sport. However, football (ie, soccer) and basketball players appear to have the highest prevalence, and female athletes may be at greater risk [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/1\">",
"     1",
"    </a>",
"    ]. Notable risk factors include prior injury, higher level of play (eg, intercollegiate athletes are at higher risk than secondary school athletes), game participation (versus practice), and type of sport. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Mechanism of injury and healing'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Various other risk factors have been proposed ranging from equipment (eg, ski bindings) to different shoe-surface interfaces, but no definitive data exist to confirm these claims.",
"   </p>",
"   <p>",
"    MCL injuries are often accompanied by damage to other structures. Medial meniscal tears occur in up to 5 percent of MCL injuries, and trauma to other ligaments occurs in 20 to 78 percent of cases, depending upon the severity of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinically important anatomy related to the medial collateral ligament is described here. General anatomy of the knee is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=see_link&amp;anchor=H2#H2\">",
"     \"Evaluation of the active adult patient with knee pain\", section on 'Basic knee anatomy and biomechanics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The medial collateral ligament is part of the capsuloligamentous complex supporting the medial knee. This complex contains static (eg, capsule, ligaments) and dynamic (eg, muscles) structures. The dynamic stabilizers include the vastus medialis, semimembranosus, gracilis, and sartorius muscles (",
"    <a class=\"graphic graphic_figure graphicRef69611 \" href=\"UTD.htm?34/27/35251\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef74251 \" href=\"UTD.htm?5/7/5241\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The MCL is approximately 8 to 10 cm long and shaped like an hour-glass. It originates from the medial femoral condyle anterior to the adductor tubercle and inserts on the anterior medial tibia just distal to the pes anserine on the tibial metaphysis. The MCL is well vascularized and innervated.",
"   </p>",
"   <p>",
"    There are two accepted ways to describe the anatomy of the MCL and the medial knee. The classic description most referenced in the literature is based upon a series of 154 knee dissections [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/6\">",
"     6",
"    </a>",
"    ]. This study describes three layers of anatomy: the first and most superficial is deep sartorial fascia, the second includes the superficial MCL and posterior medial complex ligaments (including the posterior oblique ligament), and the third includes the deep MCL and posterior medial capsule [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The deep MCL and posterior oblique ligaments have attachments to the medial meniscus. Therefore, the MCL and medial meniscus are often injured simultaneously.",
"   </p>",
"   <p>",
"    An alternative description divides the medial structures of the knee into anterior, middle, and posterior thirds. The anterior third includes the capsular ligaments and retinaculum, the middle third includes the superficial and deep MCL, and the posterior third includes the posterior medial complex (including the posterior oblique and popliteal ligaments) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/8\">",
"     8",
"    </a>",
"    ]. A bursa lies between the deep and superficial layers of the MCL.",
"   </p>",
"   <p>",
"    The MCL and related medial structures provide restraint against valgus stress. Due to the orientation of the MCL, its fibers stay fairly isometric throughout knee flexion and extension [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/5\">",
"     5",
"    </a>",
"    ], although this concept remains a source of debate. One researcher describes tightening of the MCL fibers at full extension, thereby increasing resistance to valgus stress [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/8\">",
"     8",
"    </a>",
"    ]. Sectioning studies suggest that the superficial MCL provides the principal restraint to valgus stress with the knee in flexion, but less restraint at full extension.",
"   </p>",
"   <p>",
"    The medial knee structures also provide the primary restraint to external tibial rotation. The deep MCL provides a secondary restraint to such rotation. The anterior crucial ligament also provides a secondary restraint to valgus and rotational stress, particularly in full extension [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY AND HEALING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The MCL is commonly injured (or sprained) in contact and collision sports, as well as sports that require significant twisting and torque of the lower extremity, such as football (ie, soccer), basketball, tennis, and skiing. The ligament may be injured via a direct valgus stress from a blow to the lateral aspect of the knee or via an indirect stress through abduction or rotation of the lower leg. Direct blows typically cause more severe injury [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Injury through an indirect mechanism typically occurs when a shoe catches on a playing surface (eg, cleat catches on turf, sneaker adheres to a court surface) while the athlete is trying to change direction quickly. A similar force is generated when an athlete catches a tip or the inside edge of a ski or skate. This results in a valgus stress at the knee, often with external tibial rotation. The MCL may also be injured if the knee is forced into hyperextension. This can cause injury to multiple ligaments and, sometimes, the peroneal nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MCL injuries heal in classic stages: hemorrhage, inflammation, repair, and remodeling. Scar tissue may form, with the amount of scarring depending upon both the degree and the location of the injury. In animal models, injury to the midsubstance of the MCL seems to demonstrate better healing than injury to the proximal or distal ligament [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of an MCL sprain is based upon the history, clinical presentation, and examination findings and is generally straightforward. The examiner should be alert to other potential injuries, particularly to the anterior cruciate ligament, trauma to which frequently accompanies higher grade MCL tears. Typically, patients' injuries involving multiple ligaments present with significant knee swelling and instability. The diagnosis may be missed if the patient presents several days or weeks after the inciting event. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/24/32138?source=see_link\">",
"     \"Anterior cruciate ligament injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mechanism responsible for MCL sprains can cause injury to static structures in the posterior medial corner of the knee (eg, medial meniscus) and medial muscles, such as the vastus medialis, pes anserine, and semitendinosus [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/15/16632?source=see_link\">",
"     \"Meniscal injury of the knee\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A knee (ie, tibiofemoral) dislocation causes multiple severe ligament injuries, including MCL sprain, and can be limb-threatening. The mechanism usually involves major trauma (eg, motor vehicle collision or high-speed sports) and results in a large hemarthrosis and abnormal knee alignment. Of note, knee dislocations can spontaneously reduce prior to medical evaluation making diagnosis difficult. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38038?source=see_link\">",
"     \"Knee (tibiofemoral) dislocation and reduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other entities to be considered in the differential diagnosis of an MCL sprain include osteoarthritis or rheumatoid arthritis, medial joint compartment arthrosis (which may present with an examination finding of \"pseudo laxity\"), patellar subluxation or dislocation, bony injury to the medial femoral condyle or medial proximal tibia, osteochondritis dissecans, extensor mechanism injury, proximal medial gastrocnemius strain, and distal medial hamstring strain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33287?source=see_link&amp;anchor=H13#H13\">",
"     \"Diagnosis and classification of osteoarthritis\", section on 'Osteoarthritis of the knee'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation of the active adult patient with knee pain\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In younger patients, ligaments exhibit greater tensile strength; therefore, medial physeal injuries must be included in the differential diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28455?source=see_link\">",
"     \"Traumatic causes of acute knee pain and injury in the young athlete\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Overall approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general knee examination is described separately. Aspects of the examination of particular importance for assessment of the medial collateral ligament (MCL) are described below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=see_link&amp;anchor=H30#H30\">",
"     \"Evaluation of the active adult patient with knee pain\", section on 'Examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Examination of an injured knee is best accomplished within 20 or 30 minutes of the injury, before pain, swelling, and muscle spasm make assessment difficult. Often, the examination cannot be performed in this time frame. In some cases, it is best to provide symptomatic treatment and have the patient return for reevaluation once symptoms have subsided.",
"   </p>",
"   <p>",
"    The patient must be relaxed for the knee to be examined properly. This can be accomplished by having the patient concentrate on relaxing their hip muscles, providing adequate support for the injured limb throughout the examination, monitoring tension in the hamstrings, and performing examination maneuvers gently.",
"   </p>",
"   <p>",
"    Examine the knee systematically. Begin with the uninjured knee and compare findings in the uninjured and injured joints.",
"   </p>",
"   <p>",
"    Be sure to look for other injuries that may occur in association with an MCL sprain, particularly those of greater severity. These include injuries to the meniscus, distal femur or proximal tibia, anterior cruciate ligament, posterior oblique ligament, adjacent muscles, and the peroneal nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/9,12\">",
"     9,12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Inspection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observe the patient's stance and gait. Inability to bear weight suggests the presence of a significant injury necessitating imaging. The Ottawa knee rules provide guidance for determining when such imaging is necessary in the setting of minor trauma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=see_link&amp;anchor=H51#H51\">",
"     \"Evaluation of the active adult patient with knee pain\", section on 'Knee trauma and Ottawa knee rule'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The knee should be inspected carefully for swelling, ecchymosis, and deformity. Joint effusions are",
"    <strong>",
"     not",
"    </strong>",
"    common in isolated MCL sprains, particularly with lower grade injuries. More severe MCL sprains often involve concomitant injuries, such as meniscal and anterior cruciate ligament tears, which cause an effusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Palpation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Palpation is important for diagnosing MCL sprain and ruling out associated injuries (eg, avulsion fracture, tibial plateau fracture, and muscle, tendon, or ligament damage). Palpate bony and soft tissues, noting areas of tenderness, warmth, and crepitance.",
"   </p>",
"   <p>",
"    Bony landmarks to palpate include the joint lines (medial, posterior medial corner, posterior, and lateral), femoral condyles, tibial plateau, patella and patellar facets, tibial tubercle, tibial metaphysis, and the pes anserine area.",
"   </p>",
"   <p>",
"    Soft tissues to palpate include the entire length of the MCL as well as the patellar retinaculum, patellar and quadriceps tendons, extensor mechanism, and adjacent muscles, including the gracilis, sartorius, semimembranosus, semitendinosus, medial gastrocnemius, and quadriceps.",
"   </p>",
"   <p>",
"    Although rigorous studies are lacking, joint tenderness in the MCL is reported to be up to 78 percent accurate in diagnosing MCL tears [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/5\">",
"     5",
"    </a>",
"    ]. It is often difficult to distinguish a midsubstance MCL tear from an injury to the medial meniscus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Range of motion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perform range of motion testing using the following sequence: active, passive, and then resisted. The cardinal motions of the knee are flexion and extension. Typical range of motion for the knee ranges from several degrees of recurvatum (ie, past full extension) to 140 degrees of flexion, but actual ranges vary widely among patients. Therefore, it is important to compare the injured and uninjured knees.",
"   </p>",
"   <p>",
"    Assess the knee for its full range of motion, noting the ease with which it moves and any limits to mobility. Also note any pain and where in the arc of knee movement pain occurs.",
"   </p>",
"   <p>",
"    Passive range of motion need not be assessed if active range of motion is full and unrestricted. If active motion is limited, assess passive mobility. While doing so, apply gentle pressure, thereby compressing the knee joint, to determine if a true block to motion exists. A true block suggests the presence of an intraarticular derangement, such as an intraarticular loose body or a torn and displaced meniscus. Pain from an isolated MCL injury can limit active motion, particularly terminal knee extension and flexion beyond 100 degrees, but generally does not constrain passive motion.",
"   </p>",
"   <p>",
"    Resisted motion is performed last with the patient seated and the knee in neutral position (90 degrees of flexion). Note the level of strength and any pain with isometric contraction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Special tests and grade of injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perform a valgus (or abduction) stress test with the knee in both 30 degrees and 0 degrees of flexion looking for joint laxity. Baseline joint laxity varies widely so it is important to compare the injured and uninjured knees.",
"   </p>",
"   <p>",
"    A valgus stress test is performed with the patient supine, the hip in slight flexion and abduction, and the knee slightly flexed. The test can be performed in the following manner. Secure the leg by pinning the patient's ankle or foot between your elbow and the side of your body. Next, place both hands on the patient's proximal lower leg with your fingers over the medial and lateral joint lines. Exert a gentle valgus stress across the knee joint by pushing on the ankle or foot with your elbow, while holding the proximal leg in place with your hands. As you exert this gentle valgus stress, feel how much the medial joint line widens.",
"   </p>",
"   <p>",
"    If the valgus stress test reveals laxity at 30 degrees of flexion, the superficial portion of the MCL may be injured. Laxity at 0 degrees of flexion suggests injury to the deeper structures of the MCL and a possible disruption of the anterior cruciate ligament (ACL), which acts as a secondary restraint to valgus stress. Both the posterior medial corner and posterior oblique ligament may also be damaged when MCL and ACL injuries coexist.",
"   </p>",
"   <p>",
"    The Lachman test is the most reliable examination maneuver for assessing the integrity of the ACL in this setting. A pivot shift test may be inaccurate if a complete tear of the MCL exists. These tests are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/24/32138?source=see_link\">",
"     \"Anterior cruciate ligament injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The degree of joint opening and the presence or absence of a distinct endpoint when performing a valgus stress examination determines the grade of MCL injury:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Grade One",
"      </strong>",
"      &mdash; Less than 5 mm of joint opening accompanied by a solid endpoint represents a Grade 1 (or mild) injury. In such cases, a few fibers are torn but the MCL is structurally intact.",
"     </li>",
"     <li>",
"      <strong>",
"       Grade Two",
"      </strong>",
"      &mdash; Anywhere from 5 to 9 mm of joint opening represents a Grade 2 (or moderate) injury. Usually a firm or perceptible endpoint is present. This suggests an incomplete MCL tear with some remaining ligamentous integrity.",
"     </li>",
"     <li>",
"      <strong>",
"       Grade Three",
"      </strong>",
"      &mdash; 10 mm or more of joint opening with no perceptible endpoint indicates a Grade 3 (or significant) injury. This is a complete tear. In addition, this degree of laxity suggests that other knee ligaments may be injured.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Rotational instability of the tibia can be assessed by externally rotating the foot with one hand, while palpating the joint line with the other [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/13\">",
"     13",
"    </a>",
"    ]. In larger patients, this examination can be performed by leaving the patient's thigh on the table and allowing the knee and foot to drop over the edge. Compare the degree of joint opening to the uninvolved knee.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     IMAGING",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Radiographs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain x-rays are generally not necessary in the evaluation of an isolated MCL injury. However, they can be helpful in certain situations and are indicated in the setting of major trauma. In the skeletally immature patient, plain radiographs enable assessment of the physis.",
"   </p>",
"   <p>",
"    Radiographs should be obtained if the patient is unable to bear weight or if focal bony tenderness, gross deformity, or an effusion is present. The Ottawa knee rules provide guidance for determining when imaging is necessary in the setting of knee trauma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=see_link&amp;anchor=H51#H51\">",
"     \"Evaluation of the active adult patient with knee pain\", section on 'Knee trauma and Ottawa knee rule'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12489?source=see_link\">",
"     \"Radiologic evaluation of the acutely painful knee in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When radiographs are deemed necessary, the following views should be obtained:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Anterior-posterior (AP)",
"     </li>",
"     <li>",
"      Lateral",
"     </li>",
"     <li>",
"      Patellar (45 degree flexion)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In some cases, a tunnel view may be helpful. Stress views can help identify joint opening, particularly in patients with a Grade 3 MCL tear or injuries to multiple knee ligaments (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50190 \" href=\"UTD.htm?6/3/6192\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Pellegrini-Stieda sign is a calcification (usually crescent-shaped) of the MCL at the medial femoral condyle and is associated with chronic injury or insufficiency of the MCL [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/14\">",
"     14",
"    </a>",
"    ]. The calcification may cause focal pain but is not associated with specific clinical findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance imaging (MRI) is seldom necessary to assess minor (ie, isolated) MCL injuries. MRI can be used to define the extent of a severe MCL injury and to look for associated injuries (eg, anterior cruciate ligament tear) if the physical examination is limited or major knee trauma is suspected. MRI is perhaps most useful in assessing a Grade 3 injury, as it can sometimes distinguish the superficial and deep layers of the MCL [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/15\">",
"     15",
"    </a>",
"    ]. This distinction may determine the need for surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRI findings typically include bursal swelling between the deep and superficial layers, subcutaneous soft tissue swelling, and hemorrhage and tearing of MCL fibers. Fiber damage ranges from internal derangement to complete disruption (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69553 \" href=\"UTD.htm?10/61/11219\">",
"     image 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66992 \" href=\"UTD.htm?28/1/28689\">",
"     image 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81676 \" href=\"UTD.htm?26/48/27393\">",
"     image 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61894 \" href=\"UTD.htm?34/25/35219\">",
"     image 5",
"    </a>",
"    ). Other MRI findings may include hemarthrosis, contusion of the lateral femoral condyles or the tibial plateau, meniscal injury, damage to other ligaments, and (rarely) partial avulsion of the medial femoral condyle. Typically, coronal sequences provide the best visualization of the MCL and posterior medial corner [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Various clinical entities that may masquerade as an MCL injury on MRI include bursitis, osteoarthritis, retinaculum injury, and medial meniscus cyst [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preliminary observational studies and anecdotal reports suggest that bedside ultrasound is a useful tool for assessing MCL tears [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/18\">",
"     18",
"    </a>",
"    ]. Ultrasound identifies MCL lesions on the basis of abnormal sonographic appearance and quantitative assessment of joint opening. Larger, more rigorous studies are needed to confirm these preliminary findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR CONSULTATION OR REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical treatment for isolated medial collateral ligament (MCL) injury is rarely necessary. Patients with an isolated MCL injury and significant knee instability that persists despite proper conservative treatment should be referred to an orthopedic surgeon. Otherwise, most experts agree that surgery for MCL repair is indicated only for some patients with major concomitant injuries.",
"   </p>",
"   <p>",
"    Emergent surgical referral is mandatory for any open fracture, neurovascular deficit, or suspected tibiofemoral dislocation. Keep in mind that tibiofemoral dislocations can reduce spontaneously prior to evaluation; suspect the injury in any patient with a highly unstable knee following significant trauma. Patients who have sustained high velocity trauma (eg, automobile accident, downhill skiing at high speed) are best evaluated in the emergency department. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38038?source=see_link\">",
"     \"Knee (tibiofemoral) dislocation and reduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Referral to an orthopedic surgeon is necessary for the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Knee injury involving multiple ligaments (unstable knee).",
"     </li>",
"     <li>",
"      Angulated or displaced fractures.",
"     </li>",
"     <li>",
"      Suspected injury of the posterior medial corner of the knee. These often involve the posterior oblique ligament and possibly other structures (eg, meniscus) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Persistent pain and tenderness along the proximal MCL, which may indicate injury to the ligament&rsquo;s deep fibers [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Such injuries may only be diagnosed with MRI. A clinical sign consistent with this injury is pain or instability (subluxation of the tibia) elicited by pushing the tibial plateau into the distal femur (axial load) while internally rotating the tibia. This maneuver is performed with the patient supine and the hip slightly flexed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Distal MCL injuries. These do not heal as readily as proximal or midsubstance injuries and may result in a \"Stener-type\" lesion, in which one flap of the torn ligament becomes caught within the tibiofemoral joint [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Injuries involving the physis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Multiple studies have demonstrated the success of nonoperative treatment of MCL tears, including complete tears (ie, Grade 3 injury), even in the face of concomitant anterior cruciate ligament (ACL) rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/7,21-24\">",
"     7,21-24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized controlled trial of 47 patients with combined Grade 3 MCL tears and ACL rupture found that operative repair of the MCL provided no benefit over nonoperative treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. Using quantitative instruments (eg, KT-1000 arthrometer) and validated assessment tools, the researchers were unable to identify any significant differences in stability, motion, strength, or return to activities between the two groups.",
"     </li>",
"     <li>",
"      Another randomized trial involving 200 patients reported no difference in outcome among patients with MCL injuries treated operatively or nonoperatively [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, there is always a risk of residual laxity following MCL injury, particularly Grade 2 or Grade 3 tears. One prospective observational study found greater anteroposterior and valgus-varus laxity following surgical repair of the ACL in patients with combined ACL and MCL injuries compared to patients with isolated ACL rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/28\">",
"     28",
"    </a>",
"    ]. However, this increased laxity had no clinical significance.",
"   </p>",
"   <p>",
"    Many experts delay repair of a ruptured ACL until adequate healing of the MCL has been achieved and knee motion is near normal, but controversy persists about the best approach for these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/24/32138?source=see_link\">",
"     \"Anterior cruciate ligament injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial treatment of a medial collateral ligament (MCL) injury consists of the following measures:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Control pain with rest, ice, compression, elevation, and analgesics as needed.",
"     </li>",
"     <li>",
"      Protect the joint from further injury.",
"     </li>",
"     <li>",
"      Obtain appropriate consultation or transfer to the emergency department for knee injuries involving multiple ligaments or major trauma. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Indications for consultation or referral'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Ice can be applied for approximately 20 minutes every two to three hours for two or three days following the injury. Gentle compression with an elastic bandage and protected motion using a brace and crutches are often helpful. Weight bearing is as tolerated. A brief period in a functional or hinged brace is preferable to a straight-leg knee immobilizer because the latter can result in joint stiffness.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     Acetaminophen",
"    </a>",
"    is commonly used for acute pain control and appears to have no adverse effect upon healing [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/32\">",
"     32",
"    </a>",
"    ]. Nonsteroidal anti-inflammatory drugs (NSAIDs) are frequently used for analgesia following an acute MCL injury. While NSAIDs provide effective short-term pain relief, their effect on ligament and bone healing remains unclear. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=see_link&amp;anchor=H24#H24\">",
"     \"Nonselective NSAIDs: Overview of adverse effects\", section on 'Possible effect on tendon injury'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The goals of early treatment of any ligament injury are to regain mobility and function while protecting the injured joint. This enables the patient to return to activity as rapidly and as safely as possible.",
"   </p>",
"   <p>",
"    Animal models have demonstrated weaker ligament healing and poorer outcomes in immobilized joints and clinical trials support this finding [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/10\">",
"     10",
"    </a>",
"    ]. Casting and surgery, once the standard approach to MCL treatment, provide no benefit. Observational data and clinical studies of rehabilitation of ligamentous injuries of the ankle demonstrate that early motion improves ligament healing and strength. Thus, early mobilization has become a fundamental principle of care [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/3\">",
"     3",
"    </a>",
"    ]. Temporary bracing may be needed to support unstable joints during ambulation, but prolonged immobilization of any type is to be avoided in MCL injuries of all grades.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     FOLLOW-UP AND REHABILITATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial examination of the medial collateral ligament (MCL), particularly if the patient presents several days after the injury, may be limited by swelling and pain. In such cases, we generally reexamine the patient within one week to determine the presence of associated injuries and the need for further imaging, referral, or bracing, and to begin the rehabilitation process.",
"   </p>",
"   <p>",
"    It may be best to have the patient evaluated in the emergency department if the injury involved a high velocity mechanism (eg, automobile accident, downhill skiing at high speed) or tibiofemoral dislocation may have occurred. The timing of subsequent follow-up appointments is dictated by the severity of the injury, use of bracing, and the patient's recovery. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Indications for consultation or referral'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In general, early joint motion is a central concept of rehabilitation and is encouraged in patients with an MCL injury. Weight bearing and activity are advanced as tolerated by the patient.",
"   </p>",
"   <p>",
"    If bracing is necessary, usually for pain relief, a hinged knee brace is best. Brace settings should allow for as much flexion as the patient can tolerate but should prevent full extension. Typically, the extension stop is set at 10 to 20 degrees of flexion. If the knee has a valgus deformity, more extensive bracing may be needed to mitigate valgus forces across the injured ligament. More extensive bracing entails using a brace that extends further (both proximally on the thigh and distally on the leg) and wearing it more often.",
"   </p>",
"   <p>",
"    Rehabilitation of an MCL injury is similar to other musculoskeletal injuries. The first goal is to restore active range of motion. Next, a gradual progression of exercises is used to improve strength, proprioception, agility, and general fitness. Finally, athletes perform sports-specific activities and return to play. This approach is sometimes referred to as functional rehabilitation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A typical progression of strengthening exercises for the MCL-injured knee begins with isometric quadriceps contractions and progresses to isotonic exercises through a short arc (eg, quarter squat). Gradually, the range of motion and resistance for these exercises is increased.",
"     </li>",
"     <li>",
"      The progression of general activity begins with walking, moves to jogging as tolerated, then progresses to three-quarters speed, then straight ahead sprinting, then to movement in multiple directions (sprinting with curves to figure 8 running to side-to-side bounding), and finally to sports specific drills and return to competition.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While these general principles can easily be taught in the office, the guidance of a physical therapist, athletic trainer, or other knowledgeable professional is often useful.",
"   </p>",
"   <p>",
"    Multiple prospective observational studies attest to the effectiveness and decreased morbidity (primarily decreased range of motion) of this approach to rehabilitation for isolated MCL injuries when compared to surgical repair or immobilization [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lateral hinged braces and functional rehabilitation were used as part of the treatment protocol for American football players with severe (Grade 3) MCL injuries [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/33\">",
"       33",
"      </a>",
"      ]. Follow-up over several years showed results comparable to those achieved with surgery or immobilization but with less morbidity and faster return to sports.",
"     </li>",
"     <li>",
"      In another study, 38 individuals with isolated, partial MCL injuries treated nonoperatively were followed for 10 years and had good functional outcomes using a validated assessment tool (Lysholm scale) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 40 matched patients, those with isolated MCL injuries treated nonoperatively achieved high functional scores at 10 year follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The evidence for adjunct treatment modalities such as ultrasound, laser, electrical stimulation, and glucocorticoid injection is limited and based primarily upon animal models [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/10,36-39\">",
"     10,36-39",
"    </a>",
"    ]. Given the success of functional rehabilitation, adjunct treatments are seldom needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of minor (Grade 1) MCL injuries rarely occur. In more severe injuries (Grade 2 or 3), instability can persist and may limit knee function and sports participation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with any ligamentous injury, MCL tears of any grade may cause some residual pain. In rare instances, this may lead to a complex regional pain syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32344?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of complex regional pain syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/62/6122?source=see_link\">",
"     \"Prevention and management of complex regional pain syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recurrence of injury is probably the most significant complication of an MCL tear. While the incidence of recurrence is unknown, the risk is greater for higher grade injuries. In a small series of patients with isolated Grade 3 MCL injuries, the incidence was reported to be 23 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Scarring and adhesions within the joint (ie, arthrofibrosis) most likely occur from excessive joint immobilization [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     RETURN TO SPORT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Timing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Return to sports or heavy activity following an isolated MCL injury is generally accomplished quickly and safely, although there is no high quality evidence to determine the optimal recovery period. The appropriate time to resume activity varies and is dictated by when the patient regains full motion, strength, and the ability to perform necessary sports or work-specific tasks. This, in turn, depends upon the patient's preinjury level of function and the severity of the injury. Typically, return to full activity can be achieved within three to six weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Prophylactic bracing",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of a prophylactic knee brace to prevent injury or reinjury to the MCL is controversial. A review of the studies on bracing found mixed results [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/3\">",
"     3",
"    </a>",
"    ]. The authors commented that braces may create a mechanical disadvantage in some instances. A prospective observational study of 987 college American football players with a total of 155,772 exposures found a nonsignificant trend toward MCL injury prevention overall in those using a brace [",
"    <a class=\"abstract\" href=\"UTD.htm?3/11/3257/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. However, the risk was increased among backfield players using braces.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/36/7747?source=see_link\">",
"       \"Patient information: Knee pain (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/4/24642?source=see_link\">",
"       \"Patient information: Knee pain (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Medial collateral ligament (MCL) injury is among the most common athletic knee injuries. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The MCL provides the primary restraint to valgus motion and external tibial rotation of the knee. The MCL is injured most often through a direct valgus stress from a blow to the lateral aspect of the knee or through an indirect stress through abduction or rotation of the lower leg. Direct blows typically cause more severe injury. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Anatomy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Mechanism of injury and healing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MCL injuries are categorized by grade: a Grade 1 injury is minor and stable; a Grade 2 injury is a partial tear and demonstrates some instability; a Grade 3 injury is a complete tear and creates gross instability. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Special tests and grade of injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While the MCL is often injured in isolation, concomitant injury to the anterior cruciate ligament, meniscus, and posterior medial corner must be excluded. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MCL injury can be diagnosed by a thorough history and physical examination alone in most cases. Imaging, including plain radiographs, stress x-rays, and possibly MRI, is used most often to exclude concomitant injury. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that isolated MCL injuries be treated nonoperatively with functional rehabilitation (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Surgery is indicated only for injuries refractory to rigorous conservative treatment and those with gross knee instability or multiple ligamentous injuries. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Indications for consultation or referral'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Functional or hinged bracing may be helpful early during rehabilitation, particularly for unstable injuries. However, the knee should not be fully immobilized at any time. Benefit from prophylactic bracing remains unproven. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Follow-up and rehabilitation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Prophylactic bracing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Functional rehabilitation involves a gradual progression of exercises to improve range of motion and strength. Rehabilitation of MCL injuries can often be completed quickly, with athletes returning to play within a few weeks, depending upon the severity of injury. The long-term prognosis for all grades of MCL injury is excellent. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Follow-up and rehabilitation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Return to sport'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/1\">",
"      Louw QA, Manilall J, Grimmer KA. Epidemiology of knee injuries among adolescents: a systematic review. Br J Sports Med 2008; 42:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/2\">",
"      Bollen S. Epidemiology of knee injuries: diagnosis and triage. Br J Sports Med 2000; 34:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/3\">",
"      Wilk, KE, Andrews, JR, Clancy, WG. Nonoperative and postoperative rehabilitation of the collateral ligaments of the knee. Op Tech Sports Med 1996; 4:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/4\">",
"      Majewski M, Susanne H, Klaus S. Epidemiology of athletic knee injuries: A 10-year study. Knee 2006; 13:184.",
"     </a>",
"    </li>",
"    <li>",
"     Indelicato, P, Linton, R. In: DeLee and Drez Orthopaedic Sports Medicine, DeLee, J, Drez, D, Miller, M (Eds), Saunders, Philadelphia 2003. p.1937.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/6\">",
"      Warren LF, Marshall JL. The supporting structures and layers on the medial side of the knee: an anatomical analysis. J Bone Joint Surg Am 1979; 61:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/7\">",
"      Fanelli GC, Harris JD. Surgical treatment of acute medial collateral ligament and posteromedial corner injuries of the knee. Sports Med Arthrosc 2006; 14:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/8\">",
"      Satterwhite, Y. The anatomy and biomechanics of the medial structures of the knee. Op Tech Sports Med 1996; 4:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/9\">",
"      Takagi T, Nakao Y, Takayama S, Toyama Y. Traction injury of common peroneal nerve associated with multiple ligamentous rupture of the knee: a case report. Microsurgery 2002; 22:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/10\">",
"      Creighton, RA, Spang, JT, Dahners, LE. Basic Science of Ligament Healing: Medial Collateral Ligament Healing With and Without Treatment. Sports Med Arthrosc 2005; 13:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/11\">",
"      Sims WF, Jacobson KE. The posteromedial corner of the knee: medial-sided injury patterns revisited. Am J Sports Med 2004; 32:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/12\">",
"      Shepherd L, Abdollahi K, Lee J, Vangsness CT Jr. The prevalence of soft tissue injuries in nonoperative tibial plateau fractures as determined by magnetic resonance imaging. J Orthop Trauma 2002; 16:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/13\">",
"      Kurzweil PR, Kelley ST. Physical examination and imaging of the medial collateral ligament and posteromedial corner of the knee. Sports Med Arthrosc 2006; 14:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/14\">",
"      Wang JC, Shapiro MS. Pellegrini-Stieda syndrome. Am J Orthop (Belle Mead NJ) 1995; 24:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/15\">",
"      Nakamura N, Horibe S, Toritsuka Y, et al. Acute grade III medial collateral ligament injury of the knee associated with anterior cruciate ligament tear. The usefulness of magnetic resonance imaging in determining a treatment regimen. Am J Sports Med 2003; 31:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/16\">",
"      Jones L, Bismil Q, Alyas F, et al. Persistent symptoms following non operative management in low grade MCL injury of the knee - The role of the deep MCL. Knee 2009; 16:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/17\">",
"      De Maeseneer M, Shahabpour M, Pouders C. MRI spectrum of medial collateral ligament injuries and pitfalls in diagnosis. JBR-BTR 2010; 93:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/18\">",
"      Lee JI, Song IS, Jung YB, et al. Medial collateral ligament injuries of the knee: ultrasonographic findings. J Ultrasound Med 1996; 15:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/19\">",
"      Narvani A, Mahmud T, Lavelle J, Williams A. Injury to the proximal deep medial collateral ligament: a problematical subgroup of injuries. J Bone Joint Surg Br 2010; 92:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/20\">",
"      Azar FM. Evaluation and treatment of chronic medial collateral ligament injuries of the knee. Sports Med Arthrosc 2006; 14:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/21\">",
"      Shelbourne KD, Patel DV. Management of combined injuries of the anterior cruciate and medial collateral ligaments. Instr Course Lect 1996; 45:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/22\">",
"      Marx RG. Operative and nonoperative treatments of medial collateral ligament rupture were not different in combined medial collateral and anterior cruciate ligament rupture. J Bone Joint Surg Am 2007; 89:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/23\">",
"      Millett PJ, Pennock AT, Sterett WI, Steadman JR. Early ACL reconstruction in combined ACL-MCL injuries. J Knee Surg 2004; 17:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/24\">",
"      Zaffagnini S, Bonanzinga T, Marcheggiani Muccioli GM, et al. Does chronic medial collateral ligament laxity influence the outcome of anterior cruciate ligament reconstruction?: a prospective evaluation with a minimum three-year follow-up. J Bone Joint Surg Br 2011; 93:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/25\">",
"      Halinen J, Lindahl J, Hirvensalo E, Santavirta S. Operative and nonoperative treatments of medial collateral ligament rupture with early anterior cruciate ligament reconstruction: a prospective randomized study. Am J Sports Med 2006; 34:1134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/26\">",
"      Halinen J, Lindahl J, Hirvensalo E. Range of motion and quadriceps muscle power after early surgical treatment of acute combined anterior cruciate and grade-III medial collateral ligament injuries. A prospective randomized study. J Bone Joint Surg Am 2009; 91:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/27\">",
"      Sandberg R, Balkfors B, Nilsson B, Westlin N. Operative versus non-operative treatment of recent injuries to the ligaments of the knee. A prospective randomized study. J Bone Joint Surg Am 1987; 69:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/28\">",
"      Zaffagnini S, Bignozzi S, Martelli S, et al. Does ACL reconstruction restore knee stability in combined lesions?: An in vivo study. Clin Orthop Relat Res 2007; 454:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/29\">",
"      Papalia R, Osti L, Del Buono A, et al. Management of combined ACL-MCL tears: a systematic review. Br Med Bull 2010; 93:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/30\">",
"      Osti L, Papalia R, Del Buono A, et al. Simultaneous surgical management of chronic grade-2 valgus instability of the knee and anterior cruciate ligament deficiency in athletes. Knee Surg Sports Traumatol Arthrosc 2010; 18:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/31\">",
"      Miyamoto RG, Bosco JA, Sherman OH. Treatment of medial collateral ligament injuries. J Am Acad Orthop Surg 2009; 17:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/32\">",
"      Hanson CA, Weinhold PS, Afshari HM, Dahners LE. The effect of analgesic agents on the healing rat medial collateral ligament. Am J Sports Med 2005; 33:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/33\">",
"      Reider B, Sathy MR, Talkington J, et al. Treatment of isolated medial collateral ligament injuries in athletes with early functional rehabilitation. A five-year follow-up study. Am J Sports Med 1994; 22:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/34\">",
"      Lundberg M, Messner K. Long-term prognosis of isolated partial medial collateral ligament ruptures. A ten-year clinical and radiographic evaluation of a prospectively observed group of patients. Am J Sports Med 1996; 24:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/35\">",
"      Lundberg M, Messner K. Ten-year prognosis of isolated and combined medial collateral ligament ruptures. A matched comparison in 40 patients using clinical and radiographic evaluations. Am J Sports Med 1997; 25:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/36\">",
"      Sparrow KJ, Finucane SD, Owen JR, Wayne JS. The effects of low-intensity ultrasound on medial collateral ligament healing in the rabbit model. Am J Sports Med 2005; 33:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/37\">",
"      Warden SJ, Avin KG, Beck EM, et al. Low-intensity pulsed ultrasound accelerates and a nonsteroidal anti-inflammatory drug delays knee ligament healing. Am J Sports Med 2006; 34:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/38\">",
"      Walsh WR, Wiggins ME, Fadale PD, Ehrlich MG. Effects of a delayed steroid injection on ligament healing using a rabbit medial collateral ligament model. Biomaterials 1995; 16:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/39\">",
"      Carmeli, E, Beer, Y, Halperin, N, et al. Medial collateral ligament repair following complete ligament transaction: an experimental study in rabbits. Biology of Sport 2004; 21:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/40\">",
"      Edson CJ. Conservative and postoperative rehabilitation of isolated and combined injuries of the medial collateral ligament. Sports Med Arthrosc 2006; 14:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/41\">",
"      Albright JP, Powell JW, Smith W, et al. Medial collateral ligament knee sprains in college football. Effectiveness of preventive braces. Am J Sports Med 1994; 22:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/11/3257/abstract/42\">",
"      Albright JP, Powell JW, Smith W, et al. Medial collateral ligament knee sprains in college football. Brace wear preferences and injury risk. Am J Sports Med 1994; 22:2.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 206 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-85.214.214.87-D5DBC4741A-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3257=[""].join("\n");
var outline_f3_11_3257=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MECHANISM OF INJURY AND HEALING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Overall approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Inspection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Palpation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Range of motion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Special tests and grade of injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      IMAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Radiographs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      INDICATIONS FOR CONSULTATION OR REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      INITIAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      FOLLOW-UP AND REHABILITATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      RETURN TO SPORT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Timing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Prophylactic bracing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/206\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/206|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/3/6192\" title=\"diagnostic image 1\">",
"      Knee MCL stress XR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/61/11219\" title=\"diagnostic image 2\">",
"      MCL normal MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/1/28689\" title=\"diagnostic image 3\">",
"      MCL grade1 injury MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/48/27393\" title=\"diagnostic image 4\">",
"      MCL grade2 injury MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/25/35219\" title=\"diagnostic image 5\">",
"      MCL grade3 injury MRI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/206|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/27/35251\" title=\"figure 1\">",
"      Anterior anatomy of knee",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/7/5241\" title=\"figure 2\">",
"      Knee ligaments",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/24/32138?source=related_link\">",
"      Anterior cruciate ligament injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33287?source=related_link\">",
"      Diagnosis and classification of osteoarthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32344?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of complex regional pain syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=related_link\">",
"      Evaluation of the active adult patient with knee pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38038?source=related_link\">",
"      Knee (tibiofemoral) dislocation and reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/15/16632?source=related_link\">",
"      Meniscal injury of the knee",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=related_link\">",
"      Nonselective NSAIDs: Overview of adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/4/24642?source=related_link\">",
"      Patient information: Knee pain (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/36/7747?source=related_link\">",
"      Patient information: Knee pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/62/6122?source=related_link\">",
"      Prevention and management of complex regional pain syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12489?source=related_link\">",
"      Radiologic evaluation of the acutely painful knee in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28455?source=related_link\">",
"      Traumatic causes of acute knee pain and injury in the young athlete",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_11_3258="Spitz histo";
var content_f3_11_3258=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Histologic features of Spitz nevus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histologically, Spitz nevus presents as&nbsp;a symmetric, well circumscribed, dome-shaped compound melanocytic nevus. The epidermis is acanthotic with vertical orientation of melanocytic nests.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3258=[""].join("\n");
var outline_f3_11_3258=null;
var title_f3_11_3259="Cond assoc increased CA 19-9";
var content_f3_11_3259=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F52557&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F52557&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Conditions associated with increased serum levels of the tumor marker CA 19-9",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Malignant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pancreatic exocrine and neuroendocrine cancers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Biliary cancer (gallbladder, cholangiocarcinoma, ampullary cancers)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatocellular cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastric, ovarian, colorectal cancer (less often)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lung, breast, uterine cancer (rare)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Benign",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute cholangitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cirrhosis and other cholestatic diseases (including gallstones)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3259=[""].join("\n");
var outline_f3_11_3259=null;
var title_f3_11_3260="Evaluation of an infant or child with constipation";
var content_f3_11_3260=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F79830&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F79830&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Evaluation of an infant or child with constipation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        History",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Delayed passage of meconium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Preceding acute diarrheal illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Painful defecation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blood on stool",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Problems with toilet training",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dietary issues",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Family history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Physical examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mass in suprapubic area",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abdominal distention",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anal fissure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Soiled underwear",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anal sphincter tone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Size of rectal vault",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Impacted stool (hard or soft)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lower back skin defects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Laboratory (not necessary in all cases)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Complete blood count",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thyroid tests (only in unclear cases)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Test for celiac disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Barium enema",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anorectal manometry",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rectal biopsy - suction or surgical full-thickness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Motility studies",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3260=[""].join("\n");
var outline_f3_11_3260=null;
var title_f3_11_3261="Meds that worsen UI";
var content_f3_11_3261=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F80413&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F80413&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Medications that may cause or worsen urinary incontinence",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Medication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect on continence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alcohol",
"       </td>",
"       <td>",
"        Frequency, urgency, sedation, delirium, immobility",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &alpha;-Adrenergic agonists",
"       </td>",
"       <td>",
"        Outlet obstruction (men)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &alpha;-Adrenergic blockers",
"       </td>",
"       <td>",
"        Stress leakage (women)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Angiotensin-converting enzyme inhibitors",
"       </td>",
"       <td>",
"        Associated cough worsens stress and possibly urge leakage in persons with impaired sphincter function",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anticholinergics",
"       </td>",
"       <td>",
"        Impaired emptying, retention, delirium, sedation, constipation, fecal impaction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Antipsychotics",
"       </td>",
"       <td>",
"        Anticholinergic effects plus rigidity and immobility",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calcium channel blockers",
"       </td>",
"       <td>",
"        Impaired detrusor contractility and retention; the dihydropyridine agents can cause pedal edema, leading to nocturnal polyuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Estrogen",
"       </td>",
"       <td>",
"        Worsens stress and mixed leakage in women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GABAnergic agents (gabapentin, pregablin)",
"       </td>",
"       <td>",
"        Pedal edema causing nocturia and nighttime incontinence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Latanoprost",
"       </td>",
"       <td>",
"        Urge incontinence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Loop diuretics",
"       </td>",
"       <td>",
"        Polyuria, frequency, urgency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Narcotic analgesics",
"       </td>",
"       <td>",
"        Urinary retention, fecal impaction, sedation, delirium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nonsteroidal anti-inflammatory drugs",
"       </td>",
"       <td>",
"        Pedal edema causing nocturnal polyuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oral contraceptives",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        Stress, urge, and mixed incontinence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sedative hypnotics",
"       </td>",
"       <td>",
"        Sedation, delirium, immobility",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thiazolidinediones",
"       </td>",
"       <td>",
"        Pedal edema causing nocturnal polyuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tricylic antidepressants",
"       </td>",
"       <td>",
"        Anticholinergic effects, sedation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cholinesterase inhibitors",
"       </td>",
"       <td>",
"        Alone may increase incontinence; increased functional impairment when combined with antiincontinence antimuscarinic agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Beta blockers",
"       </td>",
"       <td>",
"        Urge incontinence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Opioid analgesics",
"       </td>",
"       <td>",
"        Sedation, anticholinergic effects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Histamine 1 receptor antagonists",
"       </td>",
"       <td>",
"        Confusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lithium",
"       </td>",
"       <td>",
"        Polyuria",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reference:",
"     <br>",
"      <ol>",
"       <li>",
"        Townsend MK, Curhan GC, Resnick NM, Grodstein F. Oral contraceptive use and incident urinary incontinence in premenopausal women. J Urol 2009; 181:2170.",
"       </li>",
"      </ol>",
"      <br>",
"       Reprinted with permission: DuBeau CE. Urinary Incontinence. In: Pompei P, Murphy JB, eds. Geriatrics Review Syllabus: A Core Curriculum in Geriatric Medicine, 6th ed. New York, NY: American Geriatrics Society; 2006: 185. Table based on data from Resnick NM. Geriatric medicine. In: Principles of Internal Medicine, Isselbacher JK, Braunwald E, Wilson JD, et al (Eds), McGraw-Hill, New York 1994. p.34.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3261=[""].join("\n");
var outline_f3_11_3261=null;
var title_f3_11_3262="Intrauterine pressure in dysmenorrhea with and without NSAIDs";
var content_f3_11_3262=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F59146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F59146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 495px\">",
"   <div class=\"ttl\">",
"    Intrauterine pressure in dysmenorrhea with and without NSAID therapy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 475px; height: 276px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In women with primary dysmenorrhea, treatment with meclofenamate produces a decrease in mean intrauterine pressure as recorded by an intrauterine microtransducer (blue line). Placebo treatment did not decrease intrauterine pressure (red line). A reduction in intrauterine pressure was associated with a decrease in reported dysmenorrhea.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data adapted from: Smith, RP, the dynamics of nonsteroidal anti-inflammatory therapy for primary dysmenorrhea. Obstet Gynecol 1987; 70:785.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3262=[""].join("\n");
var outline_f3_11_3262=null;
var title_f3_11_3263="ARDS mortality trend";
var content_f3_11_3263=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F83656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F83656&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 635px\">",
"   <div class=\"ttl\">",
"    ARDS mortality from 1981 to 2006",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 615px; height: 285px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Annual pooled weighted mortality from 1981 to 2006 for all included studies, by year of conduct. The solid points show data for observational studies; the open points show data for randomized controlled trials. Upper and lower confidence intervals are shown for observational studies and randomized controlled trials, respectively. Interpolation lines are included to facilitate visual interpretation and do not indicate trends between point estimates.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission of the American Thoracic Society. Copyright &copy; 2012 American Thoracic Society. Phua J, Badia JR, Adhikari NK, et al, 2009. Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. American Journal of Respiratory and Critical Care Medicine; 179:220. Official journal of the American Thoracic Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_11_3263=[""].join("\n");
var outline_f3_11_3263=null;
